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Abstract!
The! effect! of! stimulation!with! TSLP! and!KRN7000! on! iNKT! cell! proliferation! and!cytokine!production!(S!Salman)!!iNKT! cells! are! small! subset! of! T! lymphocytes! that! bridge! innate! and! adaptive!immunity.! They! have! the! ability! to! secrete! large! amount! of! cytokines! upon!stimulation!with! their! glycolipid! ligand! such! as!αGalactosylceramide!or!KRN7000!and!therefore!skew!the! immune!response! towards!Th1,!Th2!or!Th17.!When! in!an!inflammatory!or!infectious!environment!they!are!also!targets!for!signals!from!other!cells! that! are! involved! in! the! immune! response.! Thymic! stromal! lymphopoietin!(TSLP)! is!a! cytokine! that! is!produced!by!epithelial! cells! in!allergic!diseases!and! it!promotes!Th2!responses.!!The!hypothesis!proposed!here! is! that!TSLP!may!affect! iNKT!cells!directly! through!TSLPr!that!may!be!expressed!by!these!cells!and!induce!Th2!type!cytokines!such!as!IL^4!and!IL^13.!Also!the!notion!that!the!addition!of!TSLP!to!iNKT!cell!cultures!with!KRN7000! may! stimulate! these! cells! and! result! in! increased! proliferation! and!cytokine!production.!!!The!first!approach!to! investigate!the!hypothesis!was!to!optimise!the!experimental!parameters! such!as! the!best! glycolipid! ligand!with! the!optimal! concentration!and!the!optimal!time!point.!After!that!the!expression!of!some!markers!was!investigated,!especially!TSLPr,!both!at!day!0!and!after!14!days!stimulation.!Finally! the!effect!of!adding!TSLP!to!KRN7000!on!iNKT!cells!(proliferation!and!cytokine!production)!in!PBMC! mixed! culture! and! on! enriched! iNKT! cells! and! iNKT! cell! lines! was!investigated.!!The!results!of! this!work!demonstrated! that! iNKT!cells!express!TSLPr,!which! is!up!regulated!after!stimulation!with!KRN7000!for!14!days.!Furthermore,!the!addition!of!TSLP! to! KRN7000! in! iNKT! cells! in! PBMC! cultures! significantly! increased! their!proliferation! in! the! two! healthy! donor! groups,! high! and! low! responders.! It! also!
!!
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increased!IFN^γ!production!in!both!groups,!and!IL^13!and!IL^17!production!in!high!responders.!The!cytokine!production!source!was!further!confirmed!to!be!from!iNKT!cells!after!enriching!these!cells!and!after!using!iNKT!cell!lines.!!!In! summary,! TSLP! and! KRN7000! stimulate! healthy! human! iNKT! cells! and!significantly!increase!their!proliferation!and!cytokine!production.!!!!!!
! !
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Chapter!1:!Introduction!
INKT! cells! are! a! unique! population! of! lymphocytes! which! express! receptors!characteristic! of! both! natural! killer! cells! and! T! lymphocytes.! Present! ! in! human!blood!!at!a!low!frequency,!0.1^1%!of!total!lymphocytes,!these!cells!are!also!found!in!organs! such! as! liver! and! lungs! and! at! epithelial! surfaces.! Capable! of! producing!copious!amounts!of!regulatory!cytokines!in!a!short!period!of!time,!they!are!thought!to!be!of!particular! importance!as! a!bridge!between! ! innate! and!adaptive! immune!systems! and! to! be! able! to! recognise! glycolipid! antigens.! Despite! a! potentially!important! role! at! the! interface! between! innate! and! adaptive! immunity! how! they!recognise! and! respond! to! antigen! or! may! influence! development! of! adaptive!immune! responses! is! poorly! understood.! The! work! in! this! thesis! focuses! on! the!response! of! iNKT! cells! in.vitro! to! glycolipid! stimulation! both! in! the! presence! and!absence!of! an! allergy! related! cytokine! thymic! stromal! lymphopoetin! (TSLP),! ! and!how! initial! activation! of! these! cells!may! influence! the! latter! ! pattern! of! cytokine!production.! Here! the! frequency! of! iNKT! cells! in! blood! of! healthy! volunteers!was!first!investigated.!Then!their!response!to!different!glycolipid!ligands!was!examined!including! ! determining! the! optimal! time! point! and! concentration! of! ligand! that!achieved!the!best! iNKT!cell!proliferation.!This!was!followed!by! investigating! iNKT!cell! phenotype! and! surface! marker! expression! on! stimulation,! including! TSLP!receptor! expression.! Finally! the! effect! of! TSLP! on! iNKT! cell! proliferation! and!cytokine!production! (particularly!Th2! type!cytokines! such!as! IL^4!and! IL^13)!was!examined!in!both.!!
1.1!Innate!immune!response!The! immune! system! plays! an! important! role! in! protecting! an! individual! from!infection.!The!work!described!in!this!thesis!focuses!on!the!role!of!iNKT!cells!in!the!immune!response!and!how!they!may!recognise!antigen!and!respond!to!it.!!!The! key! feature! of! the! innate! immune! response! is! rapid! reaction! to! intruding!pathogens!and!failure!to!develop!an!efficient!innate!immune!response!may!lead!to!
!!
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fatal!infections!as!has!been!demonstrated!in!murine!and!human!gene!defect!studies!(1,2)! .!Other!key!features!of!the!innate!immune!response!are!cytotoxic!cells!such!as!NK! cells,! active! especially! in! viral! infections.! These! cells! ! respond! quickly! after!initial!exposure!through!expansion!and!immediate!effector!function,!cytotoxicity,!is!!mediated!by!release!of!perforin!and!the!production!of!cytokines!such!as!IFN^γ!and!TNF^α!(3)!.!!There! are! many! different! routes! for! pathogenic! microbes! to! invade! the! body.!Various! barriers! in! the! body! are! there! to! protect! against! external! invasion! and!infection!this!include!mechanical,!chemical!and!biological!(4)!.!!The! first!encounter! for!microorganisms! is! the!epithelial!barrier!of! the!skin,!upper!respiratory!tract,!gastrointestinal!and!genitourinary!tracts.!!Then!after!entering!the!respiratory!tract!for!example,!pathogens!maybe!mechanically!removed!by!means!of!coughing! and! sneezing.! Also,! the! respiratory! and! gastrointestinal! tracts! secrete!mucosal!substances!to!trap!the!invading!agents!(5)!.!!Biological! barriers! protect! the! host! from! intruding! agents! and! pathogens! are! not!just!mediated!by!a!physical!barrier!but!also!chemically.!For!example,!antimicrobial!peptides!such!as!β^defensin!protein!(6)!produced!by!mucosal!epithelial!cells!and!are!active!against!a!wide!range!of!pathogens!by!direct!anti^microorganism!effects!(7)!.!!!!Finally,! the! chemical! barrier!may! eliminate!microorganisms!by! altering! the!pH!of!invasion!site!or!limiting!the!nutritional!resources!such!as!availability!of!iron!(4)!.!!!The! broad! range! of! cells! involved! in! the! innate! immune! response! includes!monocytes,! macrophages,! neutrophils,! basophils,! mast! cells,! eosinophil,! dendritic!cells! (DC),! natural! killer! cells! (NK! cells),! and! natural! killer! T! cells! (NKT! cells).!Among! these,! NK! and! NKT! cells! are! generated! from! lymphoid! progenitor! cells;!whereas! monocytes,! macrophages,! neutrophils,! basophils,! mast! cells,! eosinophil!and!dendritic!cells!are!generated!from!myeloid!progenitor!cells!(2)!.!!
!!
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These! cells! express!pattern! recognition! receptors! (PRRs),! a!portfolio!of! receptors!that! allow! recognition! of! foreign! components! that! are! distinctive! to! invading!pathogens.! PPRs! include! TLR! 1^9,! mannose! receptor! and! the! scavenger! receptor!which!recognise!molecular!patterns!present!on!foreign!pathogens!namely!pathogen!associated!molecular! patterns! (PAMPs)! such! as! LPS! on! a! bacterial!wall.! TLR!may!recognise!intracellular!features!such!as!motifs!on!DNA!(TLR!9!and!the!CpG!motif!of!oligodeoxynucleotides)! or! single! stranded! RNA! (TLR! 7,8).! The! recognition! of!PAMPs! by! TLRs! triggers! an! inflammatory! response! that! induces! expression! of!chemokines!facilitating!the!recruitment!of!inflammatory!cells!including!phagocytic!cells!to!the!site!of!inflammation!(8)!.!These!cells!may!in!turn!phagocytose!pathogens!and!inactivate!them!by!defence!mechanisms!that!involve!cytotoxic!oxidants!(9)!such!as! the! production! of! reactive! oxygen! by! the! nicotinamide! adenine! dinucleotide!phosphate!(NADPH)!complex,!the!production!of!nitric!oxide!that!can!combine!with!reactive! nitrogen! produced! by! the! phagocytes! and! is! highly! toxic! to! many!pathogens!(8)!.!!!Phagocytes! are! recruited! to! the! infection! site! by! chemotactic! agent! such! as! IL^8!(CXCL8).!After! that!and!upon! the!engulfing!of! the!pathogen! these!responses! !may!!then!be!amplified!by!the!release!of! further!chemokines!such!as!CXCL1/2/3/8!and!CCL2/3/4!(8,10,11)!and!inflammatory!cytokines!including!IL^1,!IL^6!and!TNFα.!!!An!adequate!innate!response!is!vital!in!establishing!an!environment!that!can!direct!the! appropriate! form! of! adaptive! immune! response! (2)! as! has! been! found! in!mycobacterial! pathogens.! Even! though! the! effective! control! of! these! pathogens! is!mainly! reliant! on! adaptive! Th1! response,! the! initial! priming! of! naïve! T! cells! is!particularly! dependent! on! the! innate! immune! response.! In! this! case! successful!priming!requires!the!engulfing!of!the!mycobacterial!pathogen!derived!antigens!and!their! presentation! by! DC.! This! process! is! dependent! on! the! recognition! of! the!mycobacterial! specific! antigen! by! TLR! and! a! competent! IFN^γ! response! from! the!host!(12)!.!
!!
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1.2!Adaptive!immune!response!In! contrast! to! the! innate! immune! response,! the! adaptive! immune! system! is!characterised!by!activation!of!B! and!T! lymphocytes.! It! has!high! specificity,! shows!memory! or! increased! responsiveness! to! antigen! on! repeated! exposure! and! is!normally!tolerant!or!non!responsive!to!self^antigens!(4)!.!!!The! adaptive! immune! system! was! believed! to! have! existed! first! in! jawed!vertebrates!and!compared!to!its!evolutionary!older!counterpart! it! is!more!specific!in! function! and! responsiveness.! It! builds! upon! the! innate! immune! response! to!create!a!more!vigorous!immune!response!with!high!specificity! (4)! .!and!is! initiated!by!antigen!presentation,! involving!antigen!presenting! cells! and!molecules! such!as!MHC!I,!MHC!II!and!CD1.!
1.3!Antigen!presentation!types!Antigen!presentation!is!a!vital!stage!in!generation!of!an!immune!response.!The!key!players! in! antigen! presentation! are! antigen! presenting! cells! (APC)! such! as! DC,!phagocytes,!monocytes! and!B! cells.! After! phagocytosis! of! a! foreign! agent! such! as!virus! or! bacteria,! these! cells! are! able! to! present! fragments! from! components! of!those!pathogens!on! their! cell! surface! to!other! immune! cells.!These! fragments! are!typically!peptides!presented!on!major!histocompatibility!complex!(MHC)!molecules.!!In! humans! the! genes! for! these! major! histocompatibility! complex! molecules! are!located!on!chromosome!6.!They!are!a!large!group!containing!multiple!polymorphic!alleles!clustered!into!class!I,!class!II!and!MHC!related!genes!(13)!.!!1.3.1!MHC!class!I!!
Major!histocompatibility!complex!(MHC)!molecules!are!found!on!all!nucleated!cells!in! the! body! (14)! .! Their! role! is! to! present! endogenous! peptides,! typically! proteins!produced! inside! the! cell! from! replicating! viruses! or! ! from! ! self^derived! proteins!important!in!detecting!malignant!and!other!changes!in!cells.!
!!
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In! humans! there! are! three!main!MHC! class! I! genes! known! as! HLA^A,! HLA^B! and!HLA^C.!!!MHC!class!I!complex!constitutes!a!heavy!chain!which!consists!of!three!α!domains;!the!two!distal!domains!α1!and!α2!form!a!pocket^like!peptide!binding!location.!This!binding!site!has!a!gap!between! two!α!helices!overlapping!a!podium!formed!by!β^strands! and! it! fits! peptides! 8^10! amino! acids! long! (15)! .! The! third! α3! domain!associates!with!β2^microglobulin,!which! is! important! in!MHC!stability.!The!class! I!molecule!is!anchored!in!the!cytoplasmic!membrane!by!trans!membrane!segment!of!the!heavy!chain.!(Figure!1.1)!! !
!!
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Figure'1.1'Illustration'of'an'MHC'I'molecule''MHC! I! molecule! consists! of! two! distal! α1! and! α2! domains! forming! the! peptide! binding!groove.!The!third!domain! is!α3,!which! is!has!a! transmembrane!part!and! is!non^covalently!associated!with!β2^microglobulin.!These!last!two!domains!are!important!for!MHC!molecule!stability.!!!!!Peptides!generated!by!proteasome^degraded!cytosolic!proteins!are!associated!with!newly!synthesised!MHC!class!I!moleculesin!the!endoplasmic!reticulum,!after!which!the!MHC! I^peptide! complex! is! transported! to! the!plasma!membrane! exposing! the!peptide! with! the! extracellular! part! of! the! MHC! molecule.! These! intracellular!peptides! and! protein! segments! are! presented! to! MHC! class! 1! restricted! CD8+!cytotoxic!T!cells.!!!Before!any!peptide!can!be!presented!on!the!cell!surface,!antigen!must!be!processed.!This! is!achieved!by!a!process!called!ubiquitination,!which! is!mediated!by!proteins!E1,!E2!and!E3.!These!proteins!attach!polyubiquitin! chains! to! the! targeted!protein!
!!
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(16)! .! After! that! the! ubiquitinated! polypeptides! undergo! enzymatic! cleavage! by!proteasome!(Figure!1.2)!at!which!point!additional!subunits!(MECL1)!also!partake!in!the!antigen!cleavage,!these!subunits!are!stimulated!by!IFN^γ!(17)!.!!Thereafter,! the!processed! short!peptides! are! loaded! inside! the! lumen!of!ER! in! an!ATP^dependent!manner.!This!transportation!through!the!ER!membrane!is!achieved!by! TAP1! and! TAP2! (transporters! associated!with! antigen! processing),! which! are!encoded!within!the!class!II!MHC!complex!(18)!.!! !
!!
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!!! !!!!!!!!!!!!!
Figure'1.2'Illustration'of'MHC'class'I'and'class'II'antigen'processing'and'presentation.''MHC!I!molecules!present!peptides!that!are!fragmented!in!the!cytosol!from!endogenous!(and!exogenous! in! the! case!of! cross!priming)! antigens!which!are! subject! to! endocytosis! to! late!endosome!then!through!proteasomes!to!exocytic!vesicles!and!finally!the!cell!surface.!MHC!II!molecules!present!peptides! that!are!products!of!proteolytic!degradation! in! the!endosomal!compartment!after!phagocytosis!of!exogenous!antigen!(from!http://www.medbullets.com;!!December/2014).!!! !
!!
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A! set! of! chaperone! proteins! are! essential! for! folding! the! multimeric! protein!structures! and! the! formation! of! MHC! I/peptide! complex.! The! first,! calnexin,! is!membrane!bound!and!interacts!with!the!α3!domain!of!the!three!α!chains!and!keeps!it!in!the!lumen!of!the!ER!before!β2m!binding!(17)!.!After!this!calnexin!is!replaced!by!calreticulin!which!also!is!involved!in!stabilizing!and!keeping!the!MHC!I!complex!in!place.!Finally,!tapasin!is!engaged!in!folding!and!antigen!loading!stage!in!association!with!TAP!(19)!.!!Other! proteins! such! as! gp96! and! heat! shock! proteins! Hsp! have! roles! in! the!formation!of!the!antigen/MHC!I!molecule.!These!proteins!with!the!proteasome!are!identified!as!presentasomes!(20)!.!!Finally,! the!complete!heavy!chain/β2m/peptide!complex!travels!through!the!Golgi!apparatus!towards!the!plasma!membrane.!!1.3.2!MHC!class!II!!
The! human! MHC! II! is! responsible! for! the! processing! and! presentation! of!extracellular!antigens!and!!is!therefore!called!the!endocytic!or!exogenous!pathway!as!opposed!to!the!cytosolic!pathway!in!MHC!I.!Alongside!the!MHC!I!genes!the!genes!for!class!II!are!located!on!chromosome!6!and!consist!of!HLA^DR,!HLA^DQ,!HLA^DP!and! other! non^classical! class! II! molecules! genes.! MHC! II! specificity! for! peptide!binding! is! low! and! one! molecule! can! present! range! of! peptides.! Moreover,! one!peptide!can!be!bound!by!more!than!one!HLA^DR!molecule!(14)!.!!The!MHC!class!II!family!is!found!only!on!antigen!presenting!cells!such!as!dendritic!cells,! mononuclear! phagocytes,! B! cells! (professional! APCs)! and! endothelial! cells,!thymic! epithelial! cells! (non^professional! APCs! which! only! act! as! so! under!inflammatory!stress)!(13,21)!.!!The!class!II!molecule!consists!of!two!polypeptides:!α!and!β!which!together!form!a!four^domain!structure!with!a!cytoplasmic!anchor!section!expressed!on!the!plasma!
!!
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membrane! (22)! .! MHC! class! II! is! classified! as! a! member! of! the! immunoglobulin!superfamily;!the!molecular!complex!has!four!domains,!!α2!and!β2!form!the!proximal!membrane!parts!of!α!and!β!and!the!distal!α1!and!β1!domains!that!create!the!peptide^binding! cleft.! The! shape! of! the! binding! groove! enables! the! attachment! of! longer!peptides!(13^25!residues)!in!comparison!to!class!1!MHC!(8^11!residues)!since!it!is!open!from!the!sides!(23)!;!Figure!1.3).!!!!!!!! !!!!!!!!!!!!
Figure'1.3'MHC'class'II'structure'MHC!II!molecule!consists!of!two!heavy!chains!αβ.!There!are!two!proximal!membrane!parts!
α2!and!β2!and!two!distal!parts!α1!and!β1,!which!form!the!peptide!binding!cleft.!!!The!polypeptides! are! synthesized! in! the!ER!along!with! the! chaperones!needed! in!the!function!of!MHC!class!II!and!as!part!of!the!ER!quality!control!mechanism!(24)!.!!!!There! are!many! pathways! including! phagocytosis,!macropinocytosis! or! receptor^mediated! endocytosis! (more! specific! and! involve! B! cell! receptor)! for! the!
!!
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internalization! of! exogenous! antigen! (25)! .! After! internalization! the! antigen! enters!the!least!acidic!early!endosomes!then!goes!through!compartments!to!reach!vesicles!of!lower!pH!and!higher!cathepsin!content.!These!result!in!protein!degradation!and!reduce!it!into!smaller!peptides!that!fit!into!the!MHC!II!groove!(25)!.!!Non^classical!MHC!class!II!molecules!(26)!DM!and!DO,!which!accumulate!in!the!MIIC!compartments! (27,28)!do!not!present!antigens!but! they!assist! in!antigen!processing!and!in!releasing!the!CLIP!peptide!and!loading!the!highest!affinity!antigens!into!the!class!II!groove!(26)!.!Only!cells!that!have!the!ability!to!present!antigens!express!these!two! molecules.! DM! is! present! in! all! antigen! presenting! cells! where! DO! is! only!expressed!by!B!cells! (26,28,29)! .! Interestingly,! the!expression!of!both!molecules!by!B!cells! does!not! increase!peptide! editing,! to! the! contrary,!DO!molecules! inhibit! this!operation!(27)!to!ensure!that!the!response!is!targeted!against!the!most!relevant!BCR^internalized!antigen!(26)!.!!1.3.3!CD1!
The! CD1! system! is! composed! of! five! MHC! I^like! molecules! termed! CD1a^CD1e!encoded! by! the! CD1! gene! complex! found! on! chromosome! 1.! This! structural!homology! indicates! that! CD1! and! MHC! molecules! may! have! evolved! from! an!ancestral!gene!by!duplications!(30)!.!CD1!complex!genes!are!found!in!many!!species!and!show!extensive!inter^species!conservation!(31)!.!!Five!CD1!isoforms!have!been!divided!into!three!functional!groups:!Group!I!(CD1a,!CD1b!and!CD1c),!Group!II!(CD1d)!and!Group!III!(CD1e).!While!members!of!the!first!two! groups! bind! to! and! present! ligands,! group! III! (CD1e)! do! not! and! mainly!function!in!aiding!other!CD1!molecules!to!bind!their!ligands!(31)!.!!!Although!structurally,!CD1!molecules!are!similar!to!MHC!I,!unlike!the!latter,!they!are!non^polymorphic.! Both! molecules! have! three! α^domains! that! bind! to! one! β2^microglobulin!chain!(32)! .!Despite!the!similarity,!there!are!two!major!differences!in!the! structure! of! the! CD1! molecule! that! makes! it! more! suitable! for! lipid! antigen!
!!
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presentation.! First,! CD1! molecule! has! a! groove! structure! that! allows! the!accommodation!of!large!lipid!molecules!that!may!be!larger!than!the!groove!itself!as!molecules!may! protrude! outside! it.! Second,! the! outside! edges! of! the! groove! that!interact!with!TCR!contain!hydrophilic! terminals! that!help! in!stabilising! the! ligand!within!the!groove!(32)!.!!The! ligands! bound! by! CD1! isotypes! are! related! to! its! structure.! Group! I! proteins!bind!many!externally!derived!lipids,!such!as!microbial!lipids.!The!chemical!types!of!bound!lipids!include!fatty!acids,!glycolipids,!phospholipids!and!lipopeptides!(33)!.!On!the!other!hand,!CD1d!of!group!II!is!capable!of!binding!both!externally!derived!lipids!and! internal! self^derived! ones! (34)! .! CD1d! is! able! to! bind! a! broader! range! of! lipid!types! that! include!sugar!residues! ! such!as!ceramides.!The! ligands!of!CD1d!will!be!discussed!in!details!in!1.3.4.3.!Not!being!an!externally!expressed!protein,!CD1e!does!not!bind!to!lipid!ligands.!!The! antigen! processing! of! CD1! molecules! differs! between! different!isotypes,especially! in! the! trafficking!between!ER,!where! they!are!synthesized,!and!the!endocytic! system,!where! they!are!presented.! !However,!all!molecules!are! first!directed! toward! the! plasma! membrane! and! then! led! to! the! appropriate!compartment!(35)! .!They!are!TAP^independent!since!there!are!non^peptide!ligands.!Each!CD1!molecule!always!carries!a!self^lipid!(such!as!phosphatidylinositol)!when!trafficking! (36)! .! The! complexed! CD1^self^ligand! is! transiently! expressed! on! the!surface!(37)!.!!All!isotypes!of!CD1!need!different!levels!of!pH!in!the!endocytic!vesicles!that!are!essential! for!their!various!glycolipid!antigens!to!be!loaded!(38)! .!Accessory!molecules!assure!specificity!of!antigen!loading!into!CD1!molecules,!these!are!called!lipid! binding! proteins! or! lipid! transfer! proteins! (LTPs)! (39)! such! as! SAPs!(sphingolipid!activator!proteins!or!saposins)!(40)!.!!Next! CD1d! expression,! structure,! trafficking! and! antigen! processing! will! be!discussed!in!detail.!!
!!
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1.3.3.1'CD1d'Some!cells!express!CD1d!constitutively,!mainly!antigen!presenting!cells,!especially!monocytes,!mature!and!immature!dendritic!cells!and!circulating!B!lymphocytes!(41)!.!On! the!other!hand,!other! cells! can!up^regulate!CD1d!expression!after! stimulation,!such!as!macrophages!(42)!.!The!distribution!of!CD1d!expression!in!different!parts!of!the!body!was!investigated!extensively!and!was!found!that!it!was!abundant!in!bone!marrow!derived!cells,! liver,!gastrointestinal! tract,! larynx,!skin!and!placenta! (32,43)! .!Interestingly,!Exley!et!al!studied!the!distribution!of!CD1d!in!the!secondary!follicles!of! lymph!nodes! and! found! it! to! be! expressed! in! abundance! in! the!mantle! zone!B!cells!while!lacking!completely!from!the!germinal!centre!(41)!.!!The! tertiary! protein! structure! of! the! exterior! part! of! the! CD1d!molecule! includes!three!alpha!domains!and!one!beta2!macroglobulin!chain.!The!binding!groove!of!the!CD1d!molecule!is!deep!and!has!two!long!channels,!each!of!which!can!accommodate!an!acyl!chain.!This!binding!groove!is!well!suited!for!binding!CD1d!glycolipid!ligands!such! as! KRN7000! because! of! its! large! size,! shape! and! the! presence! of! many!hydrophobic! residues! (44)! .! ! Furthermore! CD1d! has! trans^membrane! and! intra^cytoplasmic!parts!that!play!a!role!in!its!association!to!lipid!rafts,!which!may!help!in!both!its!trafficking!and!acquisition!of!lipid!ligands!(45)!;!Figure!1.4)!! !
!!
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Figure'1.4'Structure'of'human'CD1d'with'αGalCer'A.!Front!view!of!human!CD1d!molecule!that!consists!three!α!chains!(α1^3)!in!blue,!and!β2m!chain!in!yellow!with!bound!αGalCer!(in!orange).!B.!Top!view!of!αGalCer!bound!to!the!groove!between!α1!and!α2!chains!!!!Similar!to!MHC!I,!CD1d!molecules!are!constructed!in!the!endoplasmic!reticulum!in!the! presence! of! calnexin! and! calreticulin! (40)! .! This! is! coupled! with! self! ligand!loading!into!the!groove!(36)!followed!by!association!with!β2m.!This!complex!moves!to!the!cell!surface!through!the!trans^Golgi!network!(TGN).!Surface!expression!of!the!CD1d^self! ligand! complex! is! only! temporary! and! it! is! internalised!back! inside! the!endocytic! system! (45,46)! .! In! the! late! endosomes/cytosomes,! ligands! are! processed!and!digested!requiring!a!specific!enzyme,!α^galactosidase!A!(47)!and!the!low!affinity!ligand! is! replaced! with! final! antigen.! The! ligand! editing! is! assisted! by! the!involvement! of! CD1e! molecules! and! various! saposins! (40,48)! .! The! role! of! the!endocytic!system!in!the!expression!of!CD1d!molecule^ligand!complexes!extends!to!the! formation! of! lipid! rafts.!Moreover,! CD1d!was! found! to! be! exclusively! in! lipid!rafts!(49)!and!the!formation!of!lipid!rafts!is!critical!for!CD1d!antigen!presentation!(49)!.!
!!
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Figure'1.5'Human'CD1'molecule'trafficking''All! CD1a,! b! and! c!molecules! are! transported! in! association!with! ß2!microglobulin! (ß2m)!from! the! endoplasmic! reticulum! (ER)! through! the! secretory! pathway! to! the! plasma!membrane!(PM).!!Top!right:!After!transport!of!CD1d!molecules!to!the!PM,!their!endocytosis!into!clathrin^coated!pits!is!mediated!through!the!interaction!of!their!cytoplasmic!tails!with!the!cytosolic!adaptor!complex!(AP)^2.!CD1d!is!transported!then!to!early!endosomes,!where!it!accesses!late!endosomes!(LE),!lysosomes!and!the!MHC!class!II!compartments!(MIIC/Lys)!through! its! interaction!with!cytosolic!adaptor!AP^3.!Bottom!right:!CD1e!molecules! remain!intracellularly.! In! DCs! most! CD1e! molecules! are! present! in! the! Golgi.! (Adapted! from!http://edoc.hu^berlin.de;!March/!2014)!!! '
!!
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1.3.3.2'CD1d'ligands'The! specific! ligands! for! ! CD1d! are! glycolipids!which! are! to! be! presented! to! iNKT!cells.!α^Galactosylceramide! (αGalCer!OR!KRN7000)!was! the! first! glycolipid! ligand!shown!to!stimulate!NKT!cells!when!presented!by!CD1d!expressed!on!APCs! (50,51)! .!This!form!was!first!extracted!from!a!marine!sponge,!Agelas.mauritianus.!The!length!of! both! acyl! and! sphingosine! chain! of! this! ligand! show! a! perfect! fit! in! the! CD1d!pocket! as! shown! by! crystallization! studies! (44)! .! The! crucial! feature! of! αGalCer!structure! is! an! α^linkage! between! the! ceramide! and! sugar! parts! (Figure! 1.6);!mammals!cannot!synthesise!this!(52)!therefore!it!is!unlikely!that!αGalCer!is!involved!in!the!process!of!CD1d^restricted!recognition!by!!NKT!cells.!!!Furthermore,! αGalCer! is! similar! to! other! ligands! for! NKT! cells! such! as!glycosphingolipid!(53,54)! ,!which!are!found!in!some!bacterial!and!fungal!species!and!can! be! presented! by! CD1d,! monoglycosylceramides! (53)! and! phosphatidylinositol!mannosides!(55)!.!!!Moreover,! a!wide! range! of! endogenous! cellular! lipids! can! be! presented! by! CD1d.!This!was!proved!in!assays!where!NKT!cells!proliferation!was!observed!despite!the!fact! that!no!external!self^derived! ligands!are! introduced! (56,57)! .!This!demonstrates!the! reactivity!of!CD1d^restricted! cells! towards! self! derived! ligands! in!mammalian!cells.!!!!Endogenous! ligands! defined! in! mice! and! humans! include!glycosyl/phosphatidylinositol! (58,59)! ,! human! melanoma! cell! derived! GD3! (60)! ,!!phosphatidylcholine!(61)!.!!Isoglobotrihexosylceramide! (iGb3)!was! thought! to! be! a! thymic! ligand! (62,63)! .! The!main!difference!between!iGb3!and!αGalCer!is!the!presence!of!a!β!bond!between!the!sugar!group!and!ceramide!in!the!latter!(Figure!1.6).!As!iGb3!can!be!synthesized!by!mammals,! its! molecule! would! fit! the! description! of! a! self! ligand.! Experiments!showing!that!mice!suffering!from!a!lysosomal!storage!disease!due!to!the!lack!of!an!
!!
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enzyme! needed! in! iGb3! synthesis! pathway! (hexosaminidase! B,! Hex! B),! have! a!reduced!population!of!CD1d^restricted!iNKT!cells!has!been!taken!to!suggest!iGb3!is!a! self! ligand.!However,! iGb3! cannot! be! detected! in! human! tissues! using! standard!methodology! (64)! .! Furthermore,! the! gene! encoding! the! enzyme! responsible! for!primary! iGb3! generation! (α^1,3! galagctosyltransferase)! (65)! and! iGb3! synthase! (66)!are! both! non^functional! pseudogenes! in! higher! primates! (67,68)! .! These! mammals!produce! anti^α(1,3)Gal! antibodies! against! the! sugar! epitope! of! iGb3! (69^71)! as! an!immunological!response!to!lipopolysaccharides!and!polysaccharides!from!bacteria!of! gastrointestinal! tract! (67)! .! Also,! it! was! found! that! in! other! lysosomal! storage!diseases,! which! cause! disruption! at! the! level! of! the! endocytic! system! of! the! cell,!result!in!a!similar!reduction!of!NKT!cell!frequencies!(72)! .!This!is!further!supported!by! increased! iNKT! cells! numbers! observed! in! Gaucher! storage! disease! patients!treated! with! enzyme! replacement! therapy! (73)! .! In! addition,! mice! that! are! iGb3^deficient! have! normal! NKT! cell! development! (74)! .! Also! in! another! study,! it! was!found!that!non^iNKT!cells!do!not!require!this!compound!for!their!selection!(75)!.!!Moreover,! IB4! lectin!was!used! in!blocking!experiments!by!Zhou!et!al! (63)! ,!but! the!interpretation!of!their!results!must!be!done!with!caution!as!this!lectin!is!considered!promiscuous!in!terms!of!carbohydrate!structure!recognition!(70,!71)! .!Therefore!it! is!unlikely! that! iGb3! is! involved! in! positive! selection! of! NKT! cells! or! peripheral!activation!of!this!cell!population!in!humans!(64)!.!This!concludes!that!the!identity!of!the!endogenous!ligand!that!is!capable!of!driving!NKT!cells!selection!in!the!thymus!is!elusive.!!Finally,!Gadola!et!al.! found!that!CD1d!structure!differs!between!humans!and!mice.!They! first! proved! that! iGb3! does! not! activate! human! iNKT! cells! as! stimulatory!ligand! in! terms! of! both! proliferation! and! cytokine! production.! Also,! as! the! direct!binding! of! iNKT! TCR! to! CD1d^lipid! complex! is! a! pre^condition! for! iNKT! cell!activation! they! examined! the! ability! of! iGb3! to! bind! to! human! CD1d! (hCD1d)! by!comparing! the! binding! of! iNKT! cells! in! culture! with! panels! of! CD1d! tetramers!loaded! with! the! potent! ligand! α^GalCer! and! the! less! potent! OCH! with! iGb3! and!found!that!the!latter!failed!to!show!any!detectable!staining.!However,!interestingly!they!showed!that!iGb3!could!stimulate!iNKT!cells!when!presented!on!mouse!CD1d!
!!
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(mCD1d).! These! findings! suggested! that! species! differences! in! CD1d! structure!establish!the!ability!of!the!complex!CD1d^iGb3!to!bind!to!iNKT^TCR.!This!led!to!the!finding! that! a! single! amino! acid! in! the! hCD1d! α2! domains! prevents! iGb3!presentation!to!iNKT!cells!(76)!.!!There! are! a! range! of! synthetic! glycolipid! compounds! generated! such! as!αGalCer!C20:2,! OCH,! PBS^57,SGL^S23,! thio^iGb3! (77^82)! .! ! These! glycolipid! ligands!demonstrate!different!physical!and!biological!properties!and!can!be!used!for!both!activation! and! detection! of! NKT! cells! (79,83)! and! are! promising! as! therapeutic!candidates!for!CD1d^restricted!T!cell!stimulation.!!!It! is! to!be!noted! that! there! are!differential! responses!by!NKT! cells! to! some!CD1d!ligands!(77,80,84)!.!OCH!is!an!example.!It!has!a!truncated!sphingosine!chain!and!a!clear!ability!to!direct!CD1d^restricted!response!towards!a!Th2!pattern!by!stimulating!IL^4!production!(78)!.!It!is!however!a!much!weaker!stimulant!compared!with!KRN7000.!!!In! conclusion,! the! CD1d^mediated! presentation! of! different! compounds! suggests!that!the!nature!of!the!ligand!influences!the!response!observed!from!CD1d^restricted!cells.!This!observation!led!to!the!formation!of!a!theory!that!ligands!with!truncated!chains! are! presented! for! a! shorter! time! and! lead! to! secretion! of! mainly! IL^4,!whereas! longer! ligands,!with! higher! affinity! to! CD1d,! are! characterized!by! longer!stimulation!time!(85)!caused!by!prolonged!TCR!stimulation!and!produce!IFN^γ!(86)!.!!
!!








! ! 35!! ! !!
1.4!B!lymphocytes!B!lymphocytes!originate!and!develop!in!the!bone!marrow.!They!are!mainly!involved!in!the!humoral!immunity!of!the!adaptive!immune!system.!Their!main!function!is!to!produce! antibodies! against! antigens.! They! also! act! as! antigen! presenting! cells!(APCs)!and!produce!cytokines,!which!are!important!in!immune!regulatory!function!(87)!.!!!B!cells!are!distinguished!by!surface!immunoglobulin!called!B!cell!receptor!(BCR).!It!is!composed!of!two!identical!light!chains!and!two!identical!heavy!chains.!Both!heavy!and!light!chains!are!subject!to!gene!rearrangement!resulting!in!a!massive!repertoire!of!BCR!(88)!.!!!!The!B! cell! becomes!activated!upon!binding!of!BCR! to! specific! antigen.!Then!with!signals!from!T!helper!cells!it!differentiates!into!antibody^secreting!plasma!cells!(89)!.!The! secreted! antibodies! are! curtailed! BCR!with! the! same! antigen! specificity! and!function! by! neutralizing! opsonisation! of! targets! for! removal! by! phagocytes! and!activation! of! the! complement! system.! IgM! is! the! first! antibody! detectable! in! the!early! B! cell! subset.! It! can! be! detected! in! plasma! as! early! as! pre^B! stage! where!surface! expression! can!be! identified! in! the! late! immature!B! cell! stage.! IgD!on! the!other!hand!is!only!expressed!in!the!mature!B!cell!stage!(90)! .!B!cells!migrate!out!of!the! bone! marrow! in! their! immature! stage! (identified! as! IgM+! IgD^! CD27^).! The!development!of!immature!to!mature!B!cell!is!in!an!antigen^independent!manner.!!Based!on!the!cell!surface!of!phenotype!markers,!B!cells!are!classified!into!subsets.!Naïve! B! cells! circulate! in! the! peripheral! blood! and! are! present! in! the! secondary!lymphoid! organs! such! as! lymph! nodes! and! the! spleen.!Marginal! zone!memory! B!cells! may! form! short! ^lived! plasmablasts! that! produce! IgM! and! they! respond! to!polysaccharide! antigens.! Finally,! B! cells! that! have! been! activated! within! the!germinal! centre! undergo! somatic! hyper!mutation! and! class! switching! to! become!memory!cells,!plasmablasts!and!eventually!plasma!cells.!The!latter!lose!expression!of! surface! immunoglobulin! and! migrate! back! to! the! bone! marrow! where! they!become! long^lived! memory! B! cells! producing! high! affinity! antibodies! (91)! .!
!!
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Furthermore,! B! cells! express! CD1d! (92)! .! They! uptake! lipid! antigens! via!apolipoprotein!E!and!low^density!lipoprotein!(LDL)!receptor!and!present!it!to!iNKT!cells!on!CD1d!(93)!.!
1.5!T!lymphocytes!T!cells!originate!in!the!bone!marrow!and!mature!in!the!thymus.!IL^7!is!the!primary!cytokine! that! commits! T! cell! precursors! to! different! differentiation! pathways.! T!cells!are! involved! in!cell^mediated! immunity!such!as! targeting!virus^infected!cells!and!tumour!cells.!They!also!activate!and!regulate!other!cells!of!the!immune!system!by! secreting! cytokines.! ! They! express! the! TCR! on! their! surface.! The! T! cells! are!positively! selected! when! the! TCR! binds! to! MHC! complex! with! low! avidity.! High!avidity! in! this!binding! indicates!potential!auto^reactivity!and!will! lead! to!negative!selection,!which!means!deletion!of!that!T!cell!clone.!When!the!double!positive!cells!successfully!pass!the!positive!and!negative!selection,!those!restricted!to!MHC!class!I!will!become!CD8!cells!and!those!restricted!to!MHC!II!will!become!CD4!(91)! .!At!this!stage! of!maturation! T! cells! leave! the! thymus! to! circulate! in! the! blood! as! naïve! T!cells.!!!On!the!gene!level,!TCR!locus!contains!three!regions!variable!(V),!diversity!(D)!and!joining! one! (J).! The! D! region! however,! is! only! present! in! δ! and! β! TCR! loci.!Recombination!activating!genes!1!and!2!(RAG1!and!RAG2)!randomly!rearrange!the!three! regions! V,! D! and! J! and! therefore! initiate! the! rearrangement! process.! This!rearrangement!process!allows!various!combinations!to!occur!resulting!in!great!TCR!antigen!specificity.!Successful!rearrangement!of!two!TCR!genes!with!either!αβ!or!γδ!configuration! mark! the! end! of! pre^T! cell! stage! and! the! beginning! of! the! double!positive!T!cell!stage.!These!cells!at!this!point!of!development!express!both!CD4!and!CD8!with!fully!functioning!CD3!receptor!(91,94)!.!!T! cells! become! fully! activated! upon! the! interaction! of! their! TCR! with! the!MHC/antigenic! peptide! complex.! CD8!will! recognise! MHC! I! complex! loaded! with!short! peptides! whereas! CD4! will! recognise! MHC! II! complex! loaded! with! long!peptides.! The!meeting! at! the! immunological! synapse! leads! to! the! recruitment! of!
!!
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early! signalling!molecules! for! T! cell! activation.! ! Lck! is! recruited! early! by! the! co^receptor! complex! and! subsequently! activates! a! further! tyrosine! kinase,! ZAP^70,!which!binds!to!the!tyrosine^based!activation!motifs!of!the!CD3!chains.!This!leads!to!the! downstream! phosphorylation! of! several! other! signaling! molecules! including!Lymphocyte! cytosolic! protein! 2! (SLP^76),! Phospholipase! C! (PLC),!Phosphatidylinositol! 4,! 5^bisphosphate! (PIP2)! and! Inositol! trisphosphate! (IP3).!These! ultimately! lead! to! Protein! kinase! C! (PKC)! activation! (95,96)! .! PKC! further!activates!transcription!factors!AP2!and!Nfka,!leading!to!the!production!of!cytokines!(96)!.!!Calcium!signalling! is! important!for!T!cell!maturation.!Studies!have!shown!that!the!presence! of! calcineurin! inhibitors! resulted! in! failure! of! double! positive! T! cells! to!convert!to!single!positive!(97^99)!.!!CD4!T!helper!group!recognise!MHC!II!molecules!and!have!been!divided!into!further!groups! such! as! Th1,! Th2,! Th17! and! T! reg.! Th1! is! mainly! involved! in! immunity!against!intracellular!pathogens!and!tumours!and!secrete!IFN^γ!and!IL^2.!While!Th2!cells! secrete!mainly! IL^4,! IL^5,! IL^10! and! IL^13! and! are!mainly! involved! in! B! cell!production! of! neutralising! antibodies,! mast! cell! and! eosinophil! opsonisation!immune!responses.!Regulatory!T!cells!are!mainly!a!CD4+!subpopulation!and!express!CD25! and! the! transcriptional! regulator! FOX^P3.! As! the! name! indicates! they! have!regulatory!role!and!associated!with! IL^10!and!TGF^β! secretion,!which! inhibits! the!classical!Th1!and!Th2!function!(100)!.!The!final!subset!of!T!helper!cells!is!Th17.!It!was!only!recognised! in! the! last!15!years!and! is!CD4+!and!produce! IL^17A!a!member!of!IL^17!family.!IL^6!and!TGF^β!are!required!for!Th17!polarisation!where!IL^21!and!IL^23!are!for!expanding!and!sustaining!them!(101^103)!;!Figure!1.7)!! !
!!
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Figure'1.8'CD4'T'cell'subset'development''Th0!are!primed!and!activated!by!APC!and!develop! into!different! subsets!according! to! the!cytokines! secreted.! IL^12! stimulated! cells! become! Th1! cells! and! produce! IFN^γ,! IL^4!stimulated! cells! become!Th2!and!produce! IL^4.!Where! the! combination!of!TGFβ! and! IL^6,!TGFβ! and! IL^2,! TGFβ! and! IL^4! stimulation! leads! into! Th17,! Treg! and! Th9;! respectively!!(From!Brendan!et!al.!2013!Frontiers!in!GENETICS!(104)!).!!!!!
1.6!Natural!Killer!cells!!Natural! Killer! cells! (NK)! originate! in! the! bone! marrow! and! share! a! common!progenitor!with!T!cells.!They!are!mainly! involved! in! the! innate! immune!response!and!early!cytokine!secretion;!they!play!a!key!role!in!the!recognition!and!destruction!of!virus!infected!and!tumour!cells! (105)! .!NK!cells!are!potent!cytotoxic!effector!cells!and! they!have! shown!a! lysing!effect!on! target! cells!both! in.vivo! and! in.vitro.!They!
!!
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also! promptly! secrete! cytokines,! which! skew! the! immune! response! towards! Th1!type.!NK!cells!activation!and!subsequent!function!is!tightly!regulated!by!inhibitory!receptors! and! cytokines! that! control! and! possibly! terminate! the! NK! response.!Therefore! a! balance! of! signals! through! receptors,! which! can! be! stimulatory! or!inhibitory,! regulates! their! function.! NK! cells! can! recognise! the! changes! in!MHC! I!expression!on!cells!that!have!been!infected!with!virus!or!turned!into!tumour!cells!and!subsequently!kill!them!(105,106)!.!!There! are! two! sets! of! receptors! on!NK! cells,! one! an! immunoglobulin! superfamily!and! the!other!C^type! lectins.!There!many!members! in! this! immunoglobulin! super!family! such! as! human! killer! Ig^like! receptor! KIR,! leukocyte! inhibitory! receptors!(LIR)!and!activating!NKp46!to!name!a!few.!They!are!all!clustered!on!chromosome!9!in! the! leukocyte! receptor! complex! (LRC).! The! other! family! (C^type! lectin! family)!include!CD94!and!NKG2!and!are!located!on!chromosome!12!at!the!centromeric!end!of!the!natural!killer!complex!(NKC)!(107,108)!.!!!In! humans! two!main! subsets! of! NK! cells! have! been! defined:! CD3^!CD56dim!CD16+!(CD56! dim),!which! represent! the!majority! of!NK! cells! in! the!peripheral! blood,! and!CD3^!CD56bright!CD16^!(CD56! bright),! that! are! a!minority! in! the! peripheral! blood! but!present! in! the!peripheral! tissues.! !NK! cells! expressing!Killer! Immunoglobulin^like!receptors!(KIR)!which!are!specific!for!HLA^class!1!allotypes!are!!only!found!on!!on!CD56dim! !cells! but! this! population! may! also! express! the! ! CD94/NKG2A! receptor!(HLA^E!specific).!Whereas!the!CD56bright!population!express!CD94/NKG2A!but!not!KIRs!(109^111)!.!!!NKR^P1!receptors,!!the!C!type!lectin^like!molecules,!were!first!discovered!in!rodents!and!initially!thought!to!be!NK!cell!specific!!receptors!but!!they!have!been!found!on!other!cell!type!such!as!subset!of!T!cells!and!granulocytes!(112)!and!splenic!!dendritic!cells! (113)! .! In!mice! six!NKR^P1!genes!have!been! identified! (114)!whereas! in!human!there! is!only!one!gene!CD161!(NKR^PA1),!expressed!on!most!NK!cells,!a!subset!of!thymocytes! and! fetal! liver! T! cells! (115)! .! ! Subsets! of!mature! CD3+!T! cells! including!CD4+!and!CD8+!cells!also!express!CD161,!particularly!CD1d!dependent!NKT!cells!as!
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will!be!discussed!later!in!this!chapter!in!1.6!and!Table!1.1!(116)!.!In!humans,!no!clear!role! has! been! found! for! CD161! and! no! particular! ligands! have! been! identified.!However,! the!change! in!the!expression!of!CD161!in!NK!cell!cultures!may!result! in!cytotoxic! function! (115,117)! and!mAb! to! CD161! triggered! proliferation! of! immature!lymphocytes!(117)!.!!
1.7!Natural!Killer!T!cells!1.7.1!The!history,!definition!and!classification!of!iNKT!cells!!
iNKT! cells! !were! first! identified! in!mice! as! a! ! population!of!double!negative! (DN)!(CD4^,! CD8^)T! cells! with! a! repertoire! skewed! toward! TCR! Vβ8! usage! (118)! .! This!rather! skewed! TCR! use! suggested! that! these! cells! recognise! conserved! antigenic!forms.! Later! studies! on! human! lymphocytes! revealed! a! recurrent! Vα24^Jα18!rearrangement! in! a! comparable! DN! T! cell! population! (119)! .! These! findings! were!connected! together! upon! the! identification! of! IL^4! producing! CD4! and! DN!thymocytes!co^expressing!NK!markers!and!a!biased!set!of!TCR!β!(120)!.!Other!studies!demonstrated! the! ability! of! these! cells! to! produce! immunoregulatory! cytokines!such! as! IFN^?! and! TNF! (121,122)! .! The! characterisation! of! this! population! was!extended!with!the!discovery!of!mouse!and!human!NKT!cell!reactivity!to!the!MHC!I!like!molecule!CD1d!(123^125)!.!!The!name! ‘NKT!cell’!was! first!used! to!describe!a!mouse!T! cell! subset! that! shared!some! features! with! NK! cells,! including! surface! expression! of! NK1.1! (CD161! in!humans)!(126)!.!When!the!limited!TCR!chain!was!unveiled,!the!classification!changed.!These! “! invariant!natural!killer! cells! (iNKT!cells)”! represent!a!maximum!of!1%!of!PBLs!in!human!healthy!donors.!Later!it!was!found!that!not!all!iNKT!cells!co^express!the! NK! cell! marker! CD161.! Because! of! that! there! was! an! introduction! of! a! new!classification! that! stratified! “iNKT!cells”! into! three! types,! type! I:!T! cell! expressing!both!invariant!TCR!and!CD161!receptors;!type!II:!V24+!cells!without!this!NK!marker!and! type! III:! CD161+!cells,! bearing! non^invariant! TCRs! (127)! .! Nevertheless,! other!cells,!which!express!variable!TCR!receptors,!were!detected!since!the!accessibility!of!
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soluble! CD1d! molecules! and! CD1d! tetramers! (128^130)! .! These! variable! TCR! cells!respond! to! the! CD1d^mediated! presentation! of! ligands! (131,132)! .! A! recent!classification! divides! the! CD1d^restricted! cell! population! into! two! subsets:! type! I!classical! NKT! cells,! they! represent! iNKT! cells! and! type! II! non^classical! NKT! cells,!they! represent! all! other! CD1d^restricted! cells! and! have! variable! TCRs! (75,133,134)! .!TCR!sequencing!showed!that!type!II!non^classical!cells!could!express!one!of!several!
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IL^4/IFN^γ! +/+! +/+! !!^/+!!
αGalCer!reactivity! Yes! Yes/No! No!!!
Table21.12Types2of2NKT2cells2and2their2differences2in2mice2and2human2The!two!NKT!cells!subsets!are!invariant!and!non^invariant!populations.!For!the!reasons!of!phenotypic! characteristics! and! some! functional!properties,!NKT!–like! cells!were! included.!(Based!on!Godfrey!et!al!2004!(62)!,!Gadola!et.al!2002!(131)!.!!!!! !
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A! final! population! of! NKT^like! cells! does! not! respond! to! CD1d^mediated!presentation,! but! they! do! bear! both! TCR! and! NK! cell! markers.! These! mucosal^associated!invariant!T!cells!(MAIT)!are!restricted!by!another!member!of!MHC!class!Ib,! the! MR1! molecule! (137)! .! Furthermore,! they! express! limited! TCR! spectrum! i.e!Vα7.2^Jα33!paired!with!Vβ13!or!Vβ2!in!humans!and!Vα19^Jα33!paired!with!Vβ6!or!Vβ8!in!mice!(138)!.!These!MR1^restricted!cells!also!respond!to!glycolipids!(139,140)!and!secrete!cytokines!such!as!IL^4,!IL^5,!IL^10!and!IFN^?!(141)!.!!Now!however,!the!NKT!cells!term!is!applied!to!CD1!restricted!T!cells,!which!express!both!TCR!and!NK!cell!receptors.!Murine!Vα14+!NKT!cells!were!reported!as!early!as!1986! when! Imai! et! al! isolated! cDNA! encoding! the! Vα14! TCR! chain! from! a!suppressor!T!cell!hybridoma!(142)! .!Some!early!studies!found!distinct!subsets!of!αβ!TCR+! T! cells! in! mice! that! did! not! express! CD4! and! CD8! (118,143)! ,! other! research!illustrated!that!this!population!of!αβ!T!cells!also!expressed!NK1.1!(144)!.!Consecutive!studies! proved! that! these! cells! belong! mainly! to! the! double! negative! subset! in!humans! (119)! and! the! CD4+! subset! in! mice! (120,145,146)! and! are! characterised! by! a!potent!cytokine!secreting!ability!(122,124,147)!.!!!In!1997!Kawana!et!al.!discovered!that!a!group!of!glycolipids!is!presented!to!murine!NKT! lymphocytes,!α^galactosylceramide!(α^GalCer)!being! the!most!potent! (50)!and!this!was!proved!later!for!human!cells!(51)!.!This!discovery!demonstrated!for!the!first!time!that!not!only!peptides!can!be!presented!for!TCR^mediated!recognition!but!also!lipid^derived! compounds! can! also! be! antigenic.! In! addition! to! that,! this! pathway!seemed!to!be!conserved!in!the!investigated!mammalian!species!(148,149)!.!!1.7.2!NKT!cell!development!
Zhou!et!al!suggested!that!iGb3!is!needed!for!thymic!selection!of!NKT!subsets!in!mice!(63)! .!However,! this!glycolipid! is!unlikely! to!be! the!endogenous! ligand,!which!rules!the! selection! of! any! of! NKT! subsets.! Although! the! natural! selecting! ligand! is! still!unknown,!some!details!of!the!NKT!development!steps!have!been!defined!in!mice.!!!
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Like! other! T! cells,! the! development! of! NKT! cells! is! thymus! dependent! (150)! .! The!common! precursor! in! the! classical! T! cell! development! pathway! CD4^! CD8^! DN!lymphocyte! is! the! first! cell! in! the! NKT! lineage! (Figure! 1.8).! Heat! stable! antigen!(HSA)!or!CD24!molecule!(cell!adhesion!molecule)! is!highly!expressed.!NKT!cells!at!this!stage!undergo!rearrangement!of! their!TCR!chains! leading!to! iTCR!expression.!There! are! two! proposed! sequences! of! events! around! the! developmental! stage! of!TCR!rearrangement,!pre^commitment!and!instructional!type.!The!pre^commitment!theory! suggests! that! early!NKT! precursors! are! predetermined! for! rearrangement!resulting! in! iTCR! expression,! while! the! instructional! model! proposes! that!expression! of! this! receptor! instructs! the! cell! to! acquire! the! unique! properties! of!NKT!cells!(151)!.!!After! the! rearrangement! the! process! of! positive! selection! by! CD1d+!DP! cortical!lymphocytes!starts!(125)!.!At!this!stage!this!process!is!different!from!that!of!classical!T! cells,!which!are! selected!by! thymic! cortical! epithelial! cells! (152)! .!As!Gadola!et.al!showed!that!mice!with!various!lipid!storage!diseases! lack!iNKT!cells! it!seems!that!the!selecting!ligand!must!be!acquired!by!the!molecule!in!the!endocytic!system!(72)!.!!The!cells! that!have!encountered!CD1d^mediated!presentation! lose! the!majority!of!CD8!expression!and!function!as!CD4+,!CD69!high!thymocytes,!which!gradually!down!regulates! CD24! and! undergo! three! consecutive! stages! of! maturation! (based! on!studies! on! mice).! These! are:! the! naïve! thymocyte! stage! (CD44low! NK1.1neg),! a!memory!stage!(CD44high!NK1.1neg),!and! the!NK!stage!(CD44high!NK1.1pos)! (153)! .!NKT!precursors! represent! differential! cytokine! secretory! abilities! at! these! respective!points!of!development,!progressing!from!only!IL^4!precursors!to!Th1!phenotype!to!cells!which!may!secrete!more!IFN^γ!than!IL^4! (146,147,153)! .!The!cells!also!undergo!a!series! of! proliferation! post! naïve! stage! and! generate! a! CD4+! and! DN! population!(46,153)!.!!A!level!of!negative!selection!mediated!by!thymic!stromal!cells!is!a!possibility!as!the!presence!of!αGalCer,!which!is!a!high!affinity!ligand,!blocks!the!development!of!the!cells!in!this!lineage!(154)!.!In!addition!to!that,!CD8+!murine!(but!not!human)!cells!are!deleted!during!thymic!development,!which!has!been!explained!by!excessive!affinity!
!!
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of! the!TCR^CD1d! interaction! in! CD8+!NKT! cells! (not! the! classical! cytotoxic! CD8!T!cells)!causing!clonal!deletion!(123)!;!Figure!1.8).!!!While! in! mice! the! emigrant! cells! directed! to! the! periphery! commonly! show! a!mature!phenotype,!in!humans!the!majority!of!the!emigrants!leave!the!thymus!at!the!intermediate! stage! and!undergo! a!maturation! step! and! express!NK161! and!other!NK^related! markers! outside! the! thymus! (46,153)! .! In! mice! some! NKT! cells,! which!survive!past!this!step!remain!in!the!thymus!as!resident!NKT!cells!(153)!.!!In!2008!Savage!et!al.!have! identified!promyelocytic! leukaemia!zinc! finger,!Zbtb16!(PLZF)! as! a! transcriptional! factor,! which! is! exclusive! for! NKT! cell! lineage.! This!factor! could! be! detected! in! high! amounts! at! developmental! stages! from! the! first!CD24lo! cells! through! to!mature! CD44hi!NK1.1+! cells! (155)! .! These! stages! of! general!NKT!precursor!differentiation!were!also!characterised!by!detectable!expression!of!c^Krox,!which!is!a!mark!of!CD4!commitment!(156)!!! !
!!
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Figure'1.9'NKT'cell'thymic'development''Natural!killer!T!(NKT)!cells!(in!purple)!originate!from!the!thymus.!Their!common!precursor!is!CD4+CD8+!double!positive!(DP)!thymocytes!that!have!undergone!random!T^cell!receptor!(TCR)! gene! rearrangement! and! expression.! The! interaction! between! TCR! in! some!lymphocytes!and!CD1d!that!is!loaded!with!self^glycolipid!commit!these!cells!to!the!NKT^cell!lineage! (control! point! 1).! After! that! NKT^cell! precursors! experience! a! series! of!differentiation!steps!that!eventually!end!up!in!the!NKT^cell!pool.!The!immature!NK1.1^!cell!has! four! stages! according! to! differential! expression! of! CD24,! CD44! and! DX5.! Finally,! the!maturation! stage! is!manifested! in!a! range!of! functional! and!phenotypical! changes! such!as!NK1.1!expression!(control!point!2).!(Figure!is!adapted!from!(46)!).!
!!
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1.7.3!NKT!cell!phenotype!
It!was!acknowledged!that!NKT!cells!are!defined!as!invariant!TCR+!or!NK1.1+!T!cells.!In!early!literature!it!was!believed!that!these!cells!are!CD4^/CD8^!(DN)!in!humans!(119)!and!CD4+!in!mice! (147)! .!However,!other!subpopulations!according! to!CD4!and!CD8!expression!were! later! identified.!Murine! iNKT! cells! can! be! either! CD4+! or!DN! (62)!where!human!iNKT!cells!can!be!CD4+!or!CD4^!in!which!case!they!could!be!DN!or!CD8!
αα/αβ+! (157,158)! .! In! addition! to! CD3! (TCR),! CD4! and! CD8,! different! functional!properties! of! these! subsets!may! be! explained! by! differential! expression! of! other!molecules! (159)! .!These! include!perforin,!2B4,!CD94!and!CD161!markers!as!well!as!NKG2A/NKG2D!receptors.!These!proteins/!receptors!are!usually!expressed!on!the!CD4^! population! and! they! give! the! iNKT! cells! the! natural! killer^like! cytotoxicity!(157,159)!.!Notwithstanding!the!cytotoxic!property!of!iNKT!cells,!there!are!no!reports!of! their! subsets! expressing! KIR! receptors! CD158a/b! whereas! CD56! seems! to! be!abundant! on! both! CD4! subpopulations! (160)! .! Furthermore,! other! receptors!which!may! be! important! for! iNKT! cell! function! include! CD45RO,! CD45RB! and! CD69,! all!expressed!by!both!subsets!of!fresh!and!activated!iNKT!cells!(160,161)!and!considered!as!activation/memory!markers!of!these!cells.!In!additions!to!these!receptors,!Wu!et.
al.! found! that! iNKT! cells! express! thymic! stromal! lymphopoietin! receptor! TSLPr.!They!demonstrated!that!sorted!iNKT!cells,!based!on!using!anti!6B11+!mAB,!express!both!mRNA! and! protein! for! TSLPr! and! IL^7α.! Furthermore! iNKT! cell! frequencies!increased!when!activated!by!TSLP!especially! in!patients!with!severe!AD! (162)! .! !As!iNKT!cells!play!a!vital!role! in! innate! immune!responses! it! is! logical! to!suspect! the!TLR!expression!and!direct!activation!of!iNKT!cells.!It!has!been!found!that!more!than!97%!of!purified!murine! liver!NK1.1+!!TCRβ+!!NKT!cells!express!TLR4,5!and!9!gene!products! (163,164)! whilst! hepatic! CD1^d! tetramer! positive! iNKT! cells! express! TLR3!and!4!proteins!(165,166)!.!More!recently!Moreno!et.al!reported!expression!of!TLR1!to!9!except!8!at!transcript!level!in!purified!Vα24+!Vβ11+!iNKT!cells!(167)!.!!Finally,!NKT!cells!are!not!only!phenotypically!but!also!functionally!heterogeneous.!There! are! differences! in! cytokine! production! between! iNKT! cell! subpopulations.!Where!CD4+!iNKT!cells!were!shown!to!secrete!IL^4/IFN^γ!therefore!representing!a!
!!
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Th0!profile,! the!CD4^! subset! is! characterised!by! the!selective!release!of! IFN^γ!and!hence!it!represents!the!Th1!pattern!(168,169)!.!!!!The! different! subsets! of! iNKT! cells! such! as! CD4+/CD8+! subsets! or! the! invariant/!non^invariant! NKT! subsets! were! shown! to! express! different! cell! markers.! For!example!non^iNKT!cells!are!never!CD4/CD8!DN!and!most!of!these!cells!are!CD161^!(131)! .! Furthermore,! different! subsets! of! NKT! cells! express! different! levels! of!chemokine! receptors! with! CD4+! cells! expressing! higher! levels! of! CCR4! and! CD4^!cells!expressing!higher!levels!of!CCR1,!CCR6!and!CXCR6!(160,169)! .!These!differences!in!expression!of!surface!markers!added!to!differences!in!cytokine!production!from!different! NKT! subsets! can! be! explained! by! identifying! these! subsets! as! distinct!functional! populations.! This! may! explain! the! extended! abilities! of! these! cells! to!regulate! the! immune! responses! through! different! antigen! recognition,! tissue!localisation! and! cytokine! production! patterns.! It! may! also! help! to! explain! the!contradictory! effect! of! NKT! cells! in! different! experiments! on! tumours! such! as!lymphoma!(134)!and!autoimmune!diseases!such!as!autoimmune!hepatitis!(170)!.!!1.7.4!iNKT!cell!function!
Activation!of! iNKT! cells! results! in!proliferation,!prolonged! cytokine! secretion!and!TCR!down!regulation!(171^173)!.!iNKT!cells!produce!not!only!!Th1!and!Th2!cytokines!such!as! IFN^?! and! IL^4,! respectively,!but!also! !produce!other!cytokines! including!IL^2,! TNF,! IL^5,! IL^13,! IL^10! and! IL^17! (160,174^176)! .! Human! iNKT! cells! are! also!reported! to! produce! growth! factors! for! hematopoietic! cells! such! as! GM^CSF! and!chemokines!such!as!macrophage! inflammatory!protein! (MIP^1α;!CCL3)!and! (MIP^1β;!CCL4)! (174,177)! .!Also,! these!cells!have!cytolytic!activity!due! to!perforin!and!Fas!ligand!(FasL!or!CD95L)!expression!(174)!.!!The!Th1!versus!Th2!outcome!of!iNKT!cell!activation!could!be!a!result!of!the!type!of!stimulation!or!ligand!and!it!also!could!be!inter^changeable!since!the!reaction!could!start! with! Th1! and! be! later! skewed! to! Th2! depending! on! immunological! and!stimulatory! circumstances.! It!was! recently! shown! that!human! iNKT!cells!produce!
!!
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distinct! cytokines! in! response! to! increasing!TCR! signal! strength! for! example!GM^CSF! and! IL^13! are! secreted! by! exposure! to! low! doses! of!αGalCer! and! the! higher!concentration!increase!the!secretion!of!these!cytokines!and!also!induces!IFN^γ!and!IL^4!(178)!.!The!addition!of!cytokines!to!iNKT!cells!during!ligand!stimulation!reduces!the! effective! level! of! stimulatory! concentration! of! that! ligand.! It! has! been! shown!that!in!the!presence!of!IL^12,!IL^15!and!IL^18!human!iNKT!cells!are!able!to!produce!IFN^γ,! but! not! IL^4,! in! response! to! suboptimal! TCR! stimulation! (57)! .! In! mice!however,! IL^12! alone! or! associated! to! TCR! stimulation! favours! the! production! of!IFN^γ!by!iNKT!cells,!whereas!IL^18!or!IL^17!increases!the!production!of!IL^4!(179^181)!.!Moreover,!recent!studies!have!shown!that!different! iNKT!cells!agonists!can!elicit!distinct! iNKT! cells! response.! OCH! for! example! preferentially! induces! IL^4!production! (182)! ,!whereas!αGalCer!promote!a!Th1!bias! in! the!cytokine!production!profile! of! mouse! iNKT! cells! (183)! .! Together! these! observations! suggest! that! the!effector! functions! displayed! by! iNKT! cells! are! strongly! influenced! by! the! nature,!strength! and! context! of! the! stimulus,! and! also! by! the! type! of! cytokines! and!chemokines!present.!! !
!!
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1.7.5!iNKT!cell!activation!
Many! different! self! lipids! have! been! shown! to! bind! CD1d! molecules! and! recent!findings! showed! that! human! iNKT! cells! could! be! stimulated! by!lysophosphatidylcholine!and!lysosphingomyelin!loaded!onto!CD1d!at!the!surface!of!antigen!presenting!cells! (184)! .!Such!reactivity!has!not!yet!been!extended!to!mouse!iNKT!cells,!and!it!is!not!clear!what!role!these!lysophospholipids!might!have!in!iNKT!cell!positive!selection!in!the!thymus!or!iNKT!cell!auto^reactivity!in!the!periphery.!!The! identification!of!microbial! iNKT!cell! antigens!provides! an!explanation! for! the!activation!of!iNKT!cells!by!some!microorganisms,!but!does!not!shed!any!light!on!the!ability!of! iNKT!cells!to!be!activated!in!response!to!microorganisms!that! lack!those!antigens!or!during!inflammatory!or!autoimmune!responses.!!Two!major!pathways!of! iNKT!cell! activation!during!microbial! infection!have!been!proposed;! direct! and! indirect! pathways! (Figure! 1.9).! The! direct! route! is! the!recognition! by! iNKT! cells! of! specific! microbial! lipids! presented! on! CD1d! by! APC!(53,185)! .! The! indirect! pathway! involves! activation! of! iNKT! cells! through! the!recognition! of! self^antigen,! which! could! occur! with! or! without! co^stimulation! by!cytokines! produced! by! APC! upon! TLR! signalling! (186)! such! as! IL^12! and! IL^18.!Moreover,!when!APC!are!exposed! to!microbial!pathogens,! they!can!also!stimulate!iNKT!cells! in! a!CD1d^dependent!manner! that!does!not! require!microbial! antigens!(52,53)!.!This!might!be!facilitated!by!the!presentation!of!a!self^antigen!by!CD1d!that!is!not!present!in!the!resting!condition!or!absence!of!microbial!invasion.!Furthermore,!iNKT!cell!sensitivity!toward!self^antigens!may!increase!in!the!presence!of!microbial!pathogens.!For!example,! it!was!reported!that! in.Salmonella!typhimurium! infection,!an! increase! in! human! iNKT! cell! responses! to! self^antigen^CD1d! complexes! is!amplified!by!IL^12!secreted!by!DC!(52)!.!Also,!Mallevaey!et!al.!showed!that!iNKT!cells!could! be! activated! by! self^antigens! presented! by! CD1d! when! challenged! with!
Schistosoma.mansoni.egg! antigen! even! in! the! absence! of!TLR! signalling! and! IL^12!(187)! .! A! year! later! Nagarajan! and! Kronenberg! et! al! demonstrated! that! iNKT! cells!could! be! stimulated! in! response! to! IL^12! and! IL^18! produced! by!DC! activated! by!
Escherichia.coli!lipopolysaccharide!(LPS)!in!the!absence!of!TCR!stimulation!(188)!.!!
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!There! are! similar! reports! in! mice! following! in. vivo! activation! of! iNKT! cells! by!different!TLR!ligands!such!as!LPS!and!R848!(189)!.!More!recent,!it!was!suggested!that!iNKT! cell! activation! during! microbial! infection! is! mainly! a! result! of! innate! and!cytokine^driven!signals,!rather!that!microbial!antigens!(190)!.!!Similar!mechanisms!might!be!involved!in!iNKT!cell!activation!during!inflammatory!and!autoimmune!responses,! implicating!production!of!TLR!ligands,!release!of!pro^inflammatory!cytokines!and!alteration!in!glycolipid!homeostasis.!!!!!!!! !
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Figure'1.10'Direct'and'indirect'activation'pathways'of'iNKT'cells'a)! Indirect!activation,!cytokine!and!endogenous^antigen!mediated.! ! !b)! Indirect!activation,!endogenous! antigen! mediated.! ! c)! Indirect! activation,! cytokine! mediated.!2
d)2Direct!activation,!iNKT!cells!are!activated!by!recognition!of!microbial!antigens!presented!by!CD1d!molecules!on!DC.!!(Figure!is!adapted!from!(186)!).!!1.7.6!iNKT!cells!in!diseases!
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prompted the authors to see if the same were true for a 
mycobacterial variant of PI. They found that a subset of 
mouse Vα14i NKT cells and human Vα24i NKT cells 
reacted to a variant of PI, a purified glycolipid extracted 
from a mycobacterium cell-wall fraction and enriched for 
PI tetramannosides (PIM4) (FIG. 3b). Analysis with PIM4–
CD1d tetramers showed that the reactive cells comprised 
only a minority of the α-GalCer–CD1d tetramer-positive 
cells, especially in the mouse liver, indicating that PIM4 
reactivity, similar to the Leishmania spp. LPG antigen, 
might be dependent on special features of the more vari-
able β-chain of the semi-invariant TCR, as the α-chains 
are identical. Another limitation of this study was that 
only purified glycolipid extracted from mycobacteria was 
used, leaving open the possibility that a minor constitu-
ent of the purified product was responsible for the Vα14i 
NKT-cell activation. Indeed, a later article reported that 
a synthetic version of PIM4 did not stimulate iNKT cells, 
either in vitro or in vivo82.
Natural glycosphingolipid antigens from Sphingomonas 
spp. The studies on Leishmania spp.- and mycobacteria-
derived phospholipids helped establish the principle 
that the invariant TCR of iNKT cells recognizes gly-
colipids from microbial agents. However, because only 
a minority of the cells reacted, these specificities could 
not account for the conservation and selection of the 
invariant TCR. In 2005, the publication of three articles 
on GSLs from Sphingomonas spp. described antigens that 
are capable of activating essentially all iNKT cells67,83,84. 
Sphingomonas spp. are Gram-negative bacteria that 
lack LPS and are highly abundant in the environment, 
including soil, sea water and plants85. Prior to these 
studies, analyses of Sphingomonas spp. bacteria had 
revealed the presence of glycosylceramides in the cell 
wall, with structures similar to α-GalCer, including the 
rather unusual α-linkage of the sugar to the sphingosine-
containing lipid86,87. The structures of two of these are 
shown in FIG. 3c. The abundance of these bacteria in 
Figure 4 | Invariant natural killer T (iNKT) cells have different pathways leading to their activation. a–c | Indirect 
activation. The three indirect pathways do not depend on recognition by the iNKT-cell T-cell receptor (TCR) of a microbial 
antigen, but depend on cytokine release by activated dendritic cells (DCs) and/or the recognition of endogenous 
glycolipid ligands. a | Cytokine- and endogenous-antigen-mediated activation. During Salmonella typhimurium 
infection, lipopolysaccharide (LPS) stimulates Toll-like receptors (TLRs) on DCs and induces interleukin (IL)-12 release. 
iNKT cells are activated by the combination of IL-12 produced by LPS-stimulated DCs and recognition of endogenous 
antigen presented by CD1d. It has not been determined if LPS induces upregulation of endogenous antigen in DCs. 
b | Endogenous-antigen-mediated activati n. Schistosoma mansoni gg-sensitized DCs induce IFN-γ a d IL-4 production 
by iNKT cells. In this response, TLR-mediated activation of DCs is not involved. However, recognition of endogenous 
antigen is required. It has not been determined if endogenous antigen is upregulated in S. mansoni egg-sensitized DCs. 
c | Escherichia coli-LPS-stimulated DCs for IL-12 and IL-18 release. These cytokines are sufficient for IFN-γ production 
by iNKT cells, and recognition of endogenous antigen presented by CD1d is not necessary for iNKT-cell activation. 
d | Microbial-antigen-mediated direct activation. Glycosphingolipids from Sphingomonas spp. and galactosyl-
diacylglycerols from Borrelia burgdorferi induce iNKT-cell activation by engaging their invariant TCRs. TLR-mediated 
DC activation, inflammatory cytokines such as IL-12 or recognition of endogenous antigen are not involved in this 
response. Modified with permission from REF. 102 © (2007) Macmillan Publishers Ltd. 
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Many! clinical! studies! have! reported! strong! association! between! iNKT! cell! defects!and! increased! susceptibility! to! many! diseases! such! as! autoimmune,! cancer! and!infectious!diseases!(192)!.!!The!link!between!iNKT!cells!and!human!diseases!are!categorized!into!three!groups!(192)!:!i.!defects!in!iNKT!cells!such!as!decreased!frequency!and/or!impaired!cytokine!production.!This!is!believed!to!affect!immune!regulation!and!increase!susceptibility!to! autoimmune! diseases,! cancer! and! some! infections! (153,193,194)! .! ii.! iNKT! cells!normal! in!number!and!functionally!competent!but!respond!inappropriately!to!self!(or! non! self)! glycolipid! antigens! or! cytokines! triggering! a! pathogenic! immune!responses! that!could! lead! to!diseases!such!as!atherosclerosis,!asthma,!allergy!and!skin! disorders! (153,195,196)! .! iii.! iNKT! cells! do! not! necessarily! contribute! to! disease!pathology,!rather!the!artificial!stimulation!of!iNKT!cells!by!administering!glycolipid!may!have!therapeutic!function!(197)!.!!
1.7.6.1'iNKT'cells'in'autoimmune'diseases'It! has! been! found! that! some! mouse! strains! that! are! genetically! susceptible! to!autoimmunity! have! defects! in! iNKT! cells! numbers! and/or! function! (194)! .! For!example,! non^obese! diabetic! NOD! mice! have! defects! in! iNKT! cell! frequency! and!cytokine!production!(198,199)!and!adoptive!transfer!of!iNKT!cells!or!overexpression!of!the!iNKT!cell!TCR!can!prevent!development!of!diabetes!(200)!.!In!other!studies!it!was!shown!that!over!expression!of!CD1d!(201)!or!stimulation!of!iNKT!cells!with!α^GalCer!also!prevents! the!development!of!diabetes! in!NOD!mice! (202)! .! In!contrast,! in! iNKT!cell!deficient!(CD1d!or!Jα^18!deficient)!NOD!mice!diabetes!was!exacerbated!(198,201)!.!In!humans,! contradictory!studies! reported!either!defective! iNKT!cells!numbers!or!function!in!individuals!with!or!at!high!risk!of!type!I!diabetes!(203,204)! ,!no!change!in!iNKT!cells!number!or!function!(205,206)!or!increased!iNKT!cells!numbers!in!patients!with! recent! onset! of! the! disease! (207)! .! These! conflicting! findings! can! be! due! to!genetic!and!environmental!factors,!patient!age,!stage!of!disease!or!even!the!method!used!to!characterise!iNKT!cells.!!!
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It!is!important!to!note!that!iNKT!cells!numbers!in!the!blood!of!NOD!mice!are!normal!despite!the!fact!that!there!are!significant!deficiencies!of!iNKT!cells!in!other!tissues!(208)!.!Moreover,!it!is!not!clear!whether!iNKT!cells!from!the!peripheral!blood!provide!a! better! indicator! of! the! systemic! iNKT! cell! pool! in! humans! than! in! mice.!Irrespective!of! these!conflicting!studies! in!human!type!I!diabetes,!altered!function!or! decline! in! numbers! of! iNKT! cells! have! been! observed! in! patients! with!rheumatoid! arthritis! (209,210)! and! multiple! sclerosis! (211,212)! supporting! the! link!between!iNKT!cells!defects!and!human!autoimmune!diseases.!!!
1.7.6.2'iNKT'cells'in'cancer'There!was! early! recognition! of! NKT! cell’! involvement! in! tumour! immunity!when!anti^tumour! properties! of! agelasphin! glycosphingolipids!were! discovered! (213)! .! A!year!after,!a!publication!about!the!NKT^mediated!prevention!of!some!cancers!such!as!melanoma,!erythroleukemia!and!lung!carcinoma!metastases,!demonstrated!after!injection!of!αGalCer!in!wild!type!mice!compared!to!Jα18!(214)!.!Notwithstanding!the!data! from! in! vitro! research! about! iNKT! cells! and! tumour! cells! that! showed!inconsistent!outcome,! in.vivo!studies!were!more!demonstrative!to!NKT!cells’!clear!role!in!controlling!the!formation!of!many!tumours!and!the!growth!of!metastasis!(215)!.! Shin! et! al! showed! that! IL^12^mediated! inhibition! of! tumour!metastasis! requires!Vα14!NKT!cells.!They!performed!adaptive!cell!transfer!of!five!types!of!mice,!1.!Wild!type!B6!mice!bearing!normal!numbers!of!B,!T,!NK!cells!and!Vα14!NKT!cells,!2.!Vα14!NKT–KO! mice,! ! 3.! Mice! with! only! Vα14! NKT! cells! but! no! other! lymphocytes,! 4.!TCRα^/^!Vα14!tg!mice!which!allow!mice!to!develop!Vα14!NKT!with!heterogeneous!Vβ^bearing!TCRβ! and!5.!RAG1^/^!mice! in!which!only!NK!cells!but!not!T,!B,!or!NKT!cells!are!developed.!They!injected!all!types!of!mice!with!IL^12!and!studied!the!liver!metastases!of!B16!melanoma!cells!by! investigating!the!change! in! liver!weight!and!metastatic!nodules.!The!results!showed!reduced!metastasis!in!the!liver!of!wild!type!mice,! mice! that! only! developed! Vα14! NKT! cells! and! TCRα^/^!Vα14tg! mice.! This!suggests! that! iNKT! cells! are! required! for! the! IL^12! dependent! anti^tumour! effect!(216)!.!!
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Furthermore,! later! research! indicated! a! similar! role! for!CD4^! iNKT! cell! subsets! in!surveillance! of! some! tumours! in! mice! (217)! and! their! cytokine! profile! in! humans!(160,174)!.!!A! decline! in! the! frequency! and! function! of! iNKT! cells!was! reported! in! peripheral!blood!of!cancer!patients!(218)!,!in!the!tissues!surrounding!the!tumour!(219)!and!in!the!tumours!themselves!(196)! .!Other!studies!showed!an!increase!in!intra^tumour!iNKT!cell! frequency! suggesting! an! anti^tumour! role! (220)! .! There!were! also! studies! that!reported! less! IFN^γ! production! by! iNKT! cells! in! some! patients! with! cancer!compared!with!iNKT!cells!in!healthy!individuals!(218)!.!!Finally,! frequency! of! iNKT! cells! was! shown! to! correlate! positively! with! tumour!prognosis! and! inversely! with! its! burden! (221)! although! whether! iNKT! cell!deficiencies!are!the!cause!or!the!effect!of!the!cancer!is!yet!to!be!investigated.!!
1.7.6.3'iNKT'cells'in'infectious'diseases'iNKT!cells!role!in!various!infections!has!been!reported!(31)!.!Compounds!in!bacterial!wall!such!as!LPS!can,!directly!or!indirectly,!activate!iNKT!cells.!The!direct!activation!is! prompted! by! antigenic! components! in! the! bacteria! cell! wall! such! as!glycoceramide,! which! normally! provide! rigidity! to! the! cell! walls! of! Gram! +ve!bacteria! (for! example! Ehrlichia! and! Sphingomonas)! (53)! .! This! results! in! the!secretion!of!both!IFN^γ!and!IL^4!(53,188)! .!On!the!other!hand,!compounds!originated!from! Gram! –ves! such! as! Salmonella! and! Mycobacteriae! skew! cytokine! secretion!towards!a!Th1!pattern!(52)!.!The!indirect!pathway!is!induced!by!the!activation!of!APC!by! LPS,! this! results! in! endogenous! ligand! presentation! (57)! .! The! latter! pathway!induces!mainly! IFN^γ! (53)! .! ! Also,!APC!derived! IL^12!plays! a! role! in! improving! the!activation!level!of!NKT!cells!to!fight!infectious!agents!(52)!.!!Few! studies! have! examined! the! role! of! iNKT! cells! in! human! bacterial! or!mycobacterial! infection.! Some! demonstrated! a! decrease! in! iNKT! cells! in! patients!with!pulmonary!tuberculosis!(222)!,!which!suggest!a!role!of!these!cells!in!the!disease.!!
!!
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Viral!infections!in!animals!such!as!Herpes!simplex!virus,!Influenza!A!and!HIV^1,!are!also!believed!to!involve!CD1d^presentation!(223)!.!Generally,!activated!NKT!cells!have!a!protective!role!as!CD1d^/^!animals!develop!more!severe!disease,!which!may!be!a!consequence!of!decrease! in!virus^specific!T^cell! frequency!prompted!by!NKT!cells!(31)! .! Moreover,! the! anti^viral! response! of! iNKT! cells! is! blocked! when! myeloid^derived! suppressor! cells! (MDSCs)! are! stimulated! (223)! and! when! the! virus^dependent!CD1d!presentation!is!disrupted!(224)!.!!In!humans,!the!involvement!of!iNKT!cells!also!has!been!reported!in!viral!infections.!For!example,!in!human!T^lymphotropic!virus!type!1!(HTLV^1;!(225)!and!influenza!A!(IAV,! (223)! )! the! positive! role! of! NKT! cells! in! the! course! of! viral! infections! is!well!documented.! Furthermore,! HIV^1! infection! has! been! widely! investigated! and!studies!showed!a!decrease!in!NKT!cell!frequencies!and!Th1!responses!(226)!.!!Finally,!NKT!cells!are!also!involved!in!inflammatory!responses!caused!by!parasites!(31)! .! It! seems! that!NKT!cells!have!different! involvement!depending!on! the! type!of!parasite! infection.! For! instance,! human! NKT! cells! were! found! to! kill! immature!dendritic! cells! infected!with!Leishmania.infantum! in! in.vitro! studies! (227)!whereas!Schistosomiasis!in!murine!strains!that!were!CD1d!^/^!and!!Jα18!^/^!!showed!different!NKT! cell! responses! (228)! .! The! former,! lacking! both! invariant! and! non^invariant!CD1d^restricted!NKT!cells,!produced!considerably!less!IL^4!after!infection,!but!IFN^γ! levels! were! maintained! unchanged.! On! the! contrary,! Jα18! ^/^! mice,! depleted! of!iNKT!cells!only,!demonstrated! the!opposite!pattern;!dramatically!decreased! IFN^γ!and! IL^4! remained! unchanged.! These! results! demonstrate! that! these! two! strains!differed! both! functionally! in! the! involvement! of! cytokine! production! and! in! the!degree!of!liver!fibrosis.!This!suggests!that!while!iNKT!cells!played!a!role!in!clearing!the! parasite! invasion! through! the! involvement! of! Th1! cells,! the! non^invariant!subsets!resulted!in!a!reduced!parasite!clearance!in!Jα18!^/^!mice!by!promoting!the!Th2!pathway!(228)!.!!Also,! Duthie! et! al.! reported! a! negative! role! for! the! non^iNKT! cell! subsets! in!
Trypanosoma. cruzi. infection! showing! that! these! cells,! by! supporting! the!
!!
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inflammation,! resulted! in! excessive! infection^induced! damage,! which! in! turn!increased!morbidity!and!mortality!of!infected!animals!(229)!.!!
1.7.6.4'iNKT'cells'in'autoimmune'diseases'The!early!connection!between!iNKT!cells!and!autoimmunity!was!in!the!lupus^prone!C57BL/6! lpr!mouse!model! (230)! .!The!study! found! inverse!correlation!between!the!prevalence!of!NK1.1+!cells!and!the!development!of!autoimmunity.!Later!there!was!acknowledgement!of!NKT!cells’!role!in!autoimmune!process!when!a!functional!and!numerical! defect! in! these! cells! was! observed! in! non^obese! diabetic! NOD! mice,!which! spontaneously! developed! insulitis! at! an! early! age.! This! was! caused! by!autoimmune!T!cell^mediated! inflammation! that!destroys! insulin^producing!β! cells!in! the! pancreas,! which! in! turn! results! in! severe! insulin! deficiency! and! prevents!efficient! glycaemic! homeostasis.! Studies! using! the! NOD! mouse! model! showed! a!decrease! in! the! population! of! NK1.1+! thymocytes! and! functional! defects! in! IL^4!secretion! (231)! .! Furthermore,! adoptive! transfer! of! NKT^enriched! thymocytes!prevented! the! development! of! diabetes! if! applied! before! the! onset! of! the! disease!(232)!.!!Similar! findings! were! reported! in! animal! models! of! SLE! (233)! and! autoimmune!hepatitis!(234)!.!The!suggested!explanation!of!iNKT!cells’!role!in!the!prevention!of!the!diseases! is! the! suppression! of! auto^reactive! CD4+!T! cell! clones! (84)! ,! which! CD1d^restricted!cells!seem!to!control!by!the!secretion!of!IL^4!(211,235)!or!direct!killing!(158)!.!!In!humans,! the! first! study!dealing!with! iNKT!cells! and!autoimmunity!was!also!on!type1! diabetes! and! demonstrated! the! importance! of! maintaining! the! IL^4/IFN^γ!cytokine!balance!by!CD4^!CD8^!iNKT!cells!in!the!prevention!of!disease!progression.!Wilson! et! al! demonstrated! in! their! study! that! invariant! Vα24! JαQ! T! cells! in!monozygotic! diabetic! twins/! triplets! were! reduced! in! numbers! and! secrete! only!IFN^γ!when! stimulated! compared! to! cells! from!at^risk^non!diabetic! twins/triplets!and!controls.!The!two!latter!groups!produced!both!IFN^γ!and!IL^4!(236)! .!Since!then!more!studies!have!demonstrated!similar!defects! in! iNKT!cell!populations! in!other!autoimmune!diseases!such!as!multiple!sclerosis!(211)!where!Araki!et!al!investigated!
!!
! ! 58!! ! !!
frequency! and! cytokine! production! in! ! healthy! subjects,! using! cell! lines! from!MS!patients! in! remission!and!cell! lines! from!MS!patients! ! at! relapse!after! stimulating!them!with!αGalCer.!They!demonstrated!a!reduction! in!DN!NKT!cells’! frequency! in!patients! in! remission! compared! with! patients! with! relapsed! MS.! However,! there!was!no!significant!difference!in!CD4+!cells.!Furthermore,!they!reported!that!a!CD4+!cell! line!expanded!from!MS!patients!in!remission!would!produce!larger!amount!of!IL^4! than! those! from! HS! or! from!MS! in! relapse! and! according! to! the! IL^4/IFN^γ!balance! they!were! significantly! Th2! biased.! ! In! another! study! Van! der! Vliet! et! al!compared!circulating!Vα24!Vβ11!NKT!cells!in!several!autoimmune!diseases!such!as!systemic!sclerosis,!psoriasis,!Crohn’s!disease!and!Sjogren’s!syndrome!with!healthy!subjects! and! reported! decreased! NKT! cells! in! the! autoimmune! diseased! patients!(237)!.!They!also!reported!that!in!some!autoimmune!diseases!such!as!Graves!disease!and!myasthenia!gravis!NKT!cell!frequency!did!not!differ!from!healthy!subjects.!This!data!concluded! that!Vα24!Vβ11!NKT!cells!numbers!decrease!only! in!autoimmune!diseases!that!are!characterised!by!auto!reactive!tissue!damage.!!!Moreover,! CD1d^restricted! activation! may! have! a! therapeutic! potential! in! these!autoimmune! disorders.! It! was! reported! that! αGalCer! prevented! development! of!diabetes! in! wild! type! mice! but! not! in! CD1d^deficient! NOD! mice! and! disease!prevention!correlated!with!the!ability!of!αGalCer!to!suppress!IFN^γ!but!not!IL^4!by!iNKT! cells! which! in! turn! increased! IgE! levels! and! triggered! pancreatic! islet!autoantigen^specific! Th2! cells! (202,238)! .! ! In! 2002! however,! Oikawa! et! al! published!contradictory! results! regarding! iNKT! cells! and!diabetes.!Their!data!demonstrated!higher! frequencies! of! Vα24+V11β+! iNKT! cells! in! patients! with! type! 1! diabetes!compared!to!healthy!donors!(207)!.!Also!and!in!the!same!year,!Lee!et!al!showed!that!there!was!no!impairment!in!iNKT!cells!both!functionally!and!numerically!in!CD1d^tetramer+!Vα24+!cell!population!in!IDDM!patients!(205)!.!These!reports!contradict!the!role!of!Vα24+!cells!in!this!disease,!which!may!need!more!investigation.!!
1.7.6.5'iNKT'cells'in'hypersensitivity,'allergy'and'asthma'iNKT!cells!function!as!regulators!that!prevent!excessive!inflammation!which!result!in!allergic!reactions,!asthma!and!immune^tolerance.!For!example,!iNKT!cells!have!a!
!!
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role!in!the!human!placenta,!which!can!be!considered!a!semi^allogeneic!graft.!It!was!found! that! there! are! high! numbers! of! NKT! cells! at! the!maternal^foetal! interface,!which! could! suppress! immune! responses! toward! the! foetus! (239)! .! However,! in!pregnant!mice!repeated!NKT!activation!by!αGalCer!over!time!led!to!abortion!(240)!.!!Most!studies!on!NKT!cells’!role! in!transplantation!suggest!that!these!cells!support!tolerance!towards!an!allograft!as!it!was!found!that!after!activation!of!NKT!cells!with!
αGalCer!in!mice!the!survival!of!allogeneic!islet!grafts!increased!(241)! .!Interestingly,!there!were!no!secreted!cytokines!and!the!effective!protection! from!graft!rejection!was!mediated!through!cell^cell!contact!(241)!.!!In!the!same!manner,!it!has!been!suggested!that!iNKT!cells!have!a!protective!role!in!human!atopic!dermatitis! since! their!numbers!were!considerably! reduced! in! these!patients! (242,243)! .! Furthermore,! the! CD4+/CD4^! iNKT! subset! balance! seemed! to! be!disturbed! with! CD4+! dominating! (242)! .! This! may! explain! the! Th2! domination!observed!in!atopic!dermatitis.!!!!On! the!other!hand,! there! are!many! research! studies! in!which! a!protective! role!of!NKT!cells!in!allergy!was!suggested!as!they!were!not!found!in!a!murine!allergic!skin!inflammation! model! (244)! where! NKT! cell! populations! had! an! important! role! in!promoting!Th2^dependent!airway! inflammation.!Moreover,! in!another!study,!NKT!cells!were!pro^inflammatory!by!overproduction!of!IL^4!and!IL^13!(245)!.!The!harmful!impact!of!iNKT!cells!on!the!course!of!asthma!has!been!especially!linked!to!their!IL^4!production!(245)!.!!!
1.8!Thymic!stromal!lymphopoeitin!TSLP!TSLP!is!an!epithelial!derived!cytokine!that!was!first!identified!in!the!supernatant!of!a! murine! thymic! stromal! cell! line! that! supports! B! cell! development! (246)! .! It! was!found! later! that! during! allergic! inflammation,! the! main! producers! of! TSLP! are!epithelial! cells,! keratinocytes! and! stromal! cells.! Moreover,! recent! studies! suggest!that!both!DC!and!mast!cells!are!able!to!produce!TSLP!(247^249)!.!
!!
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!1.8.1!TSLP!Structure!and!genome!
TSLP! consists! of! a! four^helix! bundle,! which! shares! an! overlapping,! but! distinct!biological!profile!with!IL^7!(Figure!1.10).!Like!IL^7,!TSLP!can!stimulate!thymocytes!and!promote!B!cell!lymphopoiesis!and!was!reported!as!a!B!cell!growth!factor!(250)!.!Human!and!murine!TSLP!share!a!substantial!degree!of!functional!homology!despite!the!fact!that!both!have!only!43%!amino!acid!identity!(251,252)!.!! !
!!
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!!!!!!!!
Figure'1.10'TSLP'structure'View!of!the!four^helical!bundle!core!of!TSLP.!Trp132!is!located!at!the!centre!of!the!core!and!engages! in! stacking! interactions! with! Tyr34! that! stabilize! the! π^helical! turn! in! helix! A.!Trp132,! Thr71! and! Thr90! coordinate! the! water! molecule! in! the! core! of! TSLP.! The! void!volume!observed!in!the!core!of!TSLP!(105!Å3)!is!displayed!as!a!mesh.!(Adapted!from!Nature!structural!and!molecular!biology)!!!!In!mice! the!TSLP!gene! is! located!on! chromosome!18.!This! gene! is! expressed!as! a!140!!amino!acid!protein!with!three!potential!N^glycosylation!sites!(253)!whereas!!in!humans! the! gene! is! located! on! chromosome! 5q22.1! next! to! the! atopic! cytokine!cluster!on!5q312!and!is!159!amino!acid!long!with!two!N^glycosylation!!sites.!!1.8.2!TSLP!secretion!!
The!mRNA!for!TSLP!is!produced!mainly!by!epithelial!cells!in!the!thymus,!lung,!skin,!intestine! and! tonsils.! Stromal! cells! and! mast! cells! also! produce! it! (253,254)! .!Furthermore,!cross^linking!high^affinity!IgE!receptors!in!mast!cells!result!in!the!up^regulation!of!TSLP!mRNA!(255)!.!!!!In!human!thymus,!the!key!expression!of!TSLP!is!accountable!for!regulatory!T!cell!(T!reg)! differentiation! and!DC!modulation! (TSLP! expressed! by! the! epithelial! cells! in!the!thymic!medulla!,!activates!CD11c!positive!DC!to!express!high!levels!of!CD80!and!CD86! which! in! turn! induce! the! differentiation! of! Treg! cells)! (256)! .! Furthermore,!mucosal! DC! are! conditioned! through! the! constitutive! release! of! TSLP! by! the!
!
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epithelial! cells! which! results! in! the! induction! of! non^inflammatory! DC! releasing!!cytokines! that! polarise! T! cells! towards! non^inflammatory! T! helper! type! 2,!which!may!have!a!role!in!tolerance!to!the!commensal!flora!(254)!.!!!Many!publications! have! reported! that!TSLP! can!be! induced!by! exogenous! stimuli!(including!trauma,!bacterial!infection,!Toll^like!receptor!ligands!and!microbial!flora)!and!host^derived!pro^inflammatory!and!Th2!cytokines.! In!both!mice!and!humans,!TSLP! secretion! by! airway! epithelial! cells! was! provoked! by! the! exposure! to! pro^inflammatory! mediators! such! as! IL^1β,! TNF^α! and! some! TLR! agonists! especially!TLR2,! TLR8! and! TLR9! (257)! .! An! up^regulation! of! TSLP! in! primary! human! airway!epithelial! cells! is! dependent! on! NFκB! and! interferon! regulatory! factor! signalling!through!TLR3!and!is!induced!by!both!Th2!cytokines!and!TLR3!ligand!(ds!RNA).!!In!addition! to! that,! infection! of! airway! epithelial! cells! with! rhinovirus,! which! is! a!common! respiratory! virus! that! leads! to! exacerbation! of! asthma,! can! cause! TSLP!expression!through!stimulation!of!TLR3.!This! is! improved!by!IL^4!and!suppressed!by!glucocorticoids!(258)!.!!1.8.3!TSLPr!and!TSLPr!expression!
Many!studies!identified!a!receptor!capable!of!binding!TSLP!with!low!affinity!(TSLPr!subunit),!which!shares!24%!identity!to!the!common!γ!receptor!chain!(γc)!(259,260)!a!subunit! found! in! the! receptor! complexes! for! many! interleukins,! particularly!including!IL^7! (261)! .!More!detailed!analysis!revealed!that! the! functional!TSLPr! is!a!heterodimeric!receptor!that!consists!of!the!TSLPr!subunit!and!IL^7Rα!chain!in!both!mice!and!humans!(253,260)!.!!In!contrast!to!the!restricted!expression!of!TSLP,!TSLPr!is!more!widely!distributed.!The!mRNA!for!this!receptor!is!expressed!amongst!many!immune!cell!types!such!as!DC,!T!cells,!B!cells,!mast!cells,!monocytes!and!NKT!cells.!TSLPr!is!also!expressed!in!tissues! including! heart,! skeletal!muscle,! kidney! and! liver,!which! suggest! that! this!cytokine!can!operate!on!a!wide!range!of!cell!types!(262)!.!!
!!
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1.8.4!TSLP!signalling!
Recent! research! on! primary! human! DC! and! primary! human! and!mouse! CD4! +!! T!cells! shows! activation! of! JAK^1! and! JAK^2! as! a! result! of! TSLPr! signalling! (263,264)! .!Remarkably,! it! was! revealed! that! the! TSLPr! subunit! bound! and! utilised! JAK^2! in!concert! with! IL^7Ra^associated! JAK^1! where! the! latter! and! γc! in! IL^7! signalling!utilize! JAK^1!and! JAK^3.!These! findings! shed! light!on! the!mode!of!TSLP! signalling!and! proved! that! TSLP! induced! JAK! activation! precedes! STAT! protein! activation.!Arima!et!al!demonstrated!that!in!human!peripheral!blood^derived!CD11c+!DC!TSLP!stimulation!activated!STAT!1,3,4,5!and!6!alongside!JAK!1!and!2!(263)! .!Kitajima!and!Ziegler!et!al!found!similar!results!on!mouse!DCs!except!there!was!no!involvement!of!STAT!6!(265)!.!Although!this!data!suggest!the!involvement!of!many!STAT!proteins!in!TSLP! signalling! in!DC! and!CD4+! T! cells! this! is! yet! to! be! investigated! in! other! cell!types.!!1.8.5!Target!cells!of!TSLP!!
There! is!a! long! list!of!responding!cell! types! to!TSLP,!which!suggests!an! important!role!of!TSLP!in!the!initial!response!to!an!epithelial!insult.!These!include,!DC,!CD4+!and! CD8+! T! cells,! B! cells,! mast! cells,! basophils,! eosinophils! and! NKT! cells.! It! is!important!to!understand!the!balance!in!TSLP’s!role,!while!its!normal!function!is!to!maintain!Th2^type!homeostasis!at!barrier!surface!(266)!,!unregulated!TSLP!secretion!can!cause!a!type!2!inflammatory!response!leading!to!allergic!disease.!!!
1.8.5.1'NKT'cells'and'other'innate'immune'cells'TSLP!has!a!role!in!the!initiation!of!innate!stage!of!allergic!inflammatory!response!by!directly!acting!on!several! innate! immune!cells! such!as!eosinophils,!mast!cells!and!NKT!cells!which!lead!to!the!production!of!pro^inflammatory!and!Th2!cytokines!(267^269)!.!This!activation!serves!in!prompting!the!innate!phase!of!allergic!reaction!in!the!absence!of!T!lymphocytes!and!IgE!antibodies.!This!was!proved!by!the!data!showing!that!K5^TSLP! transgenic!mice!on!a!TCRβ^/^!background!acquire!skin! inflammation!with!epidermal!thickening!and!infiltration!of!mast!cells!and!eosinophils!(270)!.!
!!
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!In!humans,!TSLP!can!directly!activate!mast!cells!to!produce!pro^inflammatory!Th2!cytokines!in!the!presence!of!IL^1β!and!TNF^α!(270)!!!There! are! not!many! studies! about! TSLP! and!NKT! cells.! Nagata! et.al!were! first! to!investigate! the! effect! of! TSLP! on! NKT! cells,! in! terms! of! both! proliferation! and!cytokine! production,! particularly! in! allergic! immune! responses.! They! carried! out!RT^PCR! experiments! and! FACS! staining! on! purified!mouse! splenic! NKT! cells! and!found! that! all! CD4+! and!CD4^!CD8^! cells! express! TSLPr! and! IL^7! receptor!α! chain.!After!that,!to!investigate!the!effect!of!TSLP!on!NKT!cells!they!co^cultured!these!cells!in! different! environments!with! or!without! anti^CD3!mAB,! and! in! the! presence! or!absence!of!anti^CD28mAB!and!soluble!recombinant!TSLP.!They!demonstrated!that!there!was!no!significant!effect!when!CD3!was!solely!stimulated.!Similarly,!neither!anti^CD28!nor!TSLP! induced!proliferation.!Only! co^stimulation!of!CD3!or!CD28! in!the! presence! of! TSLP! induced! noticeable! proliferation.! Their! data! suggested! that!TSLP! co^stimulates!NKT! cell! proliferation! upon! TCR^mediated! stimulation.! In! the!same!manner! and! upon! investigating! cytokine! production! the! data! revealed! that!NKT! cells! co^stimulated! with! TSLP! or! anti^CD28! mAB! alone! produced! small!amounts!of! IL^4! and! IFN^γ.!However,! sole! stimulation!with!TSLP! significantly!up^regulated!IL^13!production.!Moreover!the!addition!of!TSLP!to!anti^CD3!stimulation!had! more! effect! on! apparent! up^regulation! of! cytokine! production! than! anti^CD28mAB! (267)! .!Moreover,! they! also! demonstrated! that! K5^TSLP! transgenic!mice!failed!to!develop!airway!hyper^reactivity!in!the!mouse!asthma!model.!!!In!other!studies! it!was!demonstrated! that! there! is!an! increase! in!TSLP! levels!and!iNKT! cells! frequencies! in! skin! lesions! of! atopic! dermatitis! patients.! Furthermore,!they! found! that!TSLP!directly,! through!TSLPr! activated! iNKT! cells! to! secrete! IL^4!and!IL^13!but!also!IFN^γ!in!co^cultures!with!DCs!(162,271)!.!!!
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1.8.6!TSLP!involvement!in!diseases!
TSLP! can! promote! type! 2! inflammation! through! many! different! routes.! Indeed,!many! studies! provided! evidence! on! the! direct! link! between!TSLP! expression! and!some!allergic!diseases!such!as!asthma!(272)!and!AD!(247)!.!Also,!TSLP!may!have!a!role!in!other!diseases!such!as!autoimmune!diseases!(273)!and!cancer!(274)!.!!! !
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Aims!and!hypothesis!
!The!major!hypothesis!examined!in!this!thesis!is!that!iNK!T!cells!act!at!the!interface!between! innate! and! adaptive! immune! systems! and! ! can! secrete! cytokines!which!have! the! potential! to! stimulate! Th1! or! Th2! type! T! cell! responses.! iNKT! cell!responses! can! be! modified! by! cytokines! such! as! TSLP! when! ! present! during!activation.!!!The!aims!in!this!project!were!three!fold:!!Firstly,!to!isolate!and!measure!iNKT!cells!from!the!blood!of!healthy!volunteers!and!to!culture!these!cells! in.vitro.!As!part!of!this!work!iNKT!cell!proliferation!response!to! in. vitro! antigen! exposure! was! investigated! including! identification! of! optimal!time!point,!type!of!ligand!and!ligand!concentration!that!produced!the!highest!iNKT!cells!numbers.!These!experiments!are!described!in!chapter!3.!!Second,! phenotypic! identification! of! iNKT! cells! was! carried! out! before! and! after!specific!antigen!exposure.!This!included!determining!if!iNKT!cells!express!the!TSLP!receptor!and!therefore!have!the!potential!to!respond!to!TSLP!directly.!This!work!is!reported!in!chapter!4.!!Finally,! the! effect! of! TSLP! stimulation! on! iNKT! cell! proliferation! and! cytokine!production! with! and! without! their! specific! ligand! KRN7000! was! performed.! ! As!reported! in! chapter! 5! iNKT! cells! in! a! mixed! PBMC! population! were! first!investigated.!The!results!were!subsequently!extended!and!confirmed!using!purified!iNKT!!cell!lines!as!described!!in!chapter!6.!! !
!!
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Chapter!2:!Materials!and!Methods!
2.1!Blood!samples!Blood! samples! were! obtained! from! healthy! volunteers! after! informed! consent.!Ethical!approval!was!obtained!from!the!Liverpool!Research!Ethics!Committee,!Ref.!No.!!2K/175.!!Up! to! 20ml! of! blood!was! collected! using! venepuncture! in! plastic! vials! containing!600μl! of! 1000U/ml! of! preservative^free! heparin! (Wockhardt! UK! Ltd,! Wrexham).!The!heparin!final!concentration!in!collected!blood!was!30U/ml.!!Donors’! ages! varied! between! 20^58! years! without! preference! for! either! male! or!female!gender.! ! In!donor!selection,! inclusion!and!exclusion!criteria!were!not!used!except!for!ones!that!ensure!donors!to!be!healthy.!This!included!simple!past!medical!history!check!(7!days)!to!ensure!that!donors!did!not!show!symptoms!of!any!disease!and!that!they!were!not!taking!any!medication!at!the!time!of!sample!collection.!
2.2!PBMC!preparation!!For!PBMC!separation!10ml!of!heparinized!blood! from!healthy!donors!was!slowly!layered! on! an! equal! volume! of! Ficol! Hypaque! (Sigma)! in! 50ml! falcon! tubes.! The!density! gradient! centrifugation!was! carried! out! in! centrifuge! for! 20!min! at! 400g!(1800!rpm)!at!room!temperature!and!with!the!brake!off.!!Peripheral! blood! cells! (PBMC)! accumulating! in! the! interface! between! the! plasma!and!the!Ficol!layers!were!harvested!into!a!universal!tube,!washed!twice!with!10ml!of! phosphate! buffered! isotonic! saline! (PBS)! by! centrifuging! for! 10min! at! 400g!(1800!rpm)!at!room!temperature.!The!cell!pellet!was!re^suspended!in!10ml!culture!medium!(RPMI!1640!+!10%!heat!inactivated!FBS!(both!Sigma)!+!antibiotic!mixture!of! Penicillin,! Streptomycin! and! 2mM! L^glutamine).! Cells! were! counted! using! a!Haemocytometer! and! light! microscope.! Cells! were! counted! in! 5! large! squares!
!!
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(1mmx1mmx0.1mml)! and! number! of! cells! was! divided! by! 5! to! for! the! average!number! in!one!square!(n).!Cell! concentration!per!1ml!was!counted!as!nx10x1000!cells/ml!and! the!dilution!needed! to!bring! the!cells! to!a!concentration!of!1!million!cell!was!added.!!!!!!!!!!!!!
Figure'2.1'Haemocytometer'for'PBMC'counting.''PBMC!were!counted!in!the!four!peripheral!large!squares!and!the!middle!one.!Cells!that!were!crossing! the! left! and! the! bottom! lines! of! each! square! were! excluded! to! avoid! double!counting.!! !
!!
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2.3!Tissue!culture!2.3.1!PBMC!stimulation!and!expansion!assay!
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2.3.1.2'Optimised'PBMC'stimulation'assay'The! stimulation! assay! was! optimised! for! stimulant! type! (Section! 3.5),! stimulant!concentration! (Section! 3.4)! and! best! stimulation! time! (Section! 3.3).! Different!experiments! were! performed! using! PBMCs! from! different! donors! with! various!types!of!stimulants!at!different!concentration!for!each!one!(Table!2.1).!Cell!response!was!assessed!by!surface!staining!and!FACS!analysis!for!iNKT!cells!at!different!time!points.!Stimulation!responses!were!compared!using!relative!expansion!of!iNKT!cells!compared!to!the!population!percent!at!day!0!for!the!same!PBMC!population.!!The! ligand! at! the! best! concentration! for! the! best! time! point! that! produced! the!highest!response!was!selected!for!further!iNKT/!PBMC!stimulation!assays!(Section!3.4).!!!!PBMCs! (1! million! cells/ml)! were! placed! in! a! six! well! plate! (3ml/well).!AlphaGalactosylceramide!was! re^suspended! in! 1%DMSO!with! PBS! and! added! to!the! wells! in! different! concentrations.! Cells! were! stained! and! analysed! using! a!FACSCalibur!(Figure!3.4)!at!different!time!points.!!
2.3.1.2'PBMC'stimulation'PBMC!in!culture!medium,!RPMI!with!10%!FBS!(1million!cells/ml)!were!put!in!a!six!well!plate!(3ml/well).!AlphaGalactosylceramide!(KRN7000)!was!re^suspended!in!1%! DMSO! with! PBS! and! added! to! the! wells! at! a! concentration! of! 100ng/ml.! In!further! experiments! TSLP! (Immunotech)! was! also! added! to! each! well! at! the!concentration!of!10µl/ml.!Cells!were!incubated!in!a!capnofilic!incubator!at!5%!CO2,!37°C!and!high!humidity!for!fourteen!days.!At!day!7!cells!were!topped!up!with!the!same!volume!of!culture!medium!and!the!same!concentration!of!KRN7000!and!TSLP!in!later!experiments.!Contamination!was!regularly!checked!both!macroscopically!by!looking! for! any! change! in! the!media! colour! and! turbidity,! and!microscopically! by!looking! for! any! live! bacteria! in! the! inverted!microscope.! Cells!were! stained!with!surface!anti^V?24,!anti^CD3/CD4,!and!anti^CD161!antibodies!as!shown!in!tbale!2.2!(Figure!3.4,!for!example),!data!acquired!and!analysed!using!a!BD!FACSCalibur!and!
!!
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CellQuestPro! software! at! day! 0! (fresh! PBMC)! and! day! 14! (stimulated! cells).!Stimulation!and!proliferation!were!assessed!by!relative! increase! in! the!percent!of!iNKT!cells!at!day!fourteen!compared!with!percent!at!day!0.!!For! the! ELISA! experiments! at! day! fourteen! cells! were! washed! twice! using! 10ml!sterile! PBS! and! centrifuged! for! 10min! at! 400g.! Then! cells! were! counted! and!adjusted!to!1million!cells/ml!in!culture!medium.!1million!cells!were!then!put!in!a!24!well! plate,! re^stimulated! (secondary! stimulation)! with! 100ng/ml! of! KRN7000! or!10µl/ml!of!TSLP!alone,!or!both!KRN7000!and!TSLP!together.!Plates!were!incubated!in! a! capnophilic! incubator! with! 5%CO2!at! 37°C! and! high! humidity! for! a! further!48hours.! After! 48hrs! supernatants! were! collected! by! centrifuging! for! 10min! at!400g.!!
2.4!Immunological!staining!techniques!2.4.1!FACS!monoclonal!antibody!immunological!staining!
Monoclonal! antibodies! bound! to! different! fluorescent! dyes!were! used! to! identify!and!stain!both!surface!antigens!and!intra^cellular!molecules.!!!In! multiple! staining! experiments,! monoclonal! antibodies! that! are! bound! to!different!dyes!with!different!emission!wave!lengths!were!used!(Table!2.2).!! !
!!
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!!Monoclonal!antibody! Conjugated!fluorescent! Volume! Company! Catalogue!number!Anti^CD3! PE^Cy5! 2µl! BD! 555334!Anti^CD4! PerCP^Cy5.5! 2µl! BD! 332772!Anti^CD161! FITC! 2µl! BD! 556080!Anti^Vα24! PC^CY7! 20µl! BC! A66907!Anti^Vα24! PE! 20µl! BC! IM2283!Anti^TSLPr! PE! 10µl! R&D!SYSTEMS! FAB981P!Anti^IgG1! PE! 2µl/10µl! BC! IM2283!Anti^IgG1! FITC! 2µl! BD! 555057!Anti^IgG1! PE^CY5! 2µl! BD! 555750!Anti^TLR2! FITC! 2µl! IMGENEX! IMG^6320C!Anti^TLR4! FITC! 2µl! IMGENEX! IMG^417C!Anti^IgG1! PC^CY7! 20µl! BC! PN737682^BA!
Table22.22List2of2antibodies2used2in2this2work2with2their2source,2catalogue2numbers2
and2volume.22All!antibodies!were!added!to!100µl!of!cell!suspension.!!
2.4.1.1'Surface'immunological'staining'500,000cells/ml! were! harvested! from! culture! plates! and! placed! into! 5ml! falcon!FACS!tubes.! !FACS!tubes!were!centrifuged!at!400g!for!10min.!After!discarding!the!supernatant!the!cells!were!washed!twice!in!PBS!by!centrifuging!at!400g!for!10min!each! time.! The! cell! pellet!was! then! re^suspended! in! 100µl! of! PBS.! Triple! staining!was!performed!by!adding!three!different!fluorescent!conjugated!antibodies,!PE^anti!V?24!or!PC^CY7!anti!V?24,!PC^CY5.5!anti!CD3!or!PC^CY5!anti!CD4!and!FITC^anti!CD161.! Tubes! were! incubated! on! ice! for! 30min! then! washed! twice! with! PBS! by!centrifuging!at!400g!for!10min.!After!the!last!wash!cell!pellet!was!re^suspended!in!500µl!of!PBS!and!analysed!using!a!FACSCalibur!from!BD!Biosciences.!Acquired!data!was!analysed!using!Cell!Quest!Pro!software.!!!
!!
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2.5!Viability!staining!2.5.1!Viability!staining!using!Propidium!Iodide!
10µl!of!10?g/ml!Propidium!Iodide!(Sigma!Aldrich)!was!added!when!samples!were!ready! to! be! acquired! in! the! FACSCalibur.! Viability!was! assessed! by! excluding! the!high!red!fluorescence!cluster!of!cells!appearing!in!the!FL2!channel.!!2.5.2!Viability!staining!using!Trypan!Blue!
Two!vials!of!liquid!nitrogen^frozen!invariant!natural!killer!cell!line!(iNKT!cell!line)!were! kindly! provided! by! Professor! Stephan! Gadola! (University! of! Southampton).!10µl! of! Trypan! Blue! 0.4%! (Sigma!Aldrich)!was! added! to! 10µl! of! the! thawed! and!rested! cell! line.!When! cells! are! damaged! or! dead,! trypan! blue! can! enter! the! cell!allowing!viable!cells!to!be!counted!using!a!haemocytometer.!Then!the!viability!ratio!is!calculated!in!comparison!to!the!total!cell!count.!!
2.6!Flow!Cytometry!set!up!and!analysis!After!cell!acquisition!analysis!was!carried!out!using!the!software!CellQuest!Pro!from!BD.!Based!on!the!FSC!and!SSC!of! the!total!population.!The! lymphocyte!population!was!gated.!Matching! isotype!controls!were!used!for!each! fluorochrome! ! to!set! the!cut! off! point! between! negative! and! positive! population! for! each! conjugated!antibody.! This! also! allows! detection! and! compensation! for! non^! specific! binding.!Dotplots!were!mainly!used! in! this!work!since! the!cell!population! in! interest!were!always! double! stained! with! their! specific! anti! Vα24! antibodies! and! another!antibody! (CD3,! CD4,! CD161! or! TSLPr)! and! in! many! experiments! it! was! triple!stained.! Quadrants! determining! positivity! were! set! according! to! the! matching!isotype!controls.!CellQuest!inbuilt!statistical!program!determined!%!of!total!cell,!%!of!gated!cells!and!the!mean!fluorescence!intensity!values.!!!
!!
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!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
Figure'2.2'dot'plot'illustrating'FACS'analysis'setting'up''A.!Gating! for! lymphocyte! population! on! the! forward! and! side! scatter! profile,! B.! Anti^IgG1!isotype!control! for!the!purpose!of!setting!the!cut!off!points!for!negative!values,!C.!Staining!with!anti^Vα24^PE!and!anti^CD4^PerCP!and!setting!the!quadrants!for!positive,!negative!and!double!positive!population.!!!2.7!Enzyme!Linked!Immunosorbent!assay!(ELISA)!2.7.1!ELISA!principle!
!!The! enzyme! linked! immunosorbent! assay! (ELISA)! is! used! for! the! detection! and!quantification!of!proteins!typically!secreted!or!released!from!cells.! Immobilizing!a!target^specific! capture! antibody! onto! a! high! protein! binding! capacity! ELISA! plate!enables! capture! of! target! protein.! The! captured! protein! is! then! detected! by! a!protein^specific! biotinylated! antibody.! The! target! protein! is! quantified! using! a!colorimetric!reaction!based!on!activity!of!avidin^horseradish!peroxidase!(bound!to!the! biotinylated! detection! antibody)! on! a! specific! substrate! (TMB).! The! optical!density!of!the!end^product!is!measured!using!a!spectrophotometer!or!plate!reader.!
!!
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2.7.2.!Cell!preparation!for!ELISA!analysis!
The! iNKT! cells’! response! to! the! combined! stimulation! of! their! specific! ligand!KRN7000!and!TSLP!was!investigated!by!detecting!an!array!of!cytokine!production!by! iNKT! cells! using! an! ELISA! technique.! ! PBMC!were! stimulated! with! 100ng/ml!KRN7000!and!10µl/ml!TSLP!for!fourteen!days.!At!day!14!a!sample!of!the!cells!was!stained!with!anti^!V?24!(specific!iNKT!cell!marker),!anti!CD3/CD4!and!anti!CD161!to!assess!iNKT!cell!response!and!to!determine!whether!the!donor!was!a!responder!or! a! non^responder.! The! rest! of! the! cells!were!washed! twice!with! sterile! PBS! by!centrifuging!10min!each!at!400g!at! room!temperature.!Cells!were!put! in!a!24well!plate! and! re^stimulated!with! KRN7000,! TSLP,! or! both! KRN7000! and! TSLP! at! the!same!concentration!as!above.!Plates!were!incubated!in!a!capnophilic!incubator!with!5%!CO2!at!37°C!and!high!humidity!for!48hrs.!Supernatants!were!collected!at!48hrs.!!2.7.3!Protocol!
Five! cytokines! were! investigated:! IL^4,! IL^13,! IL17,! IFN^?! (Ready^Set^Go! human!interleukin!ELISA!kits!from!eBioscience,!catalogue!numbers!88^7046^22,!88^7439^22,!88^7176^22,!88^7316^22!respectively)!and!IL^33!(R!and!D!SYSTEMS,!Catalogue!number!DY3625)!and!used!according!to!the!manufacturer’s!instructions.!!A! 96^well! high! protein! binding! capacity! ELISA! plate! was! coated! using! 100µl! of!relevant! capture! antibody! (diluted! in! accordance! to! the! kit! instruction! in! coating!buffer)! and! left! over! night! at! 4°C! or! at! room! temperature,! depending! on! the! kit!protocol.!After!five!washings!in!5%!tween!20/PBS!making!sure!to!get!rid!of!excess!liquid!in!wells!by!gentle!tapping,!the!plate!was!blocked!in!100μl!1×!Assay!Diluent!or!1×!Reagent!Diluent!(dilutions!from!10×!or!5×!were!in!distilled!water).!Plates!were!sealed! with! a! plastic! cover! and! incubated! for! an! hour! at! room! temperature.! As!before,! the! plate! was! then! washed! five! times.! ! 100µl! of! serially! diluted! protein!standard!for!a!total!of!7!or!8!data!points!and!100µl!of!neat!samples!was!added!to!wells! in! duplicates.! The! plate! was! covered!with! a! plastic! sheet! and! incubated! at!room!temperature!for!two!hours.!Another!five!washes!were!performed!like!before.!
!!
! ! 76!! ! !!
100μl!diluted!detection!antibody!was!added!after!that.!The!plate!was!covered!in!a!plastic!sheet!and!incubated!for!an!hour!at!room!temperature.!The!plate!was!washed!as! before! and! 100μl! of! Avidi^HRP!was! added! to! each!well,! the! ! plate!was! sealed!again! and! incubated! away! from! direct! light! at! room! temperature! for! 30min.!!Washing!was!performed!seven!times!as!before.!100μl!substrate!(TMB)!was!added!to!each!well.!The!plate!was!covered!and!incubated!for!15!min!away!from!direct!light!at!room!temperature.!The!enzyme^substrate!reaction!was!stopped!by!adding!50μl!of! stop! solution! (2N! H2SO4).! The! plate! was! read! using! a! microplate!spectrophotometer!reader!at!450nm.!!2.7.4!!Standard!ELISA!curves!!
ELISA! plates! were! read! using! a! plate! reader! and! results! were! analysed! using!MasterPlex!software!according! to!a! five^point!parametric! curve.!All! samples!were!tested!in!duplicate.!!A! five^point! standard! curve! for! ELISA!measurement!was! constructed! using! eight!serial! dilutions! of! each! cytokine! standard.! The! curves! were! constructed! using!Masterplex! software! and! the! curves! accuracy! was! estimated! from! Masterplex!parameters.!!!After! the! construction! of! each! of! the! five^point! curves! each! standard! dilution!concentration!was!re^estimated!and!a!per!cent!of!the!recovery!error!was!measured.!A! cut^off! point! of! 33%! or!more! was! selected! and! any! standard! point! showing! a!percentage!recovery!error!of!33%!or!more!was!rejected!as!an!outlier.!!An!ELISA! standard! curve! for! IFN^γ! cytokine!measurement!was! constructed!using!serial! dilutions! of! a! standard!with! a! concentration! of! 500ng/ml.! The! seven! point!serial! dilutions! were! made! using! a! dilution! factor! of! two! between! consecutive!points! and! ranged! from! 500ng/ml! down! to! 7.82ng/ml.! Outliers! were! identified!from!constructing!a!preliminary! five^parameter! logistics!curve!and!calculating!the!concentration! of! standard! points! using! this! curve.! A! percentage! of! recovery!
!!
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(percent! of! calculated! standard! concentration! divided! by! actual! diluted!concentration)!was!used!to!include!or!exclude!standard!points.!All!points!!showing!a!recovery! less!or!more! than!70%!were!considered!as!outliers!and!were!excluded!from!the!final!five^parameter!logistics!curve.!! !
!!
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!!!!!!!!!!!!!!
Figure'2.3(A)'FirstVpass'standard'curve'for'IFNVγ'ELISA'using'serial'dilutions.''After! calculating! the! five^point! parameter! curve! all! standard! absorbances! were! used! to!calculate!estimated!standard!concentration!levels.!The!recovery!values!of!these!points!were!used! to! spot!outliers! (*).!Any!point!with! a! recovery!outside!100±50%!were! labeled!as! an!outlier!and!excluded!from!the!second!pass!of!five^parameter!calculations.!!!! !
!!
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!!!!!!!!!!!
Table22.32IFNSγ2ELISA2standard2curve2absorbance2and2calculated2values.2Extreme!recovery!deviations! (more! than!50%)!were!used! to! identify!and!exclude!outliers!(denoted!by!*).!!!! !
Response!value! Calculated!value! Independent!value! Residuals! Recovery!(%)!1.425! 514.823! 500! 14.823! 102.965!1.349! 485.638! 500! ^14.362! 97.128!0.727! 251.174! 250! 1.174! 100.47!0.714! 246.335! 250! ^3.665! 98.534!0.413! 134.566! 125! 9.566! 107.653!0.384! 123.799! 125! ^1.201! 99.039!0.203! 56.363! 62.5! ^6.137! 90.181!0.198! 54.489! 62.5! ^8.011! 87.182!0.138! 31.914! 31.3! 0.614! 101.962!0.137! 31.536! 31.3! 0.236! 100.754!0.105! 19.391! 15.6! 3.791! 124.301!0.123*! 26.235! 15.6! 10.635! 168.173!0.085! 8.734! 7.81! 0.924! 111.831!0.087! 8.503! 7.81! 0.693! 108.873!0.042! <3.90! 3.9! NA! NA!0.046! <3.90! 3.9! NA! NA!
!!
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!!!!!!!!!!!!!!
Figure'2.4(A)'FirstVpass'standard'curve'for'ILV13'ELISA'using'serial'dilutions.''After! calculating! the! five^point! parameter! curve! all! standard! absorbances! were! used! to!calculate! an! estimated! standard! concentration! levels.! The! recovery! values! of! these!points!were!used!to!spot!outliers!(*).!Any!point!with!a!recovery!outside!100±50%!were!labeled!as!an!outlier!and!excluded!from!the!second!pass!of!five^parameter!calculations.!! !
!!
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!!! Response!value! Calculated!value! Independent!value! Residuals! Recovery!(%)!2.035. 513.289. 500. 13.289. 102.658.1.952. 489.899. 500. ^10.101. 97.98.1.082. 251.55. 250! 1.55. 100.62.1.027. 236.739. 250. ^13.261. 94.696.0.66. 137.937. 125. 12.937. 110.35.0.617. 126.319. 125. 1.319. 101.055.0.383. 62.579. 62.5. 0.079. 100.126.0.35. 53.474! 62.5. ^9.026. 85.558.0.272. 31.743. 31.25. 0.493. 101.578.0.275. 32.586. 31.25. 1.336. 104.275.0.223! 17.853. 15.625! 2.228! 114.259.0.256*. 27.234. 15.625. 11.609. 174.298.0.205. 10.672. 7.813. 2.859. 136.593.0.196. 8.056. 7.813! 0.243. 103.11.
Table22.42ILS132ELISA2standard2curve2absorbance2and2calculated2values.2Extreme!recovery!deviations! (more! than!50%)!were!used! to! identify!and!exclude!outliers!(denoted!by!*).!!!! !
!!
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2.8!iNKT!cell!separation!using!anti^PE!magnetic!beads!2.8.1!Principle!and!cell!preparation!
iNKT! cells! were! separated! using! an! EasySep! ! kit! from! STEMCELL! (catalogue!number!18551).!!A!tetrameric!antibody!complex!(PE!selection!cocktail)!targets!cells!labelled!with!PE!conjugated!antibodies!and!links!them!to!dextran!coated!magnetic!nanoparticles.!Labelled!cells!are!pulled!to!the!sides!of!the!tube!when!the!sample!is!placed! in! an! EasySep™!magnet.!Magnetically! labelled! cells! (the! positive! selected)!will!remain!in!the!tube!while!un^labelled!cells!(the!negative!selected)!can!be!poured!off!into!a!new!tube.!!This!method!is!fast!and!only!takes!about!an!hour.!It!has!high!cell!purities,!more!than!95%,!and!high!recovery.!Also,!this!method!is!versatile!since!it!uses!anti!PE!dye!it!can!be!used!for!any!monoclonal!antibody!that!is!conjugated!to!that!dye.!Although!it!is!a!fast!method!however,!only!one!sample!can!be!used!at!a!time.!!
! !
Figure'2.5'The'binding'mechanism'of'the'dextran'coated'magnetic'beads.'Tetrameric! antibody! complexes! bind! to! magnetic! nanoparticle! through! anti^dextran!antibody!and!to! target!cell! (iNKT)! through!anti^PE!antibody!(using! the!PE^labeled!specific!antibodies!for!target!cell!anti^Valpha!24).!!!!PBMC! were! stimulated! with! KRN7000! (100ng/ml)! and! TSLP! (10ng/ml)! and!incubated!for!14days!in!a!capnophilic!high!humidity!incubator,!CO2!5%!at!37°C.!At!
EXAMPLE: EASYSEP® PE SELECTION PROFILE - MOUSE CD4
Start: 16.4% CD4+ Cells Selected: 98.1% CD4+ Cells
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Product Information Sheet.
Catalog #18551 (Human) For labeling 109 total cells
Catalog #18554 (Mouse) For labeling 109 total cells
Catalog #18557 (Other) For labeling 109 total cells
Components:
• EasySep® PE Selection Cocktail 1.0 mL
• Species-Specific Blocker (Human & Mouse Only):
Anti-Human CD32 (Fcγ RII) Blocker (#18551 Only) 1.0 mL
Mouse FcR Blocker (#18554 Only) 0.1 mL
• EasySep® Magnetic Nanoparticles 1.0 mL
• RoboSep® Vial for Primary Conjugated Antibody (not required for manual use) 1 vial
EXAMPLE: EASYSEP® PE SELECTION PROFILE - HUMAN CD3
Start: 27.8% CD3+ Cells Selected: 98.7% CD3+ Cells
CD3 PE
REQUIRED EQUIPMENT:
EasySep® Magn t (Catalog #18000), or “The Big Easy” EasySep® Magnet (Catalog #18001),
or RoboSep® (Catalog #20000).
PRODUCT DESCRIPTION AND APPLICATIONS:
EasySep® PE Selection Cocktail and EasySep® Magnetic Nanoparticles target cells that are
labeled with PE-(phycoerythrin-)conjugated an ibodies ( ot supplied) for magnetic separation.
The species-specific FcR blocker (anti-human CD32, anti-mouse CD16/32) is used to
prevent non-specific selection of monocytes and macrophages. Note: When selecting cells
from other species, an appropriate species-specific FcR blocking antibody may be required
to achieve desired purities. A final concentration of 0.5 - 3.0 µg/mL is recommended for the
blocking antibody. These reagents are designed to positively select cells labeled with
PE-conjugated antibody.
EASYSEP® LABELING OF CELLS:
Tar et cells that have been specifically lab led with PE-conjugated antibody are then labeled
with dextran-coated magnetic nanoparticles using bispecific Tetrameric Antibody Complexes
(TAC). These complexes recognize both dextran and the PE molecule on the PE-conjugated
antibody (Figure 1). Magnetically labeled cells are then separated from unlabeled cells using
the EasySep® procedure (reverse side).
NOTES AND TIPS:
Preparing a Cell Suspension. Prepare a mononuclear cell suspension from human
peripheral blood by Ficoll-Paque™ PLUS density separation (Catalog #07957). Previously
frozen mononuclear cells should be incubated with 100 µg/mL DNase I (Catalog #07900) in
medium without EDTA for at least 15 minutes at room temperature prior to labeling and
separation to reduce clumping. Filter clumpy suspensions through a 70 µm mesh nylon
strainer for optimal results. Mouse spleen and bone marrow cells should be prepared
following standard procedures and filtered through a 70 µm mesh nylon strainer.
Recommended Medium. The recommended medium is PBS with 2% FBS (Catalog
#07905) and 1 mM EDTA. Medium should be Ca++ and Mg++ free.
Assessing Purity. Since the positively selected cells have already been labeled by the PE-
conjugated antibody, their purity can be assessed by flow cytometry without additional
labeling.
Optimizing Purity. For samples with a desired cell starting frequency of less than 10 - 15%,
additional separation rounds will likely improve purity. If desired, repeat Steps 7 and 8 an
additional 1 - 3 times. Please note that recovery will decrease with each additional round of
separation. When isolating cells representing less than 2% of the initial population,
the purity of the enriched sample may be improved by starting with a cell concentration of
2 x 108 cells/mL. For some cell types, decreasing the amount of PE Selection Cocktail added
can increase purity while decreasing recovery. This will also reduce side scatter during
subsequent flow cytometry analysis. Performance may also be improved by adding a wash
step. After incubating the sample with PE-conjugated antibody (Step 3), wash once with
10-fold excess medium and resuspend to original volume. Please note that this wash step
can not be automated by RoboSep®.
Optimizing Recovery. Recovery of positively selected PE-labeled cells is dependent on the
quality of the PE-conjugated antibody used. Antibodies that have expired or that have been
stored improperly may show lower affinity for the surface marker on the target cell, resulting
in lower recovery. It is important to add sufficient PE-conjugated antibody to ensure a
significant fluorescence intensity of the target cells, as there is a strong correlation between
fluorescence intensity and cell recovery.We recommend that the fluorescence intensity of the
positively selected cells be at least 100-fold (2 logarithms) greater than that of the negative
control for adequate recovery. Recovery may also be improved by increasing separation times
















EasySep® PE Selection Cocktail code #18151
This cocktail contains a combination of monoclonal antibodies purified from hybridoma culture
supernatant by affinity chromatography using Protein A or Protein G Sepharose. These
antibodies are bound in bispecific tetrameric antibody complexes (TAC) which are directed
against PE (phycoerythrin) and dextran. These mouse monoclonal antibodies are of subclass
IgG1. This cocktail is supplied in phosphate buffered saline. It should be noted that this product
is a biological reagent, and as such cannot be completely characterized or quantified. Some
variability is unavoidable.
Anti-Human CD32 (Fcγ RII) Blocker code #18520
This antibody recognizes human CD32 (Fcγ RII) present on monocytes, platelets, macrophages,
and granulocytes. Supplied in phosphate buffered saline.
EasySep® Mouse FcR Blocker code #18720
This antibody recognizes mouse CD16/CD32 (Fcγ III/II Receptor) present on monocytes,
macrophages and other FcR+ cells. Supplied in phosphate buffered saline in 0.1% BSA and
0.1% sodium azide.
EasySep® Magnetic Nanoparticles code #18150
A suspension of magnetic dextran iron particles in water.
RoboSep® Vial for Primary Conjugated Antibody code #18550
Empty vial compatible with RoboSep® - the fully automated cell separator. If using RoboSep®,
transfer PE-conjugated antibody to this empty vial before loading into the appropriate position
in the RoboSep® carousel. If not using RoboSep®, this vial can be discarded.
STABILITY AND STORAGE:
EasySep® PE Selection Cocktail. Stable at 4°C for 2 years. Do not freeze this product.
Contents sterile in unopened tube. This product may be shipped at room temperature, and
should be refrigerated upon receipt.
Human or Mouse FcR Blocker. Stable at 4°C for 2 years (human) or 1 year (mouse).
Contents sterile in unopened tube. This product may be shipped at room temperature, and
should be refrigerated upon receipt. Do not freeze.
EasySep® Magnetic Nanoparticles. Stable at 4°C for 2 years. Contents sterile in unopened
tube. This product may be shipped at room temperature, and should be refrigerated upon
receipt.
Hazardous Ingredient: Sodium Azide. Avoid exposure to skin and eyes, ingestion and
contact with heat, acids and metals. Wash exposed skin with soap and water. Flush eyes with
water. Dilute with running water before discharging into plumbing.
Ficoll™ and Ficoll-Paque™ PLUS are trademarks of GE Healthcare Ltd.
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Schematic Drawing of EasySep®
TAC Magnetic Labeling of Cells.
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day7! fresh! media! with! both! stimulants! at! the! same! starting! concentration! was!added!to!each!well.!!!At! day14! a! FACS! staining! and! analysis!was!performed! to!determine!whether! the!subject!is!a!responder!or!a!non^responder!according!to!the!percent!increase!in!iNKT!cells!in!comparison!with!the!day0!percentage.!!!!!2.8.2.!Protocol!
14days! cultured! cells! were! harvested! and! put! into! 12×75mm! (5ml)! FACS! tube!bringing!the!final!volume!to!700µl.!Final!concentration!was!0.4×107cell/ml.!100µl!of!human! FcR! blocking! was! added! with! gentle! mixing! and! 50µl! of! anti! Va24^PE!conjugated!antibodies!was!added!at! final! concentration!of!0.3^3.0µg/ml.!This!was!optimised! by! achieving! fluorescent! intensity! of! the! positively! selected! cells! to! be!100^fold!greater!than!the!negative!control.!!!The!tube!was!incubated!for!15min!at!room!temperature!and!away!from!direct!light.!100µl/ml! cell! of! PE! selection! cocktails! was! added! with! mixing.! The! tube! was!incubated! for! 15min! at! room! temperature! and! away! from! direct! light.! ! The!magnetic! Nanoparticles! were! added! at! 50µl/ml! cells,! pipetting! up! and! down!vigorously!5! times!and! incubated! for!10min!at! room!temperature!and!away! from!direct!light.!!!The! cell! suspension! was! brought! to! a! total! volume! of! 2.5ml! by! adding!recommended! medium! (PBS! with! 2%! FBS! and! 1mM! EDTA,! Ca++! and! Mg++! free,!!catalogue! number! 07905)! and! the! suspension! was! mixed! by! 2^3! times! gentle!pipetting.!The!tube!was!placed!into!an!EasySep!magnet!(catalogue!number!18000)!and!left! for!5min!at!room!temperature.!While!the!tube!was!still! in!the!magnet!the!supernatant!fraction!was!poured!off!into!a!universal!tube.!The!magnetically!labelled!cells!remained!inside!the!tube!held!by!the!magnetic!field!of!the!EasySep!Magnet.!!!
!!
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After!removing!the!tube!from!the!magnet!2.5ml!of!medium!was!added!with!mixing!by! gentle! pipetting.! The! tube! was! placed! again! in! the! magnet! and! left! at! room!temperature! for! 5min.! After! repeating! the! last! two! steps! for! couple! of! times!bringing!the!5min!separation!to!a!total!three!times,!the!tube!was!removed!from!the!magnet!and!positively!selected!cells!were!resuspended!in!1ml!of!the!recommended!medium.!The!negatively!selected!cells!were!kept!as!a!negative!control!and!to!assess!the!recovery.!
2.9!Cytometric!magnetic^bead!array!assay!Samples!from!this!project!were!included!in!a!multiparameter!cytometric!magnetic^bead!array!experiment!performed!by!Dr!B!Michael.!A!brief!principle!of!the!protocol!will!be!discussed!here.!!The!kit!for!the!assay!was!from!Affymetrix,!Milano!Italy!and!it!assessed!thirty!eight!mediators! (cytokines,! chemokines! and! associated! enzymes)! and! the! choice! of!cytokines! was! based! on! the! reflection! of! leucocyte! proliferation/differentiation!(granulocyte^colony! stimulating! factor! G^CSF,! granulocyte^macrophage^colony!stimulating! factor! GM^CSF,! Granzyme! B,! myeloperoxidase! MPO,! leptin! and!eSelectin),! leucocyte! chemotaxis! (CCL2,! CCL3,! CCL5,! CXCL9,! CXCL10),! adhesion!molecules!(vascular!cell!adhesion!molecule!VCAM,!intercellular!adhesion!molecule!ICAM),! marker! of! blood^brain! permeability! (vascular! endothelial! growth! factor!VEGF)!and!matrix!metalloproteinases!MMP,!antiviral!polypeptides!(!interferon!IFN^
α,β,ο,?! ,! TNF! α! and! its! soluble! receptor! TNFR1! and! TNFR2)! and! TNF! related!apoptosis!including!ligand!TRAIL.!Also!pro^inflammatory!interleukins!(LI^1α,!1β,!6,!8,!17a)!and!anti^inflammatory! interleukins! (! IL^1^receptor!antagonist,! IL1RA,! IL^4!and!IL^10).!!Fluorescence!intensity!was!determined!using!a!Bio^Rad!platform!(BioPlex!Manager!4.1,!Bio^Rad!laboratories).!Standards!and!samples!were!analysed!in!duplicates!with!the!mean!value!used!in!analysis.!Measurements!with!coefficients!of!variation!more!that!20%!were!removed.!!
!!
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2.10!Statistical!Analysis!!In! order! to! select! statistical! analysis! tests! for! each! data! set! the! normality! of! the!distribution! of! these! data! sets! was! first! investigated.! The! normality! check! was!performed!using!the!GraphPad!prism!v5.01!software.!The!significance!of!the!results!was! accepted! as! a! cut! off! level! of! 5%! of! p! values.! All! data! set! investigated! was!normally! distributed! (p<0.05)! and! for! all! further! statistical! tests! parametric! tests!were!selected!without!any!need!of!data!transformation.!!!The! analysis! of! PBMC! iNKT! cell! levels! in! healthy! donors! was! performed! using!GraphPad! prism! 5.01! statistical! package.! Each! specific! statistical! test! used! is!detailed!in!its!relevant!place!in!each!results!chapter!(3,!4,!5!and!6).!The!significance!cut! off! point! was! selected! at! p<! 0.05! and! significant! differences! were! shown! on!corresponding!graphs!as!a!*!(0.01<P<0.05),!**!(0.001<P<0.01)!or!***!(P<0.001).!!!In! the! statistical! analysis! for! experiments! that! involved! paired! readings! of! two!different!populations,!a!paired!student!t^test!was!used!using!the!software!package!GraphPad! prism! version! 5.01.! When! more! than! two! populations! with! paired!readings!are!involved!ANOVA!analysis!was!used!to!test!whether!the!populations!are!significantly! different! from! each! other.! After! that! each! pair! of! populations! was!tested!whether!they!are!different!from!each!other!using!Tukey’s!post!test!analysis.!Both!ANOVA!and!Tukey’s! test!were!performed!using!GraphPad!prism.!Correlation!between!values!of!two!populations!were!performed!by!calculating!R!squared!using!regression! analysis! with! GraphPad! prism! version! 5.01.! The! significance! of! the!regression! analysis! was! estimated! by! calculating! a! P! value! using! the! Pearson!product^moment! correlation! coefficient! using! an! on^line! calculator!(http://www.vassarstats.net;!November/!2014).!!! !
!!
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!Chapter! 3! :! Optimising! investigation!parameters! of! iNKT! cell! stimulation!and!identifying!normal!values!of!iNKT!cell!subsets!in!healthy!volunteers!
!! !
!!
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3.1!Aim!The!major!objective!of!the!work!presented!in!this!thesis!is!to!examine!the!function!and!role!of!iNKT!cells!in!healthy!human!blood.!!As!discussed!in!Chapter!1!these!cells!are!found!in!the!peripheral!blood!and!other!organs!of!human!body.!!!In! this! chapter! experiments! were! aimed! to,! optimize! and! test! the! best! available!monoclonal!antibodies!that!specifically!target!the!variable!Vα24!part!of!the!human!T! cell! receptor! (TCR).! ! This! was! done! by! testing! four! different! fluorescent^conjugated!anti^Vα24!antibodies!and!analysed!by!FACSCalibur.!!!!Second,!iNKT!cell!frequency!in!blood!from!15!healthy!volunteers!was!measured!in!order!to!investigate!iNKT!cell!percentage!and!numbers.!!!Third,!this!chapter!aimed!at!optimising!the!time!point!at!which!the!best!iNKT!cell!increase! is! achieved,! the! best! stimulating! ligand! and! the! best! working!concentration.!!!As! mentioned! in! Chapter! 1,! iNKT! cells! recognize! glycolipid! antigens! that! are!presented! on! the!MHC! class! I^like!molecule! CD1d.! Three! glycolipid! ligands! were!used!in!this!study!to!stimulate!iNKT!cells!in!vitro.!In!order!to!do!that!the!time!point!at!which! these! ligands! caused! the! optimal! iNKT! cell! proliferation! and!percentage!increase! compared! with! the! day! 0! values! was! investigated.! Three! ligands! were!used,! α! GalactosylCeramide! or! KRN7000,! iGb3! and! GSL^1.! In! addition! to! these!ligands!LPS!and!PG!were!used!to!study!their!effect!on!iNKT!cells.!FACS!analysis!was!used!to!investigate!iNKT!cell!percentages!at!day7,!day10!and!day14.!!Once!that!was!established!a!comparison!between!all!five!ligands!used!before!in!this!study! was! conducted! to! determine! the! most! effective! one! in! stimulating! and!inducing!iNKT!cell!proliferation.!!Finally,! since! all! the! ligands! were! synthetic! or! semi^synthetic,! three! different!bacterial!extracts,!from!Salmonella,!Pseudomonas!and!Pneumococcus!were!used!to!
!!
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study! the!possibility! of! an! induction! and! stimulation! effect! of! a! natural! ligand!on!iNKT!cells.!!! !
!!
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3.2!Materials!and!Methods!!iNKT!cells!are!a!subset!of!T!cells.!They!have!a!specific!and!restricted!V!chain!in!their!TCR!called!Vα24.!Also,!iNKT!cells!have!some!of!the!natural!killer!receptors!such!as!CD161.!The!fact!that!iNKT!cells!belong!to!both!groups!was!used!to!identify!them!in!this! research.! All! three! different! markers! were! conjugated! with! three! different!compatible!fluorochromes.!!!PBMCs!were!isolated!as!mentioned!in!Chapter!2.2,!triple!stained!with!anti^Vα24!PE,!anti^! CD3! PCY5.5! and! CD161! FITC.! Cells!were! analysed! using! the! FACSCalibur! as!described!in!Chapter!2.4.1.2.!A!gate!was!set!around!the!lymphocyte!population!and!the!Vα24+,!CD161+!cells!and!the!Vα24+!CD3+!populations!were!assessed!as!shown!in!Figure!3.1.!!All! FACS! staining! was! performed! in! comparison! to! the! matching! fluorescent!conjugate!IgG!isotype!control!to!detect!any!nonspecific!binding!!
Salmonella.bacterial!extract!was!kindly.provided!by!Professor!P.!Wigley!(Infection!Biology,!IGH,!University!of!Liverpool).!Soluble!Salmonella!lysates!were!prepared!as!follows,! overnight! cultures!were! used! to! inoculate! 100ml! broth! and! incubated! at!37°C! and! 150rpm.! After! that! to! obtain! bacterial! pellets,! cultures!were! aseptically!transferred! into! sterile! tubes! and! centrifuged! at! 400x! g! for! 25min! at! 4C°.! After!pouring!off! the!supernatant!the!bacterial!pellet!was!re^suspended!in!20ml!X1!PBS!and! incubated! in!water! bath! at! 65°C! for! 5! hours! and! small! aliquots!were! put! in!nutrient!agar!and!incubated!overnight!at!37°C!(275)!.!!! !
!!
! ! 92!! ! !!
The! Pneumococcal! extracts! were! also! kindly! provided! by! Professor! A.! Kadioglu!(CIMI,!IGH,!University!of!Liverpool)!and!were!prepared!from!overnight!cultures!of!the!bacteria!at!37°C!in!brain!heart!infusion!(BHI).!Then!they!were!sub^cultured!and!grown!to!an!OD500!of!1.2^1.6!in!BHI!then!boiled!at!100°C!for!15min.!!!! !
!!
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!!3.3!Results!3.3.1! iNKT! cell! measurement:! selection! of! the! best! working!monoclonal!anti^Vα24!antibody!
There! are! many! types! of! antibodies! directed! against! the! human! invariant! alpha!chains!of!the!CD3!complex!in!iNKT!cells.!Firstly!a!comparison!of!iNKT!cell!staining!with! four! different! fluorescent! conjugated! antibodies! was! conducted.! These!antibodies! were! Beckman! Coulter! PE,! Becton! Dickinson! PE,! eBiosciences! PE! and!Beckman!Coulter!FITC.!!!As! part! of! this! analysis! the! affect! of! antibody! concentration! on! cell! staining!was!measured.!All! these!antibodies!were!assessed!at!different!concentrations! for! their!ability!to!stain!iNKT!cells!and!identify!them!as!a!distinct!population.!In!general,!to!1×106!cells!5µl,!10µl!or!20µl!were!used!to!stain!the!cells!beside!the!recommended!manufacturer!volume,!if!it!was!not!already!one!of!the!above.!!! !
!!
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3.3.1.1'Detection'of'Vα24'positive'PBMC:'Beckman'Coulter'(BC)'PE'conjugate'Three!different!experiments!were!performed!using!Bechman!Coulter!PE!conjugate!monoclonal!antibodies.!!After!separating!PBMC!as!described!in!Chapter!2!cells!were!stained! with! anti! Vα24! PE! conjugate! monoclonal! antibodies.! Three! different!concentrations! of! the! anti! Vα24! antibodies! were! used,! 5µl,! 10µl! and! 20µl.! The!lymphocyte!population!was!gated!according!to!the!forward!and!side!scatter!(Figure!3.1!a).!A!matching!PE!conjugate! isotype!control!was!used!to!eliminate!nonspecific!bindings!at!only!one!concentration!of!20µl!(Figure!3.1b).!The!negative!cut!off!point!was!determined!according!to!the! isotype!control,!which! is!at! just!after!101.!At! the!three! different! concentrations! there!was! a! clear! and! distinct! separation! between!positive! and! negative! populations.! ! In! the! example! shown! here! the! iNKT! cell!frequency!was!0.29%!at!5μl!concentration,!0.36%!at!10μl!and!0.41%!at!20μl.!These!results!were!consistent! in! the! three!experiments!performed.!The!concentration!of!20μl!was!used!in!proceeding!experiments!throughout!this!project.!!! !
!!







Figure'3.1'DotVplots'showing'an'example'of'antibody'staining'using'BC'PE'conjugate.'PBMC!isolated!from!a!healthy!donor!were!stained!with!three!different!concentrations!using!BC!PE!conjugate!anti!Vα24!antibodies!in!three!different!concentrations!5μl,!10μl!and!20μl.!After! gating! for! lymphocytes! (A)! and! excluding! nonspecific! binding! by! using! 20µl! PE!conjugate!matching! isotype! control! (B),!which! also! determined! the! cut! point! for! negative!readings,! the! figure! shows! two! distinct! positive! and! negative! populations! in! all! three!concentrations!with! iNKT!cells!consisting!of!0.29%,!0.36%!for!and!0.41%!for!5μl!(C),!10μl!(D)!and!20μl!(E),!respectively.!! !
!!
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!!
3.3.1.2.'Detection'of'Vα24'positive'PBMC:'BectonVDickinson' (BD)'PE' conjugate'
antiVVα24'antibodies'In! the! same! manner! as! the! previous! antibody,! three! experiments! on! different!donors! with! BD! PE! conjugate! were! performed.! All! experiments! failed! to! show!distinct!positive!and!negative!populations.!At! all! concentrations! it!was!difficult! to!identify!positively!stained!cells.!Furthermore,!at!higher!concentrations!a!shift!in!the!negative!population!towards!positive!values!made!it!more!difficult!to!identify!Vα24!PE! stained! iNKT! cells.! The! percentage! of! lymphocytes! that!was! positive! for! iNKT!cells!staining!was!0.65%,!4.15%!and!29.62%!at!the!concentration!of!5μl,!10μl!and!20μl;!respectively.!!PE! conjugated! IgG1! isotype! control! at! 20μl! concentration!was! used! to! determine!the! cut^off! point! for! the! negative! population! and! to! eliminate! background!nonspecific! staining! (Figure! 3.2).! Only! one! graph! of! the! isotype! control! was!presented!here!as!all!the!concentrations!showed!similar!staining!patterns.!! !
!!
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!
3.3.1.3'Detection'of'Vrom'a'healthy'donor'were'stained'with'three'different24'
antibody'Similar! to! the! previous! antibodies! three! experiments! with! eBiosciences! PE!conjugate! also! failed! to! show! distinct! positive! and! negative! populations! in! three!independent!samples! investigated.! It!was!difficult!at!all! concentrations! to! identify!the! positively! stained! cells.! The! shift! in! the! negative! population! towards! positive!values! made! it! difficult! to! identify! iNKT! cells! similar! to! BD! PE! conjugated!antibodies.!As!in!the!BD!antibodies!the!shift!towards!the!positive!values!increases!as!the!concentration!of!the!antibodies!increased.!The!readings!in!percentage!of!the!whole! lymphocytes! was! 14.80%,! 61.51%! and! 81.82%! for! 5?l,! 10?l! and! 20?l;!respectively! with! obvious! decrease! in! the! negative! population! in! the! lower! left!quadrant.!Again,! isotype! control! IgG1!was!used! to!determine! the! cut^off!point! for!the!negative!population!and! to! eliminate!background!nonspecific! staining! (Figure!3.3).!! !
!!
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Fig' 3.3' DotVplots' showing' an' example' of' antibody' staining' using' eBiosciences' PE'
conjugate.'PBMC!isolated!from!a!healthy!donor!were!stained!with!three!different!concentrations!5,!10!and!20µl!of!BD!PE!labeled!antibody!conjugate!to!Vα24.!After!gating!for!lymphocytes!(A)!and!excluding! nonspecific! binding! by! using! 20µl! PE! conjugate! matching! isotype! control! (B),!which!also!determined!the!cut!off!point!for!negative!readings,!the!figure!shows!a!clear!shift!towards!the!positive!population!rather!than!two!distinct!separate!ones.!This!becomes!more!apparent!as!the!concentration!of!the!antibodies!increases!consisting!of!14.80%,!61.51%!and!81.28%!for!5μl!(C),!10μl!(D)!and!20μl!(E),!respectively.!!
!!
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3.3.1.4.'Detection'of'Vα24'positive'PBMC:'Beckman'Coulter'(BC)'FITC'conjugate'!Similar! to! the! previous! antibodies! all! experiments! with! BD! FITC! conjugate!antibodies! failed! to! produce! any! distinct! staining.! ! For! three! different! healthy!donors! it!was! difficult! to! detect! any! FITC! signals! on! the! FACSCalibur! at! all! three!different!concentrations!of!5,10!and!20µl.!(Data!not!shown).!! !
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3.3.2! ! Frequencies! of! iNKT! cells! in! freshly! collected! blood! in!healthy!donors.!
!Fifteen! different! healthy! volunteers! from! staff! and! students! in! the! University! of!Liverpool! ! ! were! enrolled! to! investigate! the! prevalence! of! iNKT! cells! in! freshly!collected! peripheral! blood.! Ethical! approval! for! the! use! of! blood! samples! from!healthy!subjects!was!obtained! from!The!Liverpool!Research!Committee!(2K/175).!Informed! consent! was! obtained.! Blood! was! collected! from! these! subjects! and!Peripheral!Blood!Mononuclear!Cells!(PBMCs)!were!separated!using!Ficol^hypaque!separation!method!as!described!in!Materials!and!Methods.!Relative!percentages!of!iNKT! cell! populations! were! measured! after! staining! with! Beckman^Coulter! PE!conjugate!anti^Vα24!antibodies!and!gating!for!lymphocytes!using!forward!and!side!scatter!(Figure!3.4).!!Some!experiments!were! repeated! for! certain! individuals!more! than!once,! and! for!statistical! analysis! purposes,! these! experiments! were! considered! as! single!experiments!using!their!average!numbers.!!The! normal! values! for! iNKT! cell! relative! concentrations! in! PBMC! for! these!individuals!ranged!from!0.22%!and!0.96%!(Figure!3.5).!!! !
!!














freshly'collected'PBMCs.'!The! figure!shows!scatter!plots! for! lymphocyte!gating! (A)!after!double!staining!with!Vα24!and!CD161!(C)!for!Donor!11!with!elimination!of!the!non!specific!background!staining!using!matching! isotype! control! (B).! Total! iNKT! cells! in! subject! 11! are! 1.21%! with! 0.13%! are!CD161! positive.! In! the! same! manner! for! Donor! 13,! lymphocyte! gating! (D)! after! double!staining! with! Vα24! and! CD161! (F)! with! elimination! of! nonspecific! background! staining!using! isotype! control! (E).! Total! iNKT! cells! in! subject! 13! are! 0.28%! with! 0.02%! CD161!positive.!! !
!!
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DONOR!NUMBER! TOTAL! iNKT!cells!(%)! CD161! Positive!(%)! CD4! Positive!(%)!D!01! 0.40! 0.08! 0.12!D!02! 0.45! 0.09! 0.12!D!03! 0.53! 0.06! 0.20!D!04! 0.62! 0.14! 0.37!D!09! 0.46! 0.05! 0.21!D!10! 0.60! 0.14! 0.31!D!11! 0.96! 0.25! 0.45!D!12! 0.33! 0.05! 0.19!D!13! 0.22! 0.04! 0.11!D!14! 0.41! 0.08! 0.23!D!15! 0.38! 0.06! 0.15!D!19! 0.41! 0.06! 0.26!D!20! 0.84! 0.20! 0.51!D!21! 0.33! 0.06! 0.19!D!29! 0.72! 0.18! 0.47!!
Table2 3.12 iNKT2 cell2 values2 at2 day2 02 with2 the2 CD1612 positive2 and2 CD42 positive2
subpopulations2in2percentages.2For! 15! different! healthy! volunteers! the! total! iNKT! cells! day! 0! numbers! varied! between!0.22%! and! 0.96%.! The! CD161! positive! iNKT! cells! at! day! 0! ranged! between! 0.04%! and!0.25%.!CD4!positive!iNKT!cells!ranged!between!0.11%!and!0.51%.!!!!!!!!!!! !
!!
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3.3.3! Optimizing! the! best! time! point! in! iNKT! cells! proliferation!after!stimulation!with!KRN7000!and!other!ligands!iGb3,!GSL^1,!LPS!and!PG!
!A!set!of!experiments!on!six!healthy!volunteers!were!performed! to! investigate! the!optimal! time! point! where! the! best! iNKT! cells! proliferation! is! achieved! after!stimulating!with!KRN7000!at!100ng/ml!as! recommended! in! literature! (276)! .!Total!iNKT! cells! and! relative! percentages! of! their! subsets! (CD4+,! CD4^,! CD161+! and!CD161^)!were!measured!after!7,!10!and!14!days!of!stimulation.!!The!PBMCs!were!isolated!from!fresh!blood!and!separated!as!mentioned!in!Chapter!2.2! after! adjusting! the! cell! concentration! to! 1! million! cells/ml! in! culture! media.!These!cells!were!stimulated!with!100ng/ml!KRN7000!and!distributed!equally!into!six!well!culture!plate.!!The!cells!were!stained!with!three!different!fluorescent!conjugated!antibodies,!anti!TCR!Vα24!PE,!anti!CD3!PerC^Cy5!(or!CD4!CY5)!and!anti!CD161!FITC!and!were!read!using!a!FACSCalibur! from!Becton!Dickinson!at! three! time!points!day7,!day10!and!day14.! Day! 0! staining! of! PBMCs! was! always! performed! at! the! day! of! blood!collection!for!comparison.!!!!Figure!3.5!shows!the!best!time!point!that!had!the!highest!fold!increase!of!iNKT!cell!was!day!14.!The!average!fold!increase!of!iNKT!cells!was!3!fold!at!day!7,!7!fold!at!day!10!and!20!fold!at!day!14.!!!The!data!is!given!as!percentage!increase!among!the!lymphocyte!population!where!the! average! increase! in! iNKT! cells! numbers! at! day!14!was! statistically! significant!(P<0.05)!compared!with!day!0.!Also!as!how!many!folds!the!cells!numbers!increased!in!comparison!with!day0.!!
!!
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At! day7! there! were! no! noticeable! increase! in! iNKT! cell! percentage! where! as! at!day10!the!percentage!increased!to!an!average!of!2%!and!ranged!between!1^3%.!!The!same!experiments!were!performed!using!another! four!different! ligands! iGb3,!GSL^1,! LPS! and! PG.! Stimulation! with! GSL^1! and! iGb3! showed! the! same! increase!trend!in!the!iNKT!cells!numbers!at!day!fourteen!with!less!than!5!fold!of!the!day!0!values! as! shown! in! Figures! 3.9! and! 3.10,! respectively.! However,! the! stimulation!with!both!LPS!and!PG!showed!different!trend!where!the!highest!fold!increase!was!at!day10!with!increases!of!less!than!2!fold,!then!there!was!a!decline!in!the!trend!at!day!14!as!shown!in!Figures!3.11!and!3.12,!respectively.!!! !
!!









Figure' 3.5' A' line' graph' demonstrating' the' trend' of' iNKT' cell' increase' in' folds' after'
stimulating'with'KRN7000'for'7,'10'and'14'days.''iNKT!cell!fold!increase!was!3.5!folds!at!days!7,!8!folds!at!day!10!and!20!at!day!14!in!relation!to!day!0!after!stimulating!PBMCs!with!KRN7000.!Results!are!shown!as!mean!+/^!SEM,!n!=!6.!!!!!!!!!!!!! !
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'
Figure' 3.7' A' line' graph' demonstrating' the' trend' of' iNKT' cell' increase' in' folds' after'
stimulating'with'GSLV1'for'7,'10'and'14'days.'''There!was!no!increase!at!days!7,!2!folds!at!day!10!and!4!folds!at!day!14!in!relation!to!day!0!after!stimulating!PBMCs!with!GSL^1!Results!are!shown!as!mean!+/^!SEM,!n!=!6.!!! !
!!
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Figure'3.8'A' line' graph'demonstrating' the' trend'of' iNKT' cells' increase' in' folds' after'
stimulating'with'iGb3'at'days'7,'10'and'14.''There!was!no!increase!at!days!7,!2!folds!at!day!10!and!4!folds!at!day!14!in!relation!to!day!0!after!stimulating!PBMCs!with!iGB3!Results!are!shown!as!mean!+/^!SEM,!n!=!6.! !
!!





Figure' 3.9' A' line' graph' demonstrating' the' trend' of' iNKT' cell' increase' in' folds' after'
stimulation'with'LPS'at'days'7,'10,'and'14.''There!was!no!increase!at!day!7!nor!at!day!14,!where!there!was!a!slight!increase!of!only!one!fold! at! day! 14! a! less! than! 1! fold! in! relation! to! day! 0! after! stimulating! PBMCs! with! LPS.!Results!are!shown!as!mean!+/^!SEM,!n!=!6.!!!!!!!!!!!!
!!








Figure'3.10'A' line'graph'demonstrating' the' trend'of' iNKT' cell' increase' in' folds'after'
stimulation'with'PG'at'days'7,'10'and'14.''There!was!no! increase!at!day7!and!day10,!where!at!day!14,! there!was!a!decrease! in! iNKT!cells!in!comparison!with!day0!values!to!after!stimulating!PBMCs!with!PG.!Results!are!shown!as!mean!+/^!SEM,!n!=!6! !
!!
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3.3.4!Optimising!the!best!concentration!of!KRN7000!in!achieving!the!best!iNKT!cell!proliferation!!To! determine! the! stimulant! concentration! that! produces! the! maximum! effect,! a!dose^response! experiment! looking! at! counts! of! iNKT! cells! following! stimulation!with!different!concentrations!was!performed.!The!increase!in!iNKT!cell!count!after!14! days! of! stimulation!was!measured! in! folds! compared! to! the! original! count! at!time!point!0.!!Two! different! stimulants! were! used,! KRN7000! and! iGb3! each! at! four! different!concentrations,!30ng/ml,!100ng/ml,!300ng/ml!and!1000ng/ml.!!!PBMC! were! double! stained! with! anti^Vα24! PE^conjugated! and! anti^CD3! PCY5.5!monoclonal!antibodies.!!Experiments! showed! that! 100ng/ml! was! the! best! concentration! for! both! alpha^GalCer!(KRN7000)!and!iGb3.!iNKT!cell!numbers!increased!20!fold!after!stimulation!with! 100ng/ml!KRN700!where! it!was! less! than! 18! folds! at! 300ng/ml! and! only! 5!folds!at!30ng/ml.! !Interestingly,!there!was!a!reduced!stimulatory!effect!at!extreme!high!concentrations!(1000ng/ml),!14!folds!(Figures!3.12!and!3.11).!!Similarly,! stimulations! with! iGb3! at! 100ng/ml! gave! the! highest! fold! increase! in!iNKT!cells,!2.5!folds,!compared!with!2!folds!at!300ng/ml!and!2.1!folds!at!30ng/ml.!Also!similar!to!the!stimulation!with!the!previous!ligand,!the!smallest!fold!increase!of!iNKT! cells! numbers! was! at! high! concentration! of! iGb3! of! 1000ng/ml,! 0.8! fold!(Figure!3.13).!! !
!!






Figure' 3.11' Fold' increase' in' iNKT' cell' numbers' after' dose' response' of' KRN7000'
stimulation.'Stimulating!experiment!with!30,!100,!300!and!1000!ng/ml!KRN7000!showed!that!there!was!5,! 20,! 19!and!14! folds! increase! in! iNKT! cell! percentage!numbers! respectively.!Results! are!shown!as!mean!+/^!SEM,!n!=!6.!!!!!!!!!!!!!
Figure'3.12'Fold'increase'in'iNKT'cell'numbers'after'dose'response'of'iGb3'stimulation.'Stimulating!experiment!with!30,!100,!300!and!1000!ng/ml!iGb3.!There!was!2,!2.4,!2!and!0.8!folds!increase!in!iNKT!cell!percentage!numbers;!respectively.!Results!are!shown!as!mean!+/^!SEM,!n!=!6.!!!!!
!!
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Figure' 3.13' Representative' dotVplot' for' dose' response' experiment' of' total' iNKT' cell'
stimulation'with'KRN7000.'Four! different! concentrations!were! used! to! stimulate! iNKT! cells! in! PBMC! population,! (A)!30ng/ml,!!(B)!100ng/ml,!(C)!300!ng/ml!and!(D)!1000!ng/ml!at!14!days!of!stimulation.!iNKT!cell!proportions!were!27.98%,!29.88%,!18.44%!and!16.40%,!respectively.!!!!!
3.3.5! Comparing! the! stimulatory! effect! of! different!ligands!!!!
!!
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iNKT! cells! are! stimulated! by! different! glycolipid! ligands! of! synthetic! and! semi^synthetic! origins.! The! ligands! used! in! this! experiment! are:! iGb3,! αGalCer!(KRN7000),!GSL^1,!LPS!and!peptidoglycan.!!In! ligand!assessment! isolated!PBMC!were!stimulated!with!a!high!concentration!of!ligand!(100ng/ml)!at!day!0.!The!stimulation!culture!was!re^applied!with!both!cell!culture!medium!and!the!stimulator!at!day!seven.!Ligands’!ability!to!stimulate!iNKT!cells!were! assessed! from! the! relative! increase! in! the! cells! population! at! different!time!points!up!to!day!14.!Experiments!showed!that!KRN7000!was!the!best! ligand!for!stimulating!iNKT!cells.!The!average!fold!increase!in!iNKT!cells!was!3,!7!and!19!folds! at! days! 7,! 10! and! 14! respectively! compared! to! 1,! 2! and! three! average! fold!increase!after!stimulating!with!iGb3.!Figure!3.14!shows!a!comparison!of!the!average!fold!increase!of!iNKT!cells!after!stimulation!with!KRN7000!and!iGb3.!!The!rest!of!the!ligands!showed!no!effect!on!iNKT!cell!proliferation!at!all!time!points.!! !
!!
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Figure' 3.14' Comparing' KRN7000' (aVGalCer,' in' blue)' and' iGb3' (in' red)' stimulating'
effects'on'iNKT'cells'at'multiple'time'points.'The! average! increase! in! iNKT! cells! from! 0.52%! at! day! 0! to! 2.5%,! 6%! and! 19%! after!stimulation!with!KRN7000! for!7,!10!and!14!days,! respectively,!whereas! the! increase!after!stimulation! with! iGb3! was! not! significant! with! the! highest! increase! at! day! 14! to! 2.45%.!Results!are!shown!as!mean!+/^!SEM,!n!=!6.!!! !
!!
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3.3.6! Investigating! the! stimulatory! effect! of! Salmonella,!
Pseudomonas!and!Pneumococcus!bacterial!extracts!
!To! investigate! natural! ligands! that! may! stimulate! iNKT! cells,! different! bacterial!extracts! were! tested.! The! bacterial! extract! used! was! of! Gram^positive!(pneumococcus)!and!Gram^negative!(Pseudomonas!and!Salmonella).!!PBMCs!were!cultured!in!the!presence!of!bacterial!extract!for!14!days!and!iNKT!cells!counts!were!investigated!at!three!time!points!0!days,!7!days!and!14!days!using!FACS!analysis.!For!each!set!bacterial!extract!concentrations!cell!were!re^stimulated!at!day!7! with! the! same! concentration! of! the! bacterial! extract! used! at! the! start! of! the!experiment.!Some!PBMC!were!stimulated!with!100ng/ml!of!αGalCer!(KRN7000)!as!positive!control.!Also!as!negative!control!some!PBMC!were! left! in!culture!medium!un^stimulated.!More!culture!medium!added!at!day!7!to!provide!fresh!nutrients.!!The!results!demonstrated!that! there!was!no! increase! in! iNKT!cell! frequency! in!all!bacterial!extracts!compared!to!the!stimulation!with!KRN7000.!In!all!three!types!of!bacterial!extracts!there!was!an!increase!in!iNKT!cells!compared!with!day!0!but!iNKT!cell!frequency!did!not!exceed!0.55%.!After!day!0!the!iNKT!cell!percentage!dropped!at! day! 7! and! day! 14.! ! On! the! other! hand,! iNKT! cells! stimulated! with! KRN7000!increased!the!most!at!day!14!and!the!average!frequency!of!iNKT!cells!increased!to!5.35%.!!!In! all! experiments! there! was! a! reduction! in! the! numbers! of! iNKT! cells! both! in!bacterial! extract! stimulation! and! in! stimulation^free! cultured! cells! and! paired! t^student! tests! showed!no!significant!difference!between! the! two!groups.!However,!there! was! a! significant! difference! between! cells! stimulated! with! KRN7000!(100ng/ml)!and!both!bacterial^extract!stimulation,!in!all!tested!concentrations,!and!stimulation^free!cells!in!all!experiments!(P<0.05).!!!
!!
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Figure'3.15'iNKT'cell'stimulation'with'KRN7000'and'no'stimulation.'
Top2graph!demonstrates! iNKT!cells!stimulation!with!KRN7000!for!7,!10!and!14!days!as!a!positive!control.!The!average!increase!of! iNKT!cells!percentage!was!0.75%,!2%!and!5.35%!on! days! 7,! 10! and! 14;! respectively.! Bottom2 graph! demonstrates! iNKT! cells! incubation!without!any!stimulation.!iNKT!cells!average!percentages!declined!at!days!10!and!14!where!there!was!slight!increase!at!day7.!Data!from!a!representative!donor!are!shown.!!! !
!!




Top2graph!demonstrates!iNKT!cell!stimulation!with!Salmonella!extracts!at!1/1000!dilution!for!7,!10!and!14!days.!The!average! iNKT!cell!percentage!was!0.54%,!0.53%!and!0.56%!on!days! 7,! 10! and! 14,! respectively.!Bottom2 graph! demonstrates! iNKT! cell! stimulation! with!Salmonella! extracts! at! 1/500! dilution! for! 7,! 10! and! 14! days.! The! average! iNKT! cell!percentage!was!0.55%,!0.43%!and!0.52%!on!days!7,!10!and!14,! respectively.!Data! from!a!representative!donor!are!shown.!!! !
!!
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3.4!Discussion!3.4.1!Selecting!the!best!working!monoclonal!antibody!for!iNKT!cell!measurement!
The!best!working!anti^Vα24!antibody!is!the!Beckman!Coulter!PE!conjugate!at!20μl.!Despite! the! small! and! hard! to! detect! population! of! iNKT! cells! this! antibodies!demonstrated! two! distinct! positive! and! negative! populations! when! fresh! PBMC!were! stained! for! day0! iNKT! cell! percentage! as! was! shown! in! 3.3.1.1.! These!antibodies!are!the!main!ones!used!widely!in!literature!(277,278)!.!!Despite!the!pairing!of!Vα24!with!Vβ11!chains!and!despite!that!previous!studies!had!utilised!the!two!chains! in! identifying!iNKT!cells! (62)! ;!only!Vα24!chain!was!used!in!this! study! to! allow! less! restrictiveness! in! the! already! small! population! studied.!Furthermore,! the!pairing!of!Vα24!and!Vβ11is! restricted! to!double!negative! (CD4^/CD8^)! iNKT!cells! (279)!which!will!eliminate!a!substantial!amount!of! iNKT!cells!that!are!CD4!positive!as!was!found!in!Table!3.1,!Chapter!3.2.!!The! second! iNKT! cell! specific! antibody! tested! was! the! PE! mouse! anti^human!invariant! NKT! cell! from! Becton! Dickinson! (BD)! (catalogue! number! 552825).! The!antibody! comes! from! the! special! clone! 6B11! and! its! Fab^binding! site! is! directed!towards! a! region! of! the! invariant! Vα24^Jα18! TCR! chain.! The! manufacturer’s!recommended!number!of!cells!(1x106)!and!final!volume!of!100μl!were!used! in!all!experiments.!However,! although! the!manufacturer! recommended!20μl!of! staining!antibody,!three!random!donors!were!tested!with!5μl,!10μl,!and!20μl.!When!testing!using! the! recommended! antibody! staining! volume! of! 20μl! FACS! analysis! did! not!reveal! the! distinctive! two! negative! and! positive! staining! populations! that! is!characteristic!of!correct!staining!profile.!This!made!it!difficult!to!calibrate!the!FACS!machine!and!limit!the!negative!population!to!the!first!decade!as!recommended!by!the!manufacturer!calibrating!procedure!(Figure!3.2!E).!The!reason!behind!this!may!be! an! increase! of! non^specific! staining! of! Vα24^Jα18! TCR! negative! cells.! This!difficulty! is! usually! overcome! by! decreasing! the! antibody! concentration,! which!
!!
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selectively!reduces!non^specific!binding!reactions!more!than!specific!binding!ones.!!When!antibody^staining!volumes!of!5μl!and!10μl!were!used!the!negative!population!shift!was!reduced!but!it!remained!evident!and!interfered!with!the!identification!of!true!positive!cells!(Figure!3.2!C!and!D).!For!this!reason!this!antibody!was!not!chosen!for!the!identification!of!iNKT!cells!in!later!experiments.!!!It!is!important!to!mention!that!the!6B11!antibody!is!directed!towards!a!region!that!spans!both!the!Vα24!and!the!Jα18!chains,!which!makes!this!antibody!more!specific!than!others!used!in!identification!of!iNKT!cells.!!!Similarly,! the! PE! conjugate! anti^Vα24! from! eBiosciences! (catalogue! number:! 12^5806)! FACS! profile! (Figure! 3.3.3)! showed! a! shift! of! the! negative! population!compromising!the!separation!between!the!negative!and!positive!populations.!This!made!it!difficult!to!distinguish!the!true!positive!iNKT!cells!when!the!recommended!manufacture! staining!volume!of!20μl! antibody! to! the!volume!of!100μl!of!106!cells!was!used!(Figure!3.3!C).!Furthermore!this!shift!was!reduced!but!still!evident!in!the!smaller!concentrations!(Figure!3.3!D!and!E).!!For!these!reasons!and!again!similar!to!the! BD! PE! conjugate! antibody! (3.3.2)! this! antibody! was! not! used! any! further! to!identify!iNKT!cells!in!this!research.!!3.4.2! Optimising! the! best! time! point,! best! ligand! at! the! best!concentration!for!iNKT!cell!proliferation!
!When!investigating!the!optimum!time!point!at!which!highest!iNKT!cell!proliferation!is!achieved,!day!14!was!found!to!be!the!best!where!there!was!the!most!increase!in!their! frequency!regardless!of! ligand!used!and! in!different!random!healthy!donors.!In!a!similar!manner! to! the!earlier!choices! in! this! research! the! time!point!selected!(14! days)!was! chosen! because! the! iNKT! cell! counts!was! consistently! the! highest!which!may!maximise!the!chances!of!detecting!a!positive!response.!!!
!!
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In!all! iNKT!cell!stimulation!experiments!it! is!very!important!to!define!a!fixed!time!point! where! the! effect! of! the! stimulation! can! be! measured.! However! these! time!points!differ!in!the!literature!according!to!the!experimental!set!up!and!the!method!of! stimulation.! In! general! when! stimulation! experiment! conditions! are! narrowly!defined! such! as! stimulation! in! pulsed! dendritic! cells! (280,281)! and! stimulation!with!KRN7000!tetramers!(130)!or!with!the!addition!of!stimulation!cytokines!such!as!IL^2!and! IL^7! (282,283)! the! timepoints!used!are! relatively! short,! around!48hours.!On! the!other!hand!when!the!stimulation!experiments’!conditions!are!loosely!defined!such!as! stimulation! of! PBMC!mixtures! by! adding! ligands! directly! as! was! done! in! this!work,!researchers!showed!longer!time!point!between!7and!14!days!(209)!as!a!general!rule.! This! correlates!with! the! findings!presented!here!of! 14!days! as! the!optimum!time!point!of!iNKT!cell!stimulation.!!To! investigate! the! best! ligand! that! can! stimulate! iNKT! cells! and! increase! their!numbers,! two! glycolipid! ligands! have! been! investigated;! KRN7000! and! iGb3.!KRN7000! is! the! oldest! recognised! ligand! to! stimulate! CD1d! restricted! NKT! cells!(Natori! et! al,. 1993)! and! iGb3! (isoglobotrihexosylceramide)! is! a! natural!glycosphigolipid,!which!is!assumed!to!be!essential!for!iNKT!cell!functions!in!humans!and!mice!(284)!.!!!KRN7000! was! found! to! be! a! more! potent! stimulator! of! iNKT! cells! than! iGb3.!KRN7000!produced!the!highest!levels!of!iNKT!cell!counts!at!day!14!while!the!other!ligand,!iGb3,!produced!significantly!less!increase!in!iNKT!cells;!around!one!tenth!of!that!of!KRN7000!response!(Figure!3.14).!This!corresponds!to!previous!work!where!Xia. et. al! compared! the! biological! response! of! KRN7000! and! iGb3! and! found!KRN7000!to!be!more!potent! (285)! .!However!they!used!different!methods! in! ligand!presentation!and!measured!responses!in!IL^4!and!IFN^γ!cytokine!production!rather!than! increase! in! iNKT!cell!numbers.!Also! they!used!human!CD1d!transfected!cells!for!antigen!presentation!to!iNKT!cells!and!found!that!iGb3!is!around!one!thousand!times! less! potent! than! KRN7000! in! stimulating! iNKT! cells! while! this! experiment!shows! only! one! tenth.! The! difference! between! Xia. et. al’s! work! and! the! work!presented! here! could! be! attributed! to! different! methods! of! stimulation! and!
!!
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measuring! the! stimulation! response;! i.e.! cell! counts! in! this!work! versus! cytokine!production!in!Xia.et.al’s!work.!!Interestingly,!Sanderson.et.al!have!recently!looked!at!iGb3!antigenicity!to!iNKT!cells!and!found!that!it!is!species!specific.!They!found!that!both!human!and!mouse!iNKT!cells! respond! to! iGb3! presented! on! mouse! CD1d! (mCD1d)! but! not! human! CD1d!(hCD1d)! (76)! .! That! lack! of! cognate! interaction! with! iNKT! cells! in! hCD1d! was!overcome! by! a! single! point! mutation! in! this! molecule! enabling! proper! antigen!presentation,!which!may! indicate! that!natural!hCD1d! is!unable! to!present! iGb3! to!iNKT! cells.! On! the! other! hand! the! role! of! iGb3! in! activating! iNKT! cells! is!demonstrated! in! many! experiments! especially! in! the! presence! of! microbial!inflammation! products! (53,286)! .! It! should! be! noted! however! that! iNKT! cell!stimulation!is!very!complex!and!researchers!have!demonstrated!the!ability!of!these!cells!to!be!stimulated!indirectly!(287)!which!may!explain!the!ability!of!iGb3!to!affect!iNKT! cells! even! the! lack! of! hCD1d^TCR! cognate! interaction! through! antigen^independent!activation!mechanism.!!For! each! of! the! two! ligands! used! in! iNKT! cells! stimulation! four! different!concentrations!were! investigated,!30ng/ml,!100ng/ml,!300ng/ml!and!1000ng/ml.!The! highest! increase! in! iNKT! cells! numbers! was! achieved! at! 100ng/ml.! This! is!consistent!to!that!used!in!the!literature!(288,289)!.!!!It! is! important! to! highlight! that! response! of! iNKT! cells! to! KRN7000! stimulation!varies!between!individuals.!Subjects!in!whom!iNKT!cell!percentages!increase!to!6%!or!more!after!14!days!of!stimulation!with!KRN7000!are!considered!high!responders!whereas! subjects! with! increases! in! iNKT! cell! percentages! that! are<6%! are!considered!as!low!responders.!!! !
!!
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3.4.3!Stimulation!with!bacterial!extracts!
In! addition! to! the! previous! two! synthetic! ligands!multiple! bacterial! extracts! and!compounds!that!may!contain!a!substance!that!function!as!a!natural!ligand!for!iNKT!cells!were! investigated.! Two! Gram^negative! bacterial! compounds;! LPS! and! GSL^1!were! tested! (GSL^1! was! kindly! provided! by! professor! Paul! Savage! of! Brigham!Young!University! in!Utah,!USA).! In!addition,!three!bacterial!extracts!of!Salmonella,!
Pseudomonas!and!Pneumococcus!were!tested.!!LPS!extract!was!not!able!to!stimulate!iNKT!cells!in!all!tested!concentrations!at!the!different! timepoints.! This! indicates! that! LPS! is! unable! to! stimulate! iNKT! cells.!However,!Nagarajan!et.al!have!shown!that!LPS!from!is!able!to!produce!IFN^γ!from!stimulated!NKT!cells!using!dendritic!cells!pulsed!with!LPS!for!antigen!presentation!(188)! .! Interestingly,! they! have! also! shown! that! LPS^loaded! tetramers! failed! to!directly! stimulate! NKT! cells! in! similar! experiments.! This! demonstrates! the!importance!of! additional! cytokines! and/or! accessory! signals! in! the! stimulation!of!NKT! cells.! That! situation! may! not! be! present! in! the! PBMCs! tested! in! this! study,!which!may!explain!the!negative!results.!!!GSL^1! is!one!of! four!glycosphingolipids!extracted! from!Sphingomonadaceae! family!of! bacteria.! In! this! experiment! GSL^1! failed! to! stimulate! iNKT! cells! in! different!tested!concentrations.!On!the!other!hand,!Long!et.al.have!shown!the!ability!of!GSL^1!to! stimulate!NKT! cells! (290)! .! The! study!used!dendritic! cells!pulsed!with!GSL^1! for!antigen! presentation! followed! by! measuring! IFN^γ! production! after! 48hrs.! In!contrast,!the!work!in!here!was!mainly!performed!on!studying!the!response!of!iNKT!cells!to!adding!GSL^1!to!a!mixture!of!PBMC.!The!differences!in!antigen!presentation!and!stimulation!response!measurement!in!the!methods!used!in!this!work!may!the!reasons!behind!these!differences.!!!The! crude! bacterial! extracts! of! Salmonella,! Pseudomonas! and! Pneumococcus! that!were! tested! in! this! study! also! failed! to! stimulate! iNKT! cells.! Three! different!concentrations!were! tested! for! each!extract! in! folds!of! one!hundredth!apart.!This!was! to!ensure! that! the!natural! ligand! if!present! is!within! its!dynamic!range.! iNKT!
!!
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synthetic!ligands,!such!as!KRN7000,!are!known!to!have!toxic!effect!on!these!cells!in!higher!concentrations.! It!should!be!noted!that! these!bacterial!extracts!were!crude!extracts! of! bacterial! cultures! prepared! by! boiling! and! thus! contain! different!substances! that! may! have! suppressive! or! even! toxic! effects! that! counteract! the!natural!ligand!stimulation!if!present.!!CD1d!is!a!MHC!I!like!molecule!that!is!expressed!on!APC!and!on!B!cells.!It!presents!glycolipid!ligands!such!as!alphagalactosylceramide!and!iGb3!to!iNKT!cells.!!!The!difficulty! of! identifying! iNKT! cells’! natural! ligand! in! this! experiment! explains!the!complexity!of!using!a!loosely!defined!activation!method,!such!as!the!one!used!in!here,! to! investigate! this! natural! ligand.! There! are! multiple! parameters! present!including! different! cells! providing! complex! cell^cell! interactions! and! cytokine!production! that! makes! investigating! the! response! of! a! crude! bacterial! mixture!extremely!complex.!!!It!should!be!noted!that!the!natural!ligand!might!not!be!a!bacterial!component!itself!but! rather! a! self^component! that! is! modified! or! recognised! differently! in! the!presence!of!other!bacterial!or!infection!products.!!However,!the!incorporation!of!wide!inclusive!criteria!continued!to!be!considered!in!the!general!aim!of!this!study,!KRN7000!was!selected!to!be!the!stimulatory!ligand!of!choice! for! the! rest! of! this! work.! This! may! increase! the! chances! of! detecting! a!positive! response! and! ensures! that! the! work! is! comparable! to! others! in! wide!literature! since! most! of! stimulatory! work! on! iNKT! cells! is! performed! using!KRN7000!ligand.!!It!is!important!to!note!that!the!increase!in!iNKT!cell!numbers!is!just!one!method!of!many!to!investigate!the!stimulatory!effect!of!these!ligands.!Other!possibilities!are!to!detect! the! secretion! of! cytokines! and! other! compounds! from! activated! cells! or!detect! the! newly! acquired! expression! or! increased! expression! of! a! receptor! or! a!molecule! that! serves!as! a!maturation!marker.! It! is! known! that! iNKT!cells!possess!the! ability! to! secret! copious! amounts! of! different! cytokines! (52)! and! thus! the!
!!
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investigation!of!secretion!of!cytokines!may!be!a!logical!approach!to!investigate!the!cells’! stimulation.! However,! the! relatively! small! number! of! iNKT! cells! in! a! non^proliferated! population! will! require! either! enrichment! of! cells! or! using! highly!sensitive!methods!or!both.! ! It!will!be! interesting! for!a! further!study!to! investigate!this!possibility!using!different!synthetic!and!possible!natural!ligands.!! !
!!
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Chapter! 4:! Investigating! different!receptor! expression! by! iNKT! cells!before! and! after! stimulation! with!KRN7000!! !
!!
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4.1.!!Aims!!The!aim!of!the!work!described!in!this!chapter!was!to!study!the!phenotype!of!iNKT!cells! and! their! expression! of! different! types! of! surface! receptors.! Since! they! are!related! to!natural! killer! cells! it!was!only! logical! to! investigate! some!natural! killer!cell!markers!such!as!Killer! immunoglobulin^like!receptors!(KIRs)!using!antibodies!recognising! both! stimulatory! and! inhibitory! ones! (CD158a/h,! CD158b/i/j! and!CD158e/k),!also!the!expression!of!CD161!since!it!is!acknowledged!in!literature!as!a!natural! killer! T! cell! receptor! and! as! an! effector! and! regulator! for! lymphocyte!functions!(291)!.!Furthermore!and!according!to!their!role!in!innate!immune!response!the! expression! of! toll! like! receptors! TLR2! and! TLR4! was! investigated.! The!expression!of!CD4!and!CD3!receptors!was!studied!since!iNKT!cells!belong!to!the!T!lymphocyte!lineage.!!!Finally,! Thymic! Stromal! Lymphopoietin! is! an! epithelial! derived! cytokine.! It!exercises!its!effects!by!binding!to!a!heterodimeric!receptor,!which!has!IL^7!receptor!a^chain! (IL^7Ra)! and! TSLP! receptor! chain! (Chapter! 1.8.3).! ! TSLP! is! involved! in!triggering! the! adaptive! allergic! immune! response;! it! also! induces! a! rapid! allergic!immune!response!and! the! fact! that! iNKT!cells!are!stimulated!by! IL^7! (282)!and!are!thought! to! act! in! the! induction! of! adaptive! immune! responses! by! cytokine!production!raised!the!possibility!that!they!may!also!express!the!TSLP!receptor!and!respond!to!this!cytokine.!!!!All! receptors!were!studied! in! freshly!collected!PBMC!(day0)!and!after!stimulation!with!the!specific!iNKT!cell!glycolipid!ligand!KRN7000!for!14!days.!Furthermore,! the!work! in! this! chapter! is! aiming! to! investigate! any! differences! in!expression! pattern! in! each! individual! of! all! of! the! markers! and! the! affect! of!stimulation!on!that!pattern.!!! !
!!
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4.2.!Materials!and!Methods!!PBMC!were! isolated! as!mentioned! in! Chapter! 2.2.! Then! stained! and! analysed! by!using! the! FACSCalibur! as!mentioned! in! Chapter! 2.4.1.2.The! available!monoclonal!antibodies!for!some!receptors!!(KIR!and!TSLPr)!were!only!PE!conjugated!therefore!for! the! purpose! of! double! staining! with! iNKT! cells,! the! anti! Vα24! monoclonal!antibodies!used!were!PC7.5!conjugated.!!!To! ensure! the! comparability! of! these! new! anti^Vα24! antibodies,! a! comparison! of!staining!with! the! PE^conjugate! anti! Vα24! antibodies! used! throughout! the! rest! of!this!project!(Chapter!3.3.1.1)!of!three!different!donors!at!different!time!points!was!performed.!The!two!different!fluorescent!conjugated!antibodies’!staining!exhibited!similar!capability!and!iNKT!cell!frequencies!were!similar!with!both!antibodies!in!all!experiments!(data!not!shown).!!! !
!!
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4.3!Results!4.3.1!Investigating!the!expression!of!KIR!receptors!on!iNKT!cells!
Killer^cells!Immunoglobulin^like!receptors!(KIR!receptors)!are!surface!proteins!that!are!found!mainly!on!NK!cells!and!other!immune!system!cells!and!have!the!ability!to!interact!with!MHC^I!molecules.!!KIR!receptors!that!belong!to!the!CD158!family!of!receptors!were!investigated.2The!available!antibodies!recognise!both!inhibitory!KIR!(iKIR)!such!as!CD158a,!CD158b!and!CD158e!and!stimulatory!KIR!(sKIR).!These!receptor!families!are!vital!in!the!role!of!natural!killer!cells!(NK!cells)!to!recognize!and!attack!virus^infected!or!malignant!cells.!They!interact!with!different!forms!of!MHC^1!molecules.!!The! investigation!was!carried!out!on!PBMCs!of! four!random!donors.!PBMCs!were!double^stained! using! monoclonal! antibodies! to! V?24! and! CD158a,! b! or! e! as!described! in! Chapter! 2.4.1.1! and! FACS! analysis! was! performed! as! described! in!Chapter!2.4.1.2.!PBMCs! were! also! stimulated! for! 14! days! using! KRN7000! as! described! in! the!optimum!stimulation!method!in!Chapter!2.3.1.2!and!double!staining!on!stimulated!cells!was!also!performed.!!
4.3.1.1'Investigating'the'effect'of'iNKT'cell'stimulation'on'CD158a'expression'!Figure!4.1!shows!a!FACS!profile!of!donor!26!demonstrating!the!percentage!of!iNKT!cells! at! day! 0! (0.35%)!with! no! expression! of! CD158a! in! the! iNKT! cell! population!(double! positive! shows! 0.02%).! At! day! 14! iNKT! cells! showed! an! increase! in! the!percentage! to! 9.14%! with! 1.56%! (after! deducting! the! isotype! control! value)!expressing!CD158a.!!!The!results!of!CD158a!expression!on! iNKT!cells!at!day!0!(before!stimulation)!and!day! 14! (after! stimulation)! are! summarized! in! Figure! 4.4! both! in! absolute! double!
!!
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positives!(A)!and!relative!populations!(B).!The!results!reflect!that!CD158a!was!not!expressed!on!iNKT!cells!at!day!0!(0.02%).!After!stimulation!the!iNKT!cell!population!expressing!CD158a!increased!to!1.56.!The!mean!per!cent!for!day!0!iNKT!cells!values!for! four! donors! was! 0.4%! and! the! mean! for! iNKT! cells! that! expressed! CD158a!was0.05%! and! the! mean! per! cent! for! iNKT! cells! after! 14! days! stimulation! was!9.14%!with!mean!of!0.6%!expressing!CD158a.!However,!when!calculating!the!ratio!of!the!double!positive!population!to!the!total!iNKT!cells!it!showed!0.02%.!There!was!no!significant!difference!in!numbers!of!double!positive!cells!representing!iNKT!cells!that!express!CD158a!before!and!after!stimulation!(P>0.05).!! !
!!




in'donor'26.'''The!chart!shows!that!Vα24!positive!iNKT!Cells!did!not!express!CD158a!at!day0!(0.02%)!and!did!not!express!it!after!stimulating!PBMC!with!KRN7000!for!14days!(F)!(1.56%).!!(A)!gating!for!lymphocytes!at!day!0.!(B)!Double!staining!for!Vα24!PC7.5!and!PE^isotype!control!at!day!0.!(C)!Double!staining!with!Vα24!PC7.5!and!PE^CD158a!at!day!0.!(D)!Gating!for!lymphocytes!at! day! 14! of! KRN7000! stimulation.! (E)! Double! staining! for! Vα24! PC7.5! and! PE^isotype!control! at! day14! of! KRN7000! at! day! 14.! (F)! Double! staining! with! Vα24! PC7.5! and! PE^CD158a!at!day14!of!KRN7000.!! !
!!
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4.3.1.2'Investigating'the'expression'of'CD158b'on'iNKT'cells'Figure!4.2!shows!a!FACS!profile!of!donor!26!demonstrating!the!percentage!of!iNKT!cells! at! day!0! (0.35%)!with!no! expression! of! CD158b! in! the! iNKT! cell! population!(double! positive! shows! 0.01%).! At! day! 14! iNKT! cells! showed! an! increase! in! the!percentage!to!8.34%!with!0.81%!expressing!CD158b.!!The!results!of!CD158b!expression!on! iNKT!cells!at!day!0!(before!stimulation)!and!day! 14! (after! stimulation)! are! summarized! in! Figure! 4.4! both! in! absolute! double!positives!(A)!and!relative!populations!(B).!!The!results!reflect!that!CD158b!was!not!expressed! on! iNKT! cells! (0.01%).! After! stimulation! the! iNKT! cells! population!expressing! CD158b! increased! to! 0.81%.! The!mean! per! cent! for! day! 0! iNKT! cells!values! for! four! donors! was! 0.4%! and! the! mean! for! iNKT! cells! that! expressed!CD158b! 0.01%! was0.02%! and! the! mean! per! cent! for! iNKT! cells! after! 14! days!stimulation! was! 9.14%!with! mean! of! 0.7%! expressing! CD158b.! ! However,! when!calculating! the! ratio! of! the! double! positive! population! to! the! total! iNKT! cells! it!showed!0.025%.!There!was!no!significant!difference!in!numbers!of!double!positive!cells! representing! iNKT! cells! that! express! CD158b! before! and! after! stimulation!(P>0.05).!! !
!!




in'donor'26.'''The!chart! shows! that!Vα24!positive! iNKT!ells!did!not!express!CD158b!at!day0! (C,!0.01%)!and!it!did!not!express!it!after!stimulating!PBMC!with!KRN7000!for!14days!(F,!0.81%).! !(A)!gating!for!lymphocytes!at!day!0.!(B)!Double!staining!for!Vα24!PC7.5!and!PE^isotype!control!at! day! 0.! (C)! Double! staining! with! Vα24! PC7.5! and! PE^CD158b! at! day! 0.! (D)! Gating! for!lymphocytes!at!day!14!of!KRN7000!stimulation.!(E)!Double!staining!for!Vα24!PC7.5!and!PE^isotype!control!at!day14!of!KRN7000!at!day!14.! (F)!Double!staining!with!Vα24!PC7.5!and!PE^CD158b!at!day14!of!KRN7000.!! !
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!
4.3.1.3'Investigating'the'expression'of'CD158e'on'iNKT'cells'Figure!4.3!shows!a!FACS!profile!of!donor!26!demonstrating!the!percentage!of!iNKT!cells!at!day!0!(0.35%)!with!no!expression!of!CD158b! in! the! iNKT!cells!population!(double! positive! shows! 0.02%).! At! day! 14! iNKT! cells! showed! increase! in! the!percentage!to!8.33%!of!which!0.49%!expressed!CD158b.!!!The!results!of!CD158b!expression!on! iNKT!cells!at!day!0!(before!stimulation)!and!day! 14! (after! stimulation)! are! summarized! in! figure! 4.4! both! in! absolute! double!positives!(A)!and!relative!populations!(B).!The!results!reflect!that!CD158e!was!not!expressed! on! iNKT! cells! (0.01%).! After! stimulation! the! iNKT! cells! population!expressing! CD158e! increased! to! 0.49!%.! The!mean! per! cent! for! day! 0! iNKT! cells!values! for! four! donors! was! 0.4%! and! the! mean! for! iNKT! cells! that! expressed!CD158e!was!0.02%!and!the!mean!per!cent!for!iNKT!cells!after!14!days!stimulation!was!9.14%!with!mean!of!0.6%!expressing!CD158a.!!However,!when!calculating!the!ratio! of! the! double! positive! population! to! the! total! iNKT! cells! it! showed! 0.05%.!There! was! not! a! significant! difference! in! numbers! of! double! positive! cells!representing!iNKT!cells!that!express!CD158b!before!and!after!stimulation!(P>0.05).!! !
!!
! ! 137!! ! !!
!!
Figure'4.3'The'percentage'of'CD158e'and'Vα24'double'positive'PBMC'at'day'0'and'14'
in'donor'26.'''The!chart!shows!that!Vα24!positive!iNKT!cells!did!not!express!CD158e!at!day0!(C,!0.02%)!and!did! not! express! it! after! stimulating! PBMC!with!KRN7000! for! 14days! (F,! 0.49%).! ! (A)!Gating!for!lymphocytes!at!day!0.!(B)!Double!staining!for!Vα24!PC7.5!and!PE^isotype!control!at! day! 0.! (C)! Double! staining! with! Vα24! PC7.5! and! PE^CD158e! at! day! 0.! (D)! Gating! for!lymphocytes!at!day!14!of!KRN7000!stimulation.!(E)!Double!staining!for!Vα24!PC7.5!and!PE^isotype!control!at!day14!of!KRN7000!at!day!14.! (F)!Double!staining!with!Vα24!PC7.5!and!PE^CD158e!at!day14!of!KRN7000.!! !
!!
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!4.3.2!Investigating!the!expression!of!CD161!on!iNKT!cells!
Six! different! donors’! PBMC!were! investigated! for! iNKT! cells! expression! of! CD161!both! at! day0! (freshly! collected! PBMC)! and! on! day! 14! after! stimulation! with!KRN7000.!The!double!positive!Vα24!and!CD161!were!assessed!as!percentage!of!the!total! lymphocyte! population! using! FACS! analysis.! Then! the! ratio! (in! per! cent)! of!CD161,!Vα24!double!positive!population! to! the! total! iNKT! cells!was! calculated! to!determine! whether! the! change! in! the! desired! marker’s! expression! is! due! to! the!increase!in!iNKT!cells!numbers!or!whether!it!is!due!to!up/!down!regulation!of!that!marker!after!stimulation.!!Figure!4.5!(B,F)!shows!a!FACS!profile!of!donor!17!demonstrating!the!percentage!of!iNKT! cells! at! day! 0! (0.54%).! The! population! of! iNKT! cells! that! express! CD161!!(double! positive)! was! 0.09%.! At! day! 14! 7.81%! were! Vα24+! of! which! 7.36%!expressed!CD161.!!!The!results!of!CD161!expression!on!iNKT!cells!at!day!0!(before!stimulation)!and!day!14! (after! stimulation)! are! summarized! in! Figure! 4.6! both! in! absolute! double!positives!percentage!values!(A)!and!relative!populations!(B).!The!results!reflect!that!the!mean!of!iNKT!cells’!CD161!expression!was!0.1%!and!7.5%!at!day0!and!day14;!respectively.!The!ratio!of!double!positive!population!from!the!total! iNKT!cells!was!14.17%!and!67%!at!day!0!and!day!14!respectively.!The!increase!in!the!ratio!of!the!double! positive! population! at! day! 14! in! comparison! to! day! 0! was! statistically!different!(P=0.002).!!! !
!!
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'
Figure'4.5'FACS'profile' for'donor'17' illustrating' iNKT'cells’'expression'of'CD161,'CD3'
and'CD4'at'days0'and'14'of'KRN7000'stimulation'After!gating!for!lymphocytes!populations!(A!and!E),!cells!were!triple!stained!with!anti^!Vα24!antibodies,!anti^CD161!antibodies!and!anti^CD3!PerCP^Cy5.5!or!anti!CD4!PerCP!antibodies!at!day!0!(B,C,!and!D!respectively)!and!at!day!14!(F,!G!and!H!respectively).!!! !
!!
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!
Figure' 4.6' scatter' profile' of' CD161' expression' in' iNKT' cells' and' the' ratios' of' double'
positive'population'to'total'iNKT'cells''Figure!A!demonstrates!the!mean!percentage!expression!of!iNKT!cells!to!CD161!at!day0!and!after!14days!stimulation!with!KRN7000!(0.1%!and!7.5%!respectively).!Figure!B!demonstrates!the!ratio!of!double!positive!populations!of!CD161+!and!Vα24+!cells!to! the! total! iNKT! cells! frequency! in! per! cent! at! day0! and! after! 14days! stimulation! with!KRN7000.!The!mean! ratio!of!double!positive!CD161!and!Vα24!cells! at!day!0!was!14.17%!and!at!day!14!it!was!67%.!The!difference!between!day0!and!day14!ratios!of!double!positive!cells!to!the!total!iNKT!cells!was!statistically!significant!(P=0.002).!N!=!6!in!both!cases.!!!
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'4.3.3!Investigating!the!expression!of!CD4!and!CD3!on!iNKT!cells!
Similar! to! the! previous!marker! six! different! donors’! PBMC!were! investigated! for!iNKT!cell!expression!of!CD3!and!CD4!both!at!day0!(freshly!collected!PBMC)!and!on!day!14!after!stimulation!with!KRN7000.!The!CD3!expression!was!investigated!since!a!down!regulation!in!this!marker!was!noticed!after!stimulation!with!KRN7000.!The!double! positive! population! that! expressed! both! Vα24! and! CD3! or! CD4! were!assessed!as!percentage!numbers!from!the!total!lymphocytes!population!using!FACS!analysis.!Then!the!ratio!(in!per!cent)!of!CD3!(CD4),!Vα24!double!positive!population!to! the! total! iNKT! cells! was! calculated! to! determine! weather! the! change! in! the!desired! marker’s! expression! is! due! to! the! increase! in! iNKT! cells! numbers! or!whether!it!is!due!to!up/!down!regulation!of!that!marker!after!stimulation.!!Figure!4.5!(C,!G)!shows!a!FACS!profile!of!donor!17!demonstrating!the!percentage!of!iNKT!cells!at!day!0!(0.54%).!The!population!of!iNKT!cells!that!express!CD3!!(double!positive)!was! 0.54%.! At! day! 14! iNKT! cells! showed! increase! in! the! percentage! to!8.63%!of!which!8.51%!expressed!CD3.!!!Figure!4.5!(D,H)!shows!a!FACS!profile!of!donor!17!demonstrating!the!percentage!of!iNKT!cells!at!day!0!(0.54%).!The!population!of!iNKT!cells!that!express!CD4!!(double!positive)!was! 0.42%.! At! day! 14! iNKT! cells! showed! increase! in! the! percentage! to!8.17%!of!which!6.24%!expressed!CD4.!!!!The!results!of!CD3!expression!on!iNKT!cells!at!day!0!(before!stimulation)!and!day!14! (after! stimulation)! are! summarized! in! Figure! 4.7! both! in! absolute! double!positive!percentage!values!!(A)!and!relative!populations!(B).!The!results!reflect!that!the!mean!of! iNKT!cells’!CD3!expression!was!0.6%!and!8.95%!at!day0!and!day14;!respectively.! The! mean! of! the! ratio! of! double! positive! population! from! the! total!iNKT!cells!was!100%!and!90.3%!at!day!0!and!day!14!respectively.!The!increase!in!
!!
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the! ratio!of! the!double!positive!population!at!day!14! in! comparison! to!day!0!was!statistically!insignificant!(P>0.05).!!!In! the! same!manner! the! results!of!CD4!expression!on! iNKT!cells! at!day!0! (before!stimulation)! and! day! 14! (after! stimulation)! are! summarized! in! figure! 4.8! both! in!absolute!double!positive!percentage!values! ! (A)!and! relative!populations! (B).!The!results!reflect!that!the!mean!of!iNKT!cells’!CD4!expression!was!0.27%!and!7.9%!at!day0!and!day14;!respectively.!The!mean!of!the!ratio!of!double!positive!population!from! total! iNKT! cells! was! 51%! and! 63%! at! day! 0! and! day! 14;! respectively.! The!increase! in! the!ratio!of! the!double!positive!population!at!day!14! in!comparison!to!day!0!was!not!statistically!significant!(P>0.05).!!! !
!!
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!
Figure4.7' scatter' profile' of' CD3' and' CD4' expression' in' iNKT' cells' and' the' ratios' of'
double'positive'population'of'each'marker'to'total'iNKT'cells''Figure! A! demonstrates! the!mean! percentage! expression! of! iNKT! cells! to! CD3! and! CD4! at!day0!and!after!14days! stimulation!with!KRN7000! (0.6%!CD3,!0.27%CD4!and!8.95%!CD3,!7.9%!CD4!respectively).!Figure!B!demonstrates! the!ratio!of!double!positive!populations!of!CD3!(or!CD4)!and! iNKT!cells!to!the!total!iNKT!cells!frequency!in!percent!at!day0!and!after!14days!stimulation!with!KRN7000.!The!mean!ratio!of!double!positive!CD3!and!Vα24!cells!at!day!0!was!100%!and!at!day!14!it!was!90.3%.!The!difference!between!day0!and!day14!ratios!of!double!positive!cells!to! the! total! iNKT! cells! was! statistically! insignificant! (P>0.05).! The! mean! ratio! of! double!positive!CD4!and!Vα24! cells! at!day!0!was!51%!and!at!day!14! it!was!63%.!The!difference!between! day0! and! day14! ratios! of! double! positive! cells! to! the! total! iNKT! cells! was! not!statistically!significant!(P>0.05).!!
!!
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!4.3.4!Investigating!the!expression!of!TLR!2,4!on!iNKT!cells'
!Figure!4.8!shows!a!FACS!profile!of!donor!9!demonstrating!the!percentage!of! iNKT!cells!at!day!0!(0.73%)!with!no!expression!of!either!TLR2!or!TLR4!in!the!iNKT!cell!population!(double!positive!shows!0.02%!and!0.03;! respectively).!At!day!14! iNKT!cells! did! not! show! any! increase! in! the! percentage! that! makes! the! donor! a! non^responder.!The!lymphocyte!population!showed!increased!expression!of!both!TLR2!and!TLR4.!!!! !
!!








at'days0'and'14'of'KRN7000'stimulation!Gating! for! lymphocyte! populations! (A! and! D),! after! cells! were! double! stained! with! anti^!Vα24!antibodies,!anti^TLR2!and!TLR4!antibodies!at!day!0!(B!and!C!respectively)!and!at!day!14!(E!and!F!respectively).!!! !
!!
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4.3.5!Investigating!the!expression!of!TSLPr!on!iNKT!cells!
!Four!different!donors’! PBMC!were! investigated! for! iNKT! cells! expression!of!TSLP!receptor! (TSLPr)! both! at! day0! (freshly! collected! PBMC)! and! on! day! 14! after!stimulation!with!KRN7000.!The!double!positive!iNKT!cells!and!TSLPr!were!assessed!as! percentage! of! the! total! lymphocyte! population! using! FACS! analysis.! Then! the!ratio!(in!per!cent)!of!TSLPr,!Vα24!double!positive!population!to!the!total!iNKT!cells!was!calculated!to!determine!whether!the!change!in!the!desired!marker’s!expression!is! due! to! the! increase! in! iNKT! cells! numbers! or! whether! it! is! due! to! up/! down!regulation!of!that!marker!after!stimulation.!!In! Figure! 4.9! B! a! FACS! profile! of! donor! 27! demonstrates! double! staining! of! PE!conjugate! IgG1! isotype! control! with! PC7.5! conjugate! anti^Vα24.! The! PE! isotype!control! was! used! to! eliminate! any! PE! nonspecific! binding! for! the! purpose! of!comparing! it! with! the! PE^TSLPr! and! PC7.5^Vα24! double! stained! population.! The!percentage! of! iNKT! cells! at! day! 0! is! (0.80%).! The! population! of! iNKT! cells! that!express! TSLPr! ! (double! positive)!was! 0.10%! (figure! 4.9! C).! At! day! 14! iNKT! cells!showed!increase!in!the!percentage!to!32.19%!of!which!27.71%!expressed!TSLPr.!!!The!results!of!TSLPr!expression!on!iNKT!cells!at!day!0!(before!stimulation)!and!day!14! (after! stimulation)! are! summarized! in! figure! 4.10! both! in! absolute! double!positives!percentage!values!(A)!and!relative!populations!(B).!The!results!reflect!that!the!mean!of!iNKT!cells!that!express!TSLPr!was!0.08%!and!8.4%!at!day0!and!day14;!respectively.!The!mean!ratio!of!double!positive!population!from!the!total!iNKT!cells!was!14.25%!and!48.50%!at!day!0!and!day!14!respectively.!The!increase!in!the!ratio!of!the!double!positive!population!at!day!14!in!comparison!to!day!0!was!statistically!significant!(P=0.01).!!! !
!!





Figure' 4.9' FACS' profile' for' donor' 27' illustrating' iNKT' cells’' expression' of' TSLPr' at'
days0'and'14'of'KRN7000'stimulation'Gating! for! lymphocyte! populations! (A! and! D),! after! cells! were! double! stained! with! anti^!Vα24!antibodies^PC7,!and! IgG1!matching!PE!conjugate! isotype!control!or!anti^!Vα24!PC^7!antibodies!with!anti^TSLPr!PE!antibodies!at!day!0! (B!and!E!respectively)!and! the!same!at!day! 14! (C! and! F! respectively).! At! day! 0! the! iNKT! cells! that! expressed!TSLPr!were! 0.10%!where!at!day!14!the!frequency!of!iNKT!cells!that!expressed!TSLPr!was!27.71%.!!!!!!!
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!
Figure'4.10'Scatter'profile'of'TSLPr'expression' in' iNKT'cells'and' the' ratios'of'double'
positive'population'to'total'iNKT'cells''Figure!A!demonstrates!the!mean!percentage!expression!of!iNKT!cells!to!TSLPr!at!day0!and!after!14days!stimulation!with!KRN7000!(0.08%!and!8.4%!respectively).!Figure!B!demonstrates!the!ratio!of!double!positive!populations!of!TSLPr!and!iNKT!cells! to!the! total! iNKT! cells! frequency! in! percent! at! day0! and! after! 14days! stimulation! with!KRN7000.!The!mean!ratio!of!double!positive!TSLPr!and!Vα24!cells!at!day!0!was!14.25%!and!at!day!14!it!was!48.50%.!The!difference!between!day0!and!day14!ratios!of!double!positive!cells!to!the!total!iNKT!cells!was!statistically!significant!(P=0.02).!!
!!
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4.4!Discussion!!4.4.1!The!expression!of!natural!killer!T!cell!markers!by!iNKT!cells!!!
4.4.1.1' The' expression' of' killerVcell' immunoglobulin' like' receptors' (KIR)' by'
iNKT'cells'!Killer! Immunoglobulin^like! receptors! (KIRs)! are!major! human!NK! receptors!with!either!inhibitory!or!stimulatory!activity,!which!recognize!HLA^class!I!molecules.!The!work!in!this!chapter!did!not!show!any!significant!expression!of!CD158a,!b!or!e!by!iNKT!cells.!Both!day!0!(fresh!PBMC)!and!day14!!(after!stimulation!with!KRN7000)!iNKT!cells!populations!did!not!show!any!apparent!CD158!marker!expression!when!typing! using! FACS! analysis.! Furthermore,! the! mean! ratios! of! CD158! and! Vα24!double!positive!populations!to!the!total!iNKT!cells!populations!were!0.09,!0.04!and!0.04!for!CD158a,!CD158b!and!CD158e;!respectively.!!!!The! lack!of!expression!of!CD158!KIR!of! iNKT!cells! that!was!shown!in!this!chapter!does! not! contradict! with! the! main! proposed! functions! of! these! cells.! Cells!expressing! KIR! are! involved! in! direct! cytotoxicity! where! KIR! can! be! either!activating!or! inhibitory! according! to! their! cytoplasmic!domain! (292)! .!On! the!other!hand!iNKT!cells!demonstrate!their!effects!by!producing!large!amount!of!cytokines!rather!than!by!mediating!cytotoxicity!(293,294)!.!!Recently,! Uhrberg! et! al! have! compared! the! expression! of! different! KIRs! between!clones!of!T!cells!and!NK!cells!in!different!donors!(295)!.!The!general!finding!was!that!there! is! a! link! between! the! type! of! repertoire! of! the! Vβ! chain! of! the! TCR/CD3!receptor!and!the!number!and! level!of!expression!of!KIR!markers.! Interestingly,! in!the! two! tested!subjects!clones! that!have!Vβ11!chain!had! the! lowest!expression!of!KIR!markers.!This! chain,!Vβ11,! is! associated!with! iNKT!cells!of! limited! repertoire!(62)! .! In! this! study! the! anti^Vα24! antibodies! used! select! iNKT! cells,!which! also! co^
!!
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express!the!limited!repertoire!Vβ11!cells!in!their!TCR.!This!result!may!explain!the!low!or!lack!of!expression!of!KIR!receptors!found!in!the!healthy!volunteers.!!!
4.4.1.2'The'expression'of'CD161'on'iNKT'cells''!NKT!and!NK!cells!play!a!key!role!in!both!innate!immune!response!and!influencing!the!development!of!adaptive!immune!response.!CD161!(human!NKR^P1A),!a!C^type!lectin! protein! encoded! in! the!NK! gene! complex,! is! a!major! phenotypic!marker! of!both! these! cell! types.! It! is! also! involved! in! the! regulation! of! NK! and! NKT! cell!function! (296)! .! The! results! in! this! chapter! demonstrate! that! iNKT! cells! express!CD161.!In!freshly!collected!blood!the!average!frequency!of!iNKT!cells!that!express!CD161! was! 0.1%.! After! stimulation! with! KRN7000! for! 14! days! the! average!frequency! of! iNKT! cells! that! express! CD161!was! 7.5%.! Furthermore,! there!was! a!statistically!significant! increase! in! the!ratio!of! iNKT!cells!expressing!CD161!to! the!total!numbers!of!iNKT!cells!at!day14!of!stimulation,!this!suggest!that!the!increase!in!CD161!expression!was!not!due!to!the!increase!in!the!total!iNKT!cell!frequency!as!a!response!to!KRN7000!stimulation!but!to!the!increase!of!CD161!positive!iNKT!cells..!!It! has! been! shown! that! CD161! and! CD4! double! positive! cells! have! the! ability! to!produce! IL^17A! and! IL^17F.! CD161! is! up! regulated! in! all! human! Th17! cells!compared! to!Th1! and!Th2! clones,!which! are! CD161!negative.! Furthermore,! IL^17!producing!CD4!positive!cells!expressed!CD161!and!were!iNKT^like!cells!(not!CD1d^restricted!natural!killer!cells!as!shown!in!Table!1.1).!!!The! level! of! expression!of! CD161!on! iNKT! cells! varies! according! to! the! tissues! in!which! these! cells! are! made! and! also! according! to! the! maturation! and! activation!level!of!iNKT!cells!(297)!.!!The!experiments!in!this!chapter!demonstrated!that!at!day!0!the!mean!expression!of!CD161!was!0.11%!and!7.5%!at!day!0!and!14,!respectively!as!shown!in!Figure!4.5.!Furthermore,!there!was!an!increase!in!the!ratio!of!double!positive!CD161!and!Vα24!
!!
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cells!to!the!total!Vα24!cells!(from!14.7%!to!67%!at!day0!and!day!14;!respectively)!and!was!statistically!significant!(P=0.002;!Figure!4.6).!These!findings!match!what!is!mentioned!in!the!literature!where!the!increase!in!CD161!expression!is!considered!as!a!marker!of!iNKT!cell!maturation!and!activation!(297)!.!!4.4.2! the! expression! of! T! lymphocyte! markers! CD3! and! CD4! by!iNKT!cells!!
'
4.4.2.1''The'expression'of'CD3'on'iNKT'cells'!iNKT! cells! are! part! of! the! T! lymphocyte! family! that! are!mainly! identified! by! the!expression!of!a!T!cell!receptor!(TCR)!whose!role!is!to!recognize!antigens!presented!to!T!lymphocytes!on!major!histocompatibility!complex!(MHC)!molecules.!iNKT!cells!are!commonly!defined!by!the!co^expression!of!an!invariant!TCRα!chain!(Vα24)!and!Vβ11!(62)!.!!In!this!experiment!monoclonal!anti^CD3!antibodies!were!used!to!ensure!that! the! investigated!population!of! invariant!NKT!cells!are!all! included! in!the!CD3!positive!population.!At!day0!the!mean!expression!of!CD3!by!the!iNKT!cells!studied!was! 0.60%!with! a! ratio! of! the! double! positive! population! to! the! total! iNKT! cells!equals!100%.!At!day!14!however!the!mean!cell!number!positive!expression!was!9%!with! the! ratio! dropping! to! 90%.! Theoretically! this! is! contradictory! to! the! main!definition! of! iNKT! cells! where! the! TCR! is! a! key! marker! in! identifying! these!population! however,! in!mice! studies! it! has! been! shown! that!with! stimulation! the!CD3!marker!may!be!down!regulated!by!changing! from!surface! to! internal!marker!(172,173)!.!This!down!regulation!may!be!affecting!parts!of!the!CD!complex!holding!the!epitope! for! the! anti^CD3! used! in! this! study! (ε! chain)! but! not! the! epitope! of! anti^Vα24!(α!chain).!!! '
!!
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4.4.2.2.'The'expression'of'CD4'on'iNKT'cells'!The!results!in!this!chapter!indicate!that!there!are!two!subpopulations!of!iNKT!cells!as!defined!by!differential!CD4!expression,!CD4+ve!and!CD4^ve!subsets.! !The!mean!percentage!of!iNKT!cells!and!CD4+ve!cells!was!0.27%!at!day!0!and!7.9%!at!day!14.!The!ratio!of!the!CD4!subpopulation!of!iNKT!cells!from!the!total!iNKT!cells!was!51%!and!63%!at!day!0!and!day!14!(of!KRN7000!stimulation),!respectively.!Even!though!there!was!a!slight!increase!in!the!CD4!positive!subpopulation!this!increase!was!not!statistically!significant!(P>0.05)!and!could!be!simply!due!to!the!relative!increase!in!the!CD4+!iNKT!cell!numbers!rather!than!up!regulation!of!the!CD4!marker.!!!iNKT!cells!are!proven!to!have!different!subpopulations!according!to!CD4!and!CD8!markers.! There! are! CD4+ve/CD8+ve,! CD4+ve/CD8^ve! and! double! negative! CD4^ve/CD8^ve!subpopulations!(160)!.!!iNKT!cells!produce!large!amount!of!cytokines!(298)!of!both!Th1!or!Th2!type!(299)!which!in!turn!were!shown!to!play!a!significant!role!in!the! alteration! of! other! immune! effector! cells! including! CD4!!and! CD8!!!T! cells,! NK!cells,!and!B!cells!(300)!.!The!CD4+ve!subpopulation!produces!both!Th1!and!Th2^!type!cytokines!(301,169)!.!!!When!iNKT!cells!are!stimulated!with!KRN7000!they!expand!in!numbers!(as!shown!in!Chapter!3.3,! 3.4! and!3.5)! and! they!also!alter! in! functionality!by! secreting! large!amount!of!cytokines!of!both!Th1!and!Th2!types! (302,298)!as!will!be!discussed!in!the!next!chapter!and!as! is!described! in! the! literature! (51)! .!This!ability!of! iNKT!cells! in!expansion! and! stimulation! opened! the! opportunity! to! their! manipulation! for!therapeutic!purposes!like!anti^tumour!therapy!(303)!.!! !
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!!4.4.3!The!expression!of!TLR!2!and!TLR!4!by!iNKT!cells!
The!investigation!in!this!chapter!showed!that!iNKT!cells!had!no!expression!of!TLR2!or! TLR4! in! both! freshly! collected! PBMC! and! after! 14! days! stimulation! with!KRN7000.!!!It! has!been!demonstrated! in!many! studies! that! iNKT!cells! can!be!activated!either!directly! by! direct! TCR! engagement! or! indirectly! via! indicators! received! from!antigen^presenting! cells! (APC)! that! have! met! pathogens! and! presented! their!antigens! (186)! .! This! is! performed! through! toll^like! receptors! (TLR),! which! are!Pattern!recognition!receptors.!!!In! early! studies! TLR!were! thought! to! be! expressed! only! by! APC;! however,! it! has!been! shown! that! TLRs! are! also! expressed! by! various! T! cell! subsets! (304)! and! are!widely! expressed! innate! sensors! since! they! are! part! of! the! innate! system.! The!expression! and! function! of! TLRs! in! iNKT! cells! are! poorly! understood.! The!expression!of!some!TLR!genes!in!murine!liver!(NK1.1)!iNKT!cells!such!as!TLR2,!4,!5!and!9!was!reported!(164)! .! It!was!also!reported!that!in!mice!hepatic!CD1d!tetramer!positive! iNKT! cells! expressed! TLR3! and! TLR4! proteins! (165,166)! .! In! humans,!notwithstanding! the! fact! that! the!TLR!expression! in! iNKT!cells!was! shown!by! the!investigation!and!detection!of!mRNA!(167)! ,!the!expression!of!the!surface!marker!of!TLR!was!not!mentioned.!!!Finally,! despite! studies! that! showed! the! expression! of! certain!TLRs! in! iNKT! cells,!there! is! little! evidence! for! direct! TLR^mediated! stimulatory! or! co^stimulatory!effects! in! the!activation!of! iNKT!cells!as!was!discussed! in!Chapter!3!where!LPS,! a!TLR!specific!ligand,!failed!to!stimulate!iNKT!cells!(Figure!3.9).!!! !
!!
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4.4.4!The!expression!of!TSLPr!by!iNKT!cells!
The!experiments!in!Chapter!4.4.7!demonstrated!that!at!day!0!the!mean!expression!of!TSLPr!was!0.08%!and!8.4%!at!day!0!and!14,!respectively.!Furthermore,!there!was!an! increase! in! the! ratio! of! double! positive! TSLPr+! Vα24+! cells! to! the! total! Vα24!cells! (from! 14.25%! to! 48.50%! at! day0! and! day! 14;! respectively),! which! was!statistically!significant!(P=0.01).!!!Few! studies! have! examined! the! expression! of! TSLP! receptor! by! iNKT! cells!!(chapter1.8.5.1)!however;!Wu!et!al!looked!at!the!effect!and!prominence!of!TSLP!in!atopic! dermatitis! patients! and! compared! it! to! healthy! controls.! They! also! studied!iNKT!cells!prevalence!in!skin!lesions!and!in!peripheral!blood!and!found!that! iNKT!cell!numbers!increase!in!severe!and!moderate!patients!and!that!TSLP!expression!is!increased! in! skin! lesions! but! not! in! the! sera.! Therefore! they! investigated! TSLPr!expression!on!iNKT!cells!and!found!that!they!expressed!this!marker.!However!even!though!they!supported!their!investigation!with!mRNA!expression!of!TSLPr!protein!the! FACS! profile! did! not! seem! convincing! as! the! Vα24,! TSLPr! double! positive!populations! looked! like!more! of! a! compensation! fault! rather! than! a! true! positive!population!(162)!.!!Furthermore,! TSLPr! has! been! found! to! be! expressed! in! abundance! on! other! cells!that!are! linked! to!autoimmune!diseases!such!as!Rheumatoid!Arthritis.!These!cells!include!CD1c!positive!myeloid!dendritic!cells!which!when!primed!with!TSLP!induce!Th2,!Th17!and!Th1!cytokines!(305)!.!!These!findings!prompted!the!investigation!of!the!effect!of!TSLP!on!iNKT!cells!after!stimulation!for!14!days!in!the!presence!of!the!iNKT!cell!specific!ligand!KRN7000!in!both!proliferation!and!cytokine!production,!which!will!be!discussed!in!Chapter!5.!! !
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Chapter!5:!The!effect!of!TSLP!on!iNKT!cell! proliferation! and! cytokine!secretion!
!!!!!!!!!!!!!!!!!!!!!!!!
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5.1!Aims!One! of! the! aims! of! the!work!described! in! this! thesis!was! to! investigate! iNKT! cell!receptors,!proliferation,!and!cytokine!production.!The!work!described!in!Chapter!3!confirmed! that! iNKT! cells! respond! to! stimulation! with! glycolipid! particularly!αGalCer!(KRN7000)!especially!in!high!responding!individuals!by!proliferation.!Two!further! questions! are! addressed! in! this! chapter;! firstly,! does! thymic! stromal!lymphopoietin! (TSLP)! addition! to! iNKT! cells! along! with! the! specific! ligand!KRN7000! lead!to! increased!proliferation!and!cytokine!production?!Secondly,!does!the!time!of!TSLP!application!to!the!cultured!cells!make!any!difference!especially!in!cytokine!production?!!!TSLP!is!an!interleukin!7^like!cytokine!(Chapter!1.8.3)!mainly!expressed!by!epithelial!cells! which! promotes! a! Th2! response! in! allergy! such! as! Atopic! Dermatitis! and!Asthma! (162)! since! on! stimulation! iNKT! cells! rapidly! produce! large! quantities! of!cytokines!including!IL^4!and!IFN^γ!(306)!,!an!innate^like!immune!response,!this!quick!production!of!cytokines!could!regulate!adaptive! immune!responses!by! influencing!cytokine!production!by!other!cells!like!DC!(307)!,!T!cells,!and!B!cells!(308)!.!!!TSLP!may!activate!iNKT!cells!to!play!a!unique!role!in!pathogenesis!of!diseases!such!as!allergies.!Nagata!et!al!(2007)!(267)!suggested!that!TSLP!might!potentially!activate!iNKT!cells!to!produce!IL^13!in!a!mouse!asthma!model.!Here,!production!of!IL^4,!IFN^γ,!IL^17!and!IL^13!by!human!iNKT!cells!in!healthy!donors’!PBMCs!after!proliferating!in!a!TSLP!environment!was!investigated.!!!! !
!!
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5.2!Materials!and!methods!PBMC! from! nine! different! donors! were! separated,! suspended! in! culture!medium!and! adjusted! to! a! concentration! of! 1milion! cell/ml! as!mentioned! in! Chapter! 2.2.!Some!cells!from!each!of!the!donors!were!double!stained!with!anti^Vα24^PE!and!anti!CD161^FITC! and! analysed!using! a! FACSCalibur! for! day! 0! iNKT! cells! values..! Then!PBMC!were!cultured! in!a!six!^well!sterile!plate!under!three!different!stimulations;!TSLP!10ng/ml,!KRN7000!100ng/ml!and!both!TSLP!and!KRN7000!at!10ng/ml!and!100ng/ml,!respectively.!At!day!7!an!equal!volume!of!culture!media!with!the!same!type!and!concentration!of!stimulant!was!added.!At!day!14!cells!were!double!stained!with! anti^Vα24^PE! and! anti! CD161^FITC! and! analysed! using! a! FACSCalibur! and!CellQuest! Pro! software! to! assess! proliferation! and! to! determine! responders! from!non^! responders.! Cells! of! each! stimulatory! environment!were! then!washed! twice!and! aliquoted! in! a! sterile! 36! well! plate! in! three! groups,! one! stimulated! with!KRN7000,!one!with!TSLP!and!the!third!!with!both!KRN7000!and!TSLP.!Plates!were!kept!in!an!incubator!for!48!hours!then!ELISA!tests!were!run!on!the!supernatant!for!cytokines!IL^4,!IFN^γ,!IL^7and!IL^13.!!!The! first! supernatants! collected! from!14! day! stimulations! (before!washing)!were!analyzed! for! cytokine! production! using! ELISA! (Enzyme! Linked! Immune! Assay)!ready^set^go!(eBiosciences)!and!were!considered!as!initial!values.!!All! supernatants! collected! after! 48! hours! re^stimulation!were! examined! for! IL^4,!IFN^γ,! IL^13! and! IL^17! production! using! ELISA! (Figure! 5.1).! Cytokine! production!was!measured!from!the!same!number!of!cells!for!all!subjects!and!stimulation!type!regardless!of!the!final!proliferated!number!of!iNKT!cells.!!!Expression!of!a!larger!panel!of!cytokines!was!also!performed!on!subject!52!only!as!a! screening! experiment! using! 2.8! Cytometric! magnetic^bead! array! assay! as!mentioned!in!Chapter!2.8!!!!!!
!!
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Figure' 5.1.' Experimental' structure' and' Time' line' of' stimulation' of' PBMC' with'
KRN7000,'TSLP,'or'both'KRN7000'and'TSLP'for'14'days.!!At!day!7!culture!media!with!corresponding! ligand!at! the!same!concentration!was!added.!Then! cells! were!washed! twice! and! cells! of! the! three! different! 14days! stimulations!were!stimulated! for! 48hrs! with! KRN7000,! TSLP! or! both! KRN7000! and! TSLP.! At! this! point!supernatants!were!collected!to!perform!ELISA!for!investigation!of!cytokine!secretion.!!
!!
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5.3!Results!!5.3.1! TSLP! enhances! iNKT! cells! proliferation! when! added! with!KRN7000!in!comparison!to!KRN7000!alone!!
Co^stimulation! with! TSLP! and! KRN7000! resulted! in! higher! proliferation! in! iNKT!cells.! Figure! 5.2! shows! for! example! how! iNKT! cell! percentage! in! subject! 37! was!raised!to!20.52!%!after!14!days!stimulation!with!KRN7000,!whereas!it!increased!up!to! 29.64%! after! stimulation! with! both! KRN7000! and! TSLP.! In! both! types! of!stimulation! most! iNKT! cells! were! CD4! positive! about! 24.15%! and! 16.25%! for!KRN7000+TSLP!and!KRN7000!alone!respectively;!and!CD161!positive!were!27.18%!and!18.52%!for!KRN7000+TSLP!and!KRN7000!alone!respectively.!!!The!proliferative!response!varied!between!subjects!and!according!to!that!the!nine!subjects!were!divided! into! two!groups,!high!responders!and! low!responders.!This!was!determined!according!to!the!increase!in!the!percentage!of!iNKT!cells!at!day14!after!stimulation!with!KRN7000!in!comparison!with!day!0!values.!High!responders!were! defined! as! those! with! an! iNKT! cell! percentage! at! day! 14! of! 6%! or! more.!Subjects!with!a!response!of!less!than!6%!iNKT!cells!at!day!14!were!categorized!as!low!responders.!Figure!5.3!shows!the!effect!of!TSLP!on!subject!30!as!an!example!of!a!low!responder!subject.!iNKT!cells!in!subject!30!increased!from!0.38%!at!day!0!to!2.54%!and!5.78%!after!14!days!stimulation!with!KRN7000!and!both!KRN7000!and!TSLP,!respectively.!!!Figure!5.4!demonstrates!the!average!fold!increases!of!iNKT!cell!percentage!between!the!three!time!points!day!0,!day!7!and!day!14.!The!highest! increase!was!at!day14!when!PBMC!were!stimulated!with!both!TSLP!and!KRN7000.!This!increase!was!just!under!18!fold!compared!to!10!and!2!folds!when!stimulated!with!KRN7000!or!TSLP!alone! respectively.! Statistical! analysis! using! paired! t^student! test! did! not! show! a!
!!
! ! 161!! ! !!
significant! difference! between! KRN7000! and! combined! stimulation! at! day! 14!(P>0.05).!!The! three!different! types!of! iNKT!cell! stimulation!were! further! investigated!using!scatter! plots! of! absolute! increase! in! iNKT! cell! percentages.! ! At! day! 7! the! average!increase!was!0.47%!±!0.35,!1.9%±0.04!and!2.14%!±!0.36! for!KRN7000,!TSLP!and!KRN7000!and!TSLP!together,! respectively,!whereas!at!day!14! the!highest!average!increase!after!stimulation!with!both!KRN7000!and!TSLP!was!around!12.17%!±!3.53!followed!by!KRN7000!alone!at!9.32%!±!2.9!and!finally!less!than!2.69%!±!0.76!after!stimulation!with!TSLP!alone!(Figure!5.5).!There!was!a!statistical!difference!between!KRN7000!and!combined!KRN7000!and!TSLP!at!day!14!(P=0.0027).!!! !
!!
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Figure' 5.2' A' representative' dot' plot' FACS' profile' for' subject' 37' comparing' antibody'
staining'after'stimulation'with'KRN7000,'KRN7000'and'TSLP'together'for14'days.'A!Demonstrates.gating!for!lymphocyte!population!at!day0;!B!Demonstrates!double!staining!for! anti^Vα4! PE! and! anti^CD161! FITC! antibodies;! total! iNKT! cell! population! is! 0.49%;! C!Demonstrates! double! staining! for! anti^Vα24! PE! and! anti^CD4! PerCP;! total! iNKT! cell!population!0.53%;!!D! Demonstrates. gating! for! lymphocyte! population! at! day14! after! stimulation! with!KRN7000;! E! Demonstrates! double! staining! for! anti^Vα24! PE! and! anti^CD161! FITC!antibodies!total! iNKT!cells!population!is!20.32%;!F!Demonstrates!double!staining!for!anti^Vα24!PE!and!anti^CD4!PerCP;!total!iNKT!cell!population!20.53%;!!G! Demonstrates. gating! for! lymphocyte! population! at! day14! after! stimulation! with! both!KRN7000!and!TSLP;!H!Demonstrates!double!staining!for!anti^Vα24!PE!and!anti^CD161!FITC!antibodies;! total! iNKT!cell! population! is!20.32%;! I!Demonstrates!double! staining! for! anti^Vα24!PE!and!anti^CD4!PerCP;!total!iNKT!cell!population!20.53%.!!!!
!!
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Figure' 5.3' A' representative' dot' plot' FACS' profile' for' subject' 30' comparing' antibody'
staining'after'stimulation'with'KRN7000,'KRN7000'and'TSLP'together'for14'days.'A!Demonstrates.gating!for!lymphocyte!population!at!day0;!B!Demonstrates!double!staining!for! anti^Vα24!PE! and! anti^CD161!FITC! antibodies;! total! iNKT! cell! population! is! 0.38%;! ! C!Demonstrates! double! staining! for! anti^Vα24! PE! and! anti^CD4! PerCP;! total! iNKT! cell!population!0.38%;!!D! Demonstrates. gating! for! lymphocyte! population! at! day14! after! stimulation! with!KRN7000;! E! Demonstrates! double! staining! for! anti^Vα24! PE! and! anti^CD161! FITC!antibodies;! total! iNKT!cell! population! is!2.58%;! ! F!Demonstrates!double! staining! for! anti^Vα24!PE!and!anti^CD4!PerCP;!total!iNKT!cells!population!2.58%;!!G! Demonstrates. gating! for! lymphocyte! population! at! day14! after! stimulation! with! both!KRN7000!and!TSLP;!H!Demonstrates!double!staining!for!anti^Vα24!PE!and!anti^CD161!FITC!antibodies;! total! iNKT! cell! population! is! 5.78%;! ! I! Demonstrates! double! staining! for! anti^Vα24!PE!and!anti^CD4!PerCP;!total!iNKT!cells!population!5.79%!!!!!!!
!!
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Figure' 5.4'Average' fold' increase' in' iNKT' cell' values' after' stimulation'with'KRN7000'
(K),'TSLP'(T)'and'KRN7000'and'TSLP'(KT).'There!was!up!to! two^fold! increase! in! iNKT!cell!at!day!7! in!all! three!different!stimulations.!However,!at!day14!the!increase!was!up!to!18!fold!after!stimulation!with!both!KRN7000!and!TSLP;! about! 10! fold! increase! after! stimulation! with! KRN7000! alone! and! only! two^fold!increase!after!stimulation!with!TSLP!alone.!Error! bars! represent! standard! error! of! the! mean.! There! was! not! a! statistical! difference!between!K!and!KT!stimulation!(P>0.05).!!!!!!!!!
!!
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Figure' 5.5' Scatter' plot' showing' iNKT' cell' proliferation' as' a' response' to' stimulation'
with' three' different' stimulants' KRN7000' (K),' TSLP' (T)' and' KRN7000+TSLP' (KT)' at'
days'7'and'14.'The!average!increase!of!iNKT!cells!percentage!at!day!7!was!slightly!higher!(up!to!2%)!after!stimulation! with! both! KRN7000! and! TSLP! in! comparison! with! KRN7000! alone! (1.8%)!where! there! was! no! increase! after! stimulation! with! TSLP! alone.! Where! at! day! 14! the!average! increase! of! iNKT! cells! percentage! was! higher! (up! to! 12.17! ±! 2.93%)! after!stimulation! with! both! KRN7000! and! TSLP! in! comparison! with! KRN7000! alone! (9.31! ±!2.52%)!where!there!was!no!increase!after!stimulation!with!TSLP!alone.!**!P=0.0027!!!!!!!
!!
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5.3.1.1' Both' high' and' low' responders' show' similar' response' to' combined'
KRN7000'and'TSLP'stimulation'!As! discussed! before! in! Chapter! 3.6.2,! the! response! of! iNKT! cells! to! KRN7000!stimulation! varies! between! individuals.! Subjects! for! whom! iNKT! cell! percentage!increase!to!6%!or!more!after!14!days!of!stimulation!with!KRN7000!are!considered!high!responders.!!Subjects!with!increase!in!iNKT!cell!percentage!that!is!less!than!6%!are!considered!as!low!responders.!!!Comparison! of! iNKt! cell! numbers! from! high! versus! low! responders! after!stimulation! with! KRN7000! and! TSLP! for! 14! days! did! not! show! a! significant!difference! between! the! two! groups! (P=0.2419;Figure! 5.6).! Similarly! when!comparison!was!made! using! the! ratios! of! iNKT! cells’! percentage! increase,! rather!than! absolute! values,! also! there!was!not! a! significant!difference!between! the! two!responder’s! type! (Figure!5.7).!This! shows! that! the!average! folds! increase!of! iNKT!cells! was! not! affected! by! the! response! type! (0.4! and! 0.3! folds! for! low! and! high!responders,!respectively).!Statistical!analysis!was!performed!using!paired!t^student!test!and!P!value!was!not!significant!(P>0.05).!!!!!!!!!!! !
!!
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Figure' 5.6' A' scatter' plot' of' iNKT' cell' percentages' in' different' subject' types' after'
stimulation.'
2Both!high!and!low!responders!were!stimulated!for!14!days!with!either!KRN7000!alone!(‘K!low’! for! low!responders!and! ’K!high’! for!high!ones)!or!with!combined!KRN7000!and!TSLP!(‘KT!low’!for! low!responders!and! ‘KT!high’! for!high!ones).!The!bars!represent!the!mean!of!iNKT!cells!percentages!after!stimulation!(3.3!±!0.7%!and!16.9!±!4%!for!stimulation!with!K!in!low!and!high!responders,!respectively.!4.7!±!1.1%!and!21.5!±!4.6%!for!stimulation!with!both!K!and!T!in!low!and!high!responders,!respectively)!P>0.05.!! !
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Figure'5.7'Scatter'plot'of' the'ratio'of' iNKT'cell' increases'between'double'stimulation'
with'KRN7000'and'TSLP'and'that'of'KRN7000'alone'in'high'and'low'responders.''The!scatter!plot!shows!the!effect!of!the!addition!of!TSLP!as!a!ratio!of! increase!in!both!low!(0.41±0.06!fold)!and!high!(0.30!±!0.06!fold)!responders.!P>0.05!! !
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!5.3.2! TSLP! increases! iNKT! cell! cytokine! production! when! added!with!KRN7000!in!comparison!to!KRN7000!alone!
5.3.2.1'Standard'curves'!To! measure! the! concentrations! of! the! required! cytokines! in! the! supernatants,! a!series!of!standard!dilutions!was!prepared!and!analysed!in!the!same!way!as!actual!experimental! samples.! The! concentrations! were! assessed! based! on! the! standard!samples.!These!curves!are!illustrated!in!Figure!2.3!A^H.!The!fit!for!the!curves!ranged!from! 7.8! pg/ml! to! 500! pg/ml! for! all! studied! cytokines! except! for! IL^33,! which!ranged! from! 23.4! pg/ml! to! 1500! pg/ml.! This! ensured! that! the! technical! abilities!were!sufficient!for!the!accurate!detection!of!the!measured!analytes.!!!!!!!!!!!!!!!!!!!!
!!
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5.3.2.2'Expression'of'ILV4'by'cultured'iNKT'cells'!Only! low! values! of! IL^4! cytokine! expression! were! observed.! Cells! that! were!incubated! in! both! KRN7000! and! TSLP! for! 14! days! showed! marginally! more!production! than! the! ones! incubated! in! KRN7000! alone! except! for! the! late!introduction! of! TSLP! in! the! latter! group.! As! for! the! combined! proliferating!environment,! the! secretion! of! IL^4! was! undetectable! in! the! KRN7000! alone!environment!and!with!both!KRN7000!and!TSLP!together!(values!were! lower!than!ELISA! detection! limit).! Late! introduction! of! TSLP! in! cells! that! were! proliferated!previously!in!KRN7000!alone!for!14!days!increased!the!average!production!of!IL^4!to!4.6pg/ml!(Figure!5.9),!which!is!just!above!the!detection!limit!of!ELISA!test.!The!original! values! of! the! ELISA! test!were! left! even! if! they!were! below! the! detection!limit!to!enable!the!visualization!of!the!different!subject!values!but!a!detection!limit!line!(DL)!was!added!to!show!significant!values!above!it.!!Statistical!analysis! failed! to!reveal!a! significant!difference!of! IL^4!production!after!combined!stimulation!(P>0.05).!!!!!!!!!!!
!!
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Figure'5.8'ELISA'ILV4'levels'for'6'subjects.''PBMC!of!6!subjects!were!stimulated!with!either!KRN7000!alone!(14!day!K!proliferation)!or!with!both!KRN7000!and!TSLP! (14!day!KT!proliferation)! for!14!days! then! cells! from!each!stimulation!were!washed!and!stimulated!with!KRN7000!(K),!combined!KRN7000!and!TSLP!(KT),!TSLP!(T),!or!left!unstimulated!(BL)!for!further!48hr!then!supernatants!were!collected!for! IL^4! levels! titration! using! ELISA.! BL! is! base! line! values! of! IL^4! production! that! were!acquired! from! day! 14! cultures’! supernatants! before!washing.! Each! graph! represents! IL^4!values!of!one!subject.!! !
!!
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Figure'5.9'Scatter'plot'demonstrates'mean'ILV4'levels'in'6'different'donors.''PBMC!from!9!subjects!were!stimulated!with!either!KRN7000!alone!(K!Proliferation)!or!with!both!KRN7000!and!TSLP! (KT!Proliferation)! for!14!days.!Then! cells! from!each! stimulation!were! washed! and! stimulated! with! KRN7000! (K),! combined! KRN7000! and! TSLP! (KT)! or!TSLP! alone! (T)! or! left! un^stimulated! (BL)! for! a! further! 48hr.! The! supernatants! were!collected!for!assay!of!IL^4!levels!using!ELISA.!Bars!represent!mean!levels!of!IL^4!in!pg/ml.!After!14!days!stimulation!with!KRN7000!the!mean!IL^4!levels!were!2.42!±!0.4!pg/ml,!2.7!±!0.45!pg/ml!and!4.6!±!1.6!pg/ml!after!48hrs!stimulation!with!KRN7000,!KRN7000!and!TSLP!and!TSLP!alone,!respectively.!After!14!days!co^stimulation!with!both!KRN7000!and!TSLP!for!14!days!the!mean!IL^4!levels!were!3.6!±!0.9!pg/ml,!3.4!±!0.6!pg/ml!and!3!±!0.6!pg/ml!after!48hrs! stimulation! with! KRN7000,! KRN7000! and! TSLP! and! TSLP! alone,! respectively.!Differences!were!not! statistically! significant! (p>0.05).! IL^4! levels!below!4pg/ml!are! lower!than!the!detection!limit!of!ELISA!test!represent!by!the!horizontal!line!(DL).!!!!
!!
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5.3.2.3'Expression'of'IFNVγ'by'cultured'iNKT'cells'In!contrast!to!the!results!observed!with!interleukin!4,!differences!were!observed!in!IFN^γ! production! between! the! groups.! The!mean! IFN^γ! levels! were! higher! when!cells! were! proliferated! in! the! presence! of! TSLP! compared! to! averages! of! IFN^γ!production! in! cells! proliferated!with!KRN7000!alone! (354±45!pg/ml! and!103±18!pg/ml)! (P<0.01).! The! later! addition! of! TSLP! (day14! to! day! 16)! to! KRN7000!proliferated!cells!for!14!days!did!not!increase!IFN^γ!production!(76!±!14pg/ml!with!late!TSLP!compared!to!103!±!18pg/ml!without!TSLP).!Early!stimulation!with!TSLP!for!14!days!followed!by!removal!of!that!stimulation!for!the!last!two!days!produced!an!increase!in!IFN^γ!levels!(256!±31!pg/ml)!compared!to!the!previous!values!of!no!TSLP!or!later!introduction!of!TSLP(P<0.01).!The!highest!titers!of!IFN^γ!were!seen!in!cells!proliferated!in!the!presence!of!TSLP!throughout!the!16!days!(354!±!45!pg/ml).!Figure!5.11!A!!In! summary,! ANOVA! analysis! showed! a! significant! difference! among! the! groups!(P<0.0001).! ! When! individual! groups! were! compared! there! was! a! significant!difference!between!KRN7000!stimulation!and!combined!stimulation!(P<0.01).!Also!there! was! a! significant! difference! after! stimulation! with! KRN7000! and! the! early!addition!of!TSLP!(P<0.01).!However,!there!was!not!a!statistical!difference!between!KRN7000!stimulation!and!late!addition!of!TSLP.!!When! the! nine! subjects! divided! into! two! groups! of! high! and! low! responders! a!similar! pattern!was! observed.! In! the! high! responders! addition! of! TSLP! showed! a!significant! increase! in! IFN^γ! production! (110! ±32! pg/ml! KRN7000! alone! for! 14!days! with! no! TSLP! for! the! further! 48! hours! compared! with! 342! ±68! pg/ml!combined! stimulation! all! through).! Similarly! the! low! responders! showed! an!increase! in!IFN^γ!production!in!the!presence!of!TSLP!(98!±23!pg/ml!and!364!±67!pg/ml;!respectively).!Figure!5.11!B,C.!! !
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responders'(C)'Each!graph!compare!between!14!days!KRN7000!stimulation!(K!proliferation)!and!14!days!KRN7000! and!TSLP! combined! stimulation! (KT!proliferation).! (BL:! base! line,!K:!KRN7000,!KT:! combined,! T:! TSLP.! All! for! the! last! 48! hours).! (ANOVA! test! was! used! for! statistical!significance!and!Tukey!test!was!used!for!inter^group!comparison.!Significant!Tukey!tests!are!denoted!with!a!*).!Note!the!different!y^axis!scale!in!C.!
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5.3.2.4'Expression'of'ILV13'by'cultured'iNKT'cell'!
.IL^13!levels!were!detectable!and!high!when!cells!were!proliferated!in!the!presence!of!TSLP!whereas!there!was!no!detectable!IL^13!production!in!cells!proliferated!with!KRN7000!alone!in!the!tested!nine!subjects!(P<0.05).!The!individual!ELISA!results!of!the!stimulation!assay!for!nine!subjects!are!represented!in!figure!5.12.!!!The! later! addition! of! TSLP! to! KRN7000! proliferated! cells! for! 14! days! did! not!increase! IL^13!production! (the!mean! IL^13!production!was!2.6!±! 0.6!pg/ml,!2.9!±!!0.8! pg/ml! and! 4.6! ±! 1.3! pg/ml! for! KRN7000,! combined! KRN7000! and! TSLP! and!TSLP! alone,! respectively)(P<0.05).! Early! stimulation! with! TSLP! for! 14! days!followed!by!removal!of!that!stimulation!for!the!last!two!days!produced!an!increase!in!IL^13!levels!(mean!IL^13!production!was!77.4!±!49!pg/ml).!The!highest!levels!of!IL^13! were! seen! in! cells! proliferated! in! the! presence! of! TSLP! and! KRN7000!throughout! the!16!days!(mean!IL^13!production!was!279!±!164!pg/ml).!The!Elisa!results!of!the!nine!subjects!are!represented!in!figure!5.13!(A).!!In! summary,! ANOVA! analysis! showed! a! significant! difference! among! the! groups!(P=0.008).! ! When! individual! groups! were! compared! using! Tukey! multiple!comparison!tests!between!group!pairs,! there!was!a!significant!difference!between!KRN7000!stimulation!and!combined!stimulation!in!the!cells!that!were!proliferated!in!both!KRN7000!and!TSLP!for!14!days!(P<0.05).!On!the!other!hand,!there!was!no!significant! difference! between! KRN7000! alone! and! early! TSLP! introduction!(P>0.05).!In!the!same!manner,!there!was!no!statistical!difference!between!KRN7000!stimulation! and! late! addition! of! TSLP! (in! the! cells! that! were! proliferated! in!KRN7000!alone!for!14!days).!!When!the!nine!subjects!were!divided!into!two!groups!of!high!and!low!responders!a!similar!pattern!was!observed.!In!the!high!responders,!the!addition!of!TSLP!in!the!16!days! culture! showed! a! significant! increase! in! IL^13! production! (3! ±! 1pg/ml!KRN7000!alone!compared!with!607!±!311pg/ml!combined!stimulation).!!
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In!spite!of!the!results!showing!that!there!is!far!less!production!in!IL^13!among!the!low! responders;! there! was! a! similar! trend! in! higher! IL^13! production! in! the!presence!of!TSLP! (7!±!3!pg/ml!and!16!±!12!pg/ml;! respectively).! !The!results! for!high!and!low!responders!are!shown!in!figure!5.13!B!and!C.!!!! !
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Figure'5.12'ELISA'ILV13'levels'for'9'subjects.''PBMC!of!9!subjects!were!stimulated!with!either!KRN7000!alone!(14!day!K!proliferation)!or!with!both!KRN7000!and!TSLP! (14!day!KT!proliferation)! for!14!days,! then!cells! from!each!stimulation!were!washed!and!stimulated!with!KRN7000!(K),!combined!KRN7000!and!TSLP!(KT)!or!TSLP!alone!(T)!for!further!48hr!then!supernatants!were!collected!for!assay!of!IL^13!levels!using!ELISA.!(BL)!is!base!line!values!of!IL^13!production!that!were!acquired!from!day!14!culture!supernatants!prior!to!washing.!!!
!!
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!!
Figure'5.13'Scatter'plots'of'ILV13'levels'of'all'subjects'(A),'high'responders'(B)'and'low'
responders'(C)'Each!graph!compare!between!14!days!KRN7000!stimulation!(K!proliferation)!and!14!days!KRN7000! and!TSLP! combined! stimulation! (KT!proliferation).! (BL:! base! line,!K:!KRN7000,!KT:! combined,! T:! TSLP.! All! for! the! last! 48! hours).! (ANOVA! test! was! used! for! statistical!significance!and!Tukey!test!was!used!for!inter^group!comparison.!Significant!Tukey!tests!are!denoted!with!a!*).!Note!the!different!y^axis!scale!in!C.!!!
!!
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5.3.2.5'Expression'of'ILV17'by'cultured'iNKT'cells'!The! same! stimulation! pattern! of! nine! donors! was! repeated! for! testing! of! IL^13!production.! The! ELISA! results! of! the! nine! donors! in! different! stimulation!environments!are!represented!in!figure!5.14.!!iNKT!cells!stimulated!with!KRN7000!alone!did!not!show!a!significant!increase!in!IL^17!production.!The!same!pattern!was!noted!for!early!(from!day!0!till!day!14)!and!late! (day! 14! till! day! 16)! addition! of! TSLP.! However,! iNKT! cells! stimulated! with!combined!KRN7000! and! TSLP! showed! production! of! IL^17.! Cells! stimulated!with!KRN7000!alone!for!16!days!had!the!lowest!IL^17!production!(below!the!detection!level! of! 8pg/ml).! Similarly,! iNKT! cells!with! late! addition! of!TSLP! after! 14!days! of!KRN7000!stimulation!showed!a!low!increase!in!IL^17!production!(mean!production!in!the!9!subjects!was!below!the!level!of!detection!of!8pg/ml).!On!the!other!hand,!the!early! addition! of! TSLP! starting! from! day! 0! all! through! 14! days! increased! IL^17!production!both!when!added!in!the!first!14!days!alone!(mean!production!in!the!9!subjects! was! 24! ±! 11! pg/ml)! or! in! the! whole! 16! days! stimulation! period! (mean!production!in!the!9!subjects!was!16!±!10!pg/ml).!ANOVA!analysis!of!differences!in!IL^17!production!between!groups!was!not!significant!(P>0.05).!The!scatter!plot!of!IL^17!levels!of!the!nine!subjects!for!different!stimulations!are!shown!in!figure!5.15!A.!!The! nine! subjects! were! divided! into! two! groups! according! to! their! response! to!KRN7000!into!high!and! low!responders.! In!the! low!responders!group!IL^17! levels!were!lower!than!the!detection!level!of!8pg/ml!regardless!of!the!type!of!stimulation.!ANOVA!analysis!of!the!differences!between!the!different!stimulation!types!was!not!significant!(P>0.05).!!In!the!high!responders!group!co^stimulation!with!both!KRN7000!and!TSLP!showed!the!highest!IL^17!levels!(mean!production!in!the!high!responders!subjects!was!49.8!
±!19.0!pg/ml).!!There!was!a!small!increase!with!KRN7000!stimulation!alone!for!the!sixteen!days!(mean!production!in!the!high!responders!subjects!was!8.4!±!4.3!pg/ml)!
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(P<0.01).! Similarly,! there!was!a! small! increase! in! the! late! addition!of!TSLP! in! the!final! two! days! (mean! production! in! the! high! responders! subjects! was! 5.7! ±! 3.7!pg/ml).!However,!the!early!addition!of!TSLP!in!the!first!fourteen!days!increased!IL^17!production! !(mean!production!in!the!high!responders!subjects!was!34.9!±!18.5!pg/ml).!!ANOVA! analysis! of! IL^17! production! from! iNKT! cells! in! different! stimulation!environments!was! significant! (P<0.05).!Tukey!multiple! comparison! tests!between!group!pair!showed!significant!differences!between!stimulation!with!KRN7000!and!combined!stimulation!with!KRN7000!and!TSLP!(P<0.01).!Figure!5.15!B!and!C!show!the!scatter!plots!of!IL^17!for!high!and!low!responders,!respectively.!! !
!!
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Figure'5.14'ELISA'ILV17'levels'for'9'subjects.''PBMC!of!9!subjects!were!stimulated!with!either!KRN7000!alone!(14!day!K!proliferation)!or!with!both!KRN7000!and!TSLP! (14!day!KT!proliferation)! for!14!days! then! cells! from!each!stimulation!were!washed!and!stimulated!with!KRN7000!(K),!combined!KRN7000!and!TSLP!(KT)!or!TSLP!alone!(T)!for!further!48hr!then!supernatants!were!collected!for!assay!of!IL^17!levels!using!ELISA.!(BL)!is!base!line!values!of!IL^17!production!that!were!acquired!from!day!14!culture!supernatants!prior!to!washing.!! !
!!
! ! 186!! ! !!
!!
Figure'5.15'Scatter'plots'of'ILV17'levels'of'all'subjects'(A),'high'responders'(B)'and'low'
responders'(C)'Each!graph!compare!between!14!days!KRN7000!stimulation!(K!proliferation)!and!14!days!KRN7000! and!TSLP! combined! stimulation! (KT!proliferation).! (BL:! base! line,!K:!KRN7000,!KT:! combined,! T:! TSLP.! All! for! the! last! 48! hours).! (ANOVA! test! was! used! for! statistical!significance!and!Tukey!test!was!used!for!inter^group!comparison.!Significant!Tukey!tests!are!denoted!with!a!*).!Note!the!different!y^axis!scale!in!C.!!!!
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5.4!Discussion!
5.4.1'TSLP'enhances'iNKT'cell'proliferation'!This!chapter!aimed!to!address!the!question!whether!the!addition!of!TSLP!to! iNKT!cells! in! addition! to! the! specific! glycolipid! ligand!KRN7000!will! improve! iNKT! cell!proliferation!and!cytokine!production!and!whether! it! induces!a!Th1,!Th2!or!Th17!biased!type!of!response.!!!The!results!in!section!5.3.1!show!that!iNKT!cells’!expansion,!measured!using!FACS!cell! counting,! improved! significantly! when! cultured! with! added! TSLP! in! the!presence!of!KRN7000! for!14!days! compared! to!KRN7000!alone.! iNKT!cells’!mean!frequency! of! nine! selected! donors! increased! from! 9.31%! when! stimulated! with!KRN7000!to!12.17%!when!stimulated!with!combined!KRN7000!and!TSLP!(P<0.05).!On! the! other! hand,! when! cells’! fold! increase! was! used! instead! of! absolute!frequencies! confidence! intervals! increased! and! the! test! was! not! statistically!significant.! The! amplification! effect! of! addition! of! TSLP!was! observed! in! the! two!types! of! responders! to! KRN7000! stimulation.! There! was! not! a! statistically!significant! difference! in! TSLP! ratio! of! amplification! between! low! responders!(average!fold!increase!0.41!±!0.06)!and!high!responders!(average!fold!increase!0.30!
±!0.06).!!There!are!few!studies!that!looked!at!the!involvements!of!both!TSLP!and!iNKT!cells!in! pathogenesis! of! different! immune^related! diseases! (309)! .! Recently,! there! have!been! two! important! studies! from! allergic! diseases! about! the! combined! roles! of!TSLP!and!NKT!cells.!Wu!et!al! (162)! looked!at!atopic!dermatitis!and!found!that!iNKT!cells’!percentages!in!PBMCs!of!atopic!dermatitis!patients!were!significantly!higher!than!those!of!healthy!controls.!Furthermore,!the!level!of!increase!was!proportional!to! the! severity!of! the!disease.!They!also! found!elevated! levels!of!TSLP! in! the! skin!lesions!of!these!patients.!Also,!in!an!allergen^induced!asthma!mouse!model,!Nagata!et!al!(267)!showed!that!the!disease!can!be!induced!in!TSLP!transgenic!mice!with!NKT!cells!but!not!in!similar!mice!that!lack!these!cells.!The!results!presented!here!are!in!
!!
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accordance!with! these! studies! and! indicate! that! TSLP!may! be! able! to! specifically!stimulate!iNKT!cells.!!!The!expansion!response!of!iNKT!cells!was!estimated!using!relative!percentage!cells’!count!at!day!14!rather!than!relative!fold!increase!of!cells!at!day!14!compared!to!day!0.!The!reason!behind!this! is! two^fold.!First,! there! is!variability! in! individual!day!0!measurements!for!the!same!subject!when!PBMC’s!are!harvested!at!different!times.!Although!this!variability!is!small!in!value,!it!contributes!to!a!much!higher!variability!when!fold!ratios!are!calculated.!Secondly,!in!spite!of!small!intra^subject!variation!in!day! 14! percentage! numbers,! subjects! showed! persistently! either! high! or! low!responses.!Therefore!cell!percentages!at!day!14!were!more!effective!representation!of!the!expansion!response!in!individual!subjects.!!!The! selected! nine! subjects! were! divided! into! high! and! low! responder! groups!according! to! iNKT!cell!percentages!at!day!14! (section!3.6.2!and!section!5.3.1.1.1).!This!may!reflect!a!physiological!variation!of!iNKT!cells!among!different!individuals!or!in!their!response!to!the!glycolipid!ligand!KRN7000.!!!Similarly,! Croudace. et. al. (310)! have! identified! two! distinct! levels! of! responses! to!KRN7000!of!iNKT!cells!in!PBMCs!of!healthy!donors.!They!selected!iNKT!cells!using!6B11! antibody! and! gated! for! the! CD3+! population! to! increase! specificity! of!selection.! High! responders!were! defined! as! those!with!more! than! 2%! iNKT! cells!after!14!days!of!stimulation!with!KRN7000!(values!ranged!from!4.5%!to!18%),!and!low!responders!as!those!with!less!than!2%!NKT!cells!(values!ranged!from!0.8%!to!2%).!!!The! differences! in! gating!method! and!NKT! cell! selecting! antibodies!makes! direct!comparison!between!Croudace.et.al’s!study!and!this!study!rather!difficult.!The!fact!Croudace.et.al’s!percentages!were!represented!as!part!of!the!CD3+!population!and!not!the!gated!lymphocyte!population!may!produce!percentages!that!are!33%!higher!compared!to!this!study;!based!on!the!fact!that,!on!average,!75%!of!lymphocytes!are!CD3+.!On!the!other!hand,!this!study!has!shown!in!section!4.5.2.1!that!iNKT!cells!can!down!regulate!their!
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and!beta! chain! epitopes! (Vα24!or!6B11!epitopes).!This!makes! it!more!difficult! to!estimate!the!true!percentage!of!iNKT!cells!after!gating!for!the!CD3+!population!and!may!produce!false!lower!percentages.!!!Regardless!of!levels!of!iNKT!cells!and!cutoff!points!used,!this!study!and!Croudace.et.
al’s! study! both! confirm! the! existence! of! two! distinct! patterns! of! response! to!KRN7000! stimulation! that! is! evident! in! repeated! experiments! of! the! same!individuals.!When!the!same!healthy!donors!in!different!experiments!of!chapters!3,!4!and! 5! were! used,! they! have! persistently! shown! the! same! pattern! of! response.!Similarly,! Croudace. et. al’s! study! has! shown! reproducibility! of! response! pattern!when!six!donors!were!re^tested!(310)!,!figure!1!part!4).!!!!!!! !
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5.4.2'Cytokine'production'!In!addition!to!proliferation,!the!effect!of!different!stimulants!on!iNKT!cell!cytokine!production!was!investigated.!Four!different!cytokines!were!chosen!on!the!basis!of!investigating!a!potential! induction!of! the!adaptive! immune! response!mediated!by!stimulated!iNKT!cells:!IFN^γ,!IL^4,!IL^13,!and!IL^17.!It!should!be!noted!that!cytokine!production! was! measured! in! the! same! number! of! cells! for! all! subjects! and!stimulation!type!regardless!of!the!final!proliferated!numbers!of!iNKT!cells!present.!!IL^4! was! undetectable! in! iNKT! cells! of! the! nine! subjects! regardless! of! the!stimulation!type.!These!results!do!not!reflect!the!reported!role!of! IL^4!in!different!clinical!studies!of!allergic!diseases!(311)!such!as!in!bronchial!asthma!(312)!.!Also,!many!studies! identified!TSLP!as!a!positive! regulator!of!allergic!diseases! such!as!asthma!(267)!and!atopic!dermatitis!(162)!.!!One!explanation!could!be!that!this!experiment!has!failed!to!detect!IL^4.!This!could!be! due! to! an! experimental! error.! This! is! unlikely! because! the! standard! curve!produced! good! absorbance! readings.! ! It! is! known! that! IL^4! is! notorious! to! be!detected!compared!to!other!cytokines!and!levels!can!be!low!(BF!Flanagan,!personal!communication).! The! other! possibility! is! that! interleukin! levels! are! lower! than!other!cytokine! levels!with!subtler!variation!between!the!different!stimulants.!This!way!most! of! IL^4! levels! have! fallen! below! the! lower! dynamic! range! of! the! ELISA!used! in! this! study! (7.8pg/ml).! !Wu!et.al! (162)! investigated! the! role!of! iNKT!cells! in!atopic! dermatitis! and! found! significant! differences! in! IL^4! production! with!(10pg/ml)! or!without! TSLP! (3pg/ml).! These! levels! are! certainly! below! the! lower!limit!of!the!dynamic!range!of!this!study.!However,!they!do!report!smaller!levels!for!IL^13,!which!is!contradictory!to!the!findings!of!this!study!as!will!be!discussed!later.!Furthermore,!their!methods!are!different.!!!!It! should!be!noted!that! these! findings!do!not!exclude!the!role!of! IL^4!and!TSLP! in!iNKT!cells!of!allergic!patients!in.vivo.!Shim!et.al.(313)!have!investigated!IL^4!positive!iNKT!cells!in!patients!with!asthma!using!intracellular!cytokine!staining.!They!found!
!!
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that! although! iNKT! cell! frequency! did! not! differ! between! asthma! patients! and!healthy! controls,! the! proportion! of! IL^4+! iNKT! cells! was! increased! in! asthma!patients!compared!to!controls.!!!In!Asthma,!Fahy!et! al! (314)! ,! among!others,! investigated! the! central! role!of! IL^4! in!mediating! the! Th2! response.! TSLP! is! an! airway! epithelial! cell^produced! cytokine!that!triggers!a!Th2!type!response!(315)!which!produces!cytokines!such!as!IL^4.!Since!iNKT! cells! are! capable! of! producing! both! Th1! and! Th2! cytokines! and! they! have!TSLP! receptors,! it! is! expected! that! TSLP!will! trigger! Th2! type! responses! in! iNKT!cells! and! therefore! IL^4! production.! They! found! that! 7%! of! iNKT! cells! in! asthma!patients!were!IL^4!positive!compared!to!0.5%!of!controls.!They!also!have!shown!a!correlation! between! IL^4! positive! cells! and! the! severity! of! the! disease.! One!possibility! is! that! IL^4! production! by! iNKT! cells! in! these! patients! cells! may! be!induced!by!a!different!stimulant!than!TSLP.!!!!In! contrast! ELISA! measurement! for! IFN^γ! in! KRN7000! stimulated! cells! showed!high^level! production.! When! iNKT! cells! were! co! stimulated! with! KRN7000! and!TSLP! throughout! the! 16! days! experiment! there! was! a! statistically! significant!increase! in! IFN^γ!production! (354±45!pg/ml! compared!with!103±18!pg/ml).!The!increase! in! IFN^γ! was! statistically! significant! in! both! low! and! high! responders!groups!(figure!5.14).!There!was!a!decreased!response!when!TSLP!was!removed!in!the! final! 48! hours! (early! introduction)! (255±31! pg/ml).! This! decrease! also!happened!in!both!high!and!low!responders!groups!(figure!5.14).!!!!IFN^γ!production!from!KRN7000!stimulated!iNKT!cells’!correlates!with!other!work!in!the!literature!showing!the!ability!of!iNKT!cells!to!quickly!produce!high!levels!of!IFN^γ! upon! stimulation! (316)! .! IFN^γ! production! by! iNKT! cells! has! been! linked! to!many!pathological!effects!of!these!cells!in!different!diseases!such!as!in!sepsis!(317)!,!helminth!infections!and!other!parasites!(186)!and!Salmonella!infections!(164)!,!among!others! and! it! would! be! interesting! to! determine! if! TSLP! can! influence! iNKT! cell!functional!activity!in!these!diseases.!!!
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Notwithstanding! that! TSLP! induces! aTh2! response,! high! IFN^γ! production! in!concurrent! stimulation! can! be! as! a! result! of! an! attempt! to! counteract! possible!allergic! inflammation.! Matsuda! et. al! demonstrated! that! αGal! Cer! can! prevent!allergic! inflammation!in!airways!such!as!asthma!by!producing!IFN^γ!by!iNKT!cells!(318)! .!Finally,! IFN^γ! is!a!cytokine! that! is!critical! for! innate!and!adaptive! immunity.!Early!involvement!of!cells,!such!as!NK!and!NKT!cells!produce!it!predominantly,!as!part!of!innate!response!and!by!other!cells!such!as!CD8+!cells!after!antigen!specific!response!develops!(319)!.!!!IL^13! and! IL^17! cytokine!production!has! similar! trends! in! this! experiment.!There!was! no! detectable! IL^13! or! IL^17! cytokine! production! in! PBMCs! that! have! been!incubated!for!16!days!in!KRN7000!alone,!whereas!there!was!high!production!of!IL^13! (278±164! pg/ml)! and! moderate! production! of! IL^17! (25±11! pg/ml)! in! cells!proliferated!in!concurrent!environment!of!both!KRN7000!and!TSLP!(Figures!5.16!A!and!5.18!B).!!Also,!the!results!of!experiments!in!this!chapter!showed!significant!increase!in!these!two!cytokines!production!in!high!responders!when!compared!with!low!responders!(Figure! 5.16! B! and! C,! Figure! 5.18! B! and! C,! P<0.05).! ! These! findings! concur!with!previous! studies! since! IL^13! and! IL^17! are! both! major! cytokines! in! airway!inflammation!(320)!and!since!TSLP!is!linked!to!the!induction!of!allergic!disease!such!as!atopic!dermatitis!and!asthma!(321)!.!!iNKT!cells!have! the!ability! to!secrete!copious!amounts!of!cytokines! that!can!skew!the!immune!response!toward!a!Th2!response!(322)!hence!it!can!have!a!role!in!atopic!diseases! such!as!asthma.! !However,! similar! to!other!aspects!of! iNKT!cells,! clinical!interpretation! of! results! is! far! from! simple.! It! has! been! found! that! iNKT! cells!numbers!increase!in!asthma!with!increased!production!of!Th2!cytokines!including!IL^4,! IL^10,! IL^13! and! IL^17! (323)! .! On! the! other! hand,!NKT! cell! numbers! in! atopic!dermatitis! are! significantly! lower! than!healthy! controls!but! they!produced!higher!amounts!of!Th2!cytokines!(243)!.!!
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It!is!most!likely!that!TSLP!has!a!direct!effect!on!iNKT!cells!since!they!express!TSLP!receptor! as! was! found! in! Chapter! 4.4.7! and! as! been! found! in! a! mouse!model! of!asthma!(267)!.!However,!this!does!not!rule!out!iNKT!cell!cytokine!production!through!an! indirect!effect!of!TSLP!on!other!cells! in!PBMC.!Certainly,!experimental!work! in!mice!has!shown!that!ability!of!induction!of!hyper^reactivity!and!production!of!IL^13!from!NKT!cells!in!the!presence!of!TSLP!(267)!.!!!!Finally,! Lee! et! al! demonstrated! that! iNKT! cells’! type! of! stimulation! and! cytokine!production!is!affected!by!TSLP!concentration.!They!found!that!at!50ng/ml!of!TSLP!IL^4! production! was! highest! where! IL^13! production! was! highest! at! 1ng/ml! of!TSLP.!In!this!study,!TSLP!concentration!was!10ng/ml.!This!may!explain!the!low!IL^4!production! in! this! experiment.! Also,! for! future! work! this! experiment! can! be!repeated!with!different!TSLP!concentrations! to! investigate! the!effect!of! change!of!concentration!on!different!cytokine!production.!!Interestingly,!the!addition!of!TSLP!enhanced!iNKT!cells!percentages!at!day!14!in!all!individuals.! When! compared! in! specific! response! groups,! both! high! and! low!responders!showed!an! increase! in!numbers!with! the!presence!of!TSLP.!The!mean!increase!in!iNKT!cell!percentage!was!21.5%!and!4.7%!in!high!and!low!responders,!respectively! (Figure! 5.5).!When! the! ratio! of! iNKT! cell! increase! between! values! of!KRN7000!and!TSLP!stimulation!to!KRN7000!alone,!the!low!responders!had!0.4!fold!increase! and! the! high! responders! had! 0.3! fold! (Figure! 5.7).! This! increase! was!universal!among!all!individuals!and!there!was!not!a!significant!difference!in!ratio!of!increase! due! to! TSLP! between! the! two! responders’! groups.! This! may! be! of!importance! in! clinical! trials! of! iNKT! cells! such! as! in! tumour! therapy.! Many!researchers! have! investigated! methods! to! increase! iNKT! cells! and! further!investigation!into!this!effect!of!TSLP!may!be!beneficial.!!!TSLP!can!initiate!allergic!inflammation!without!the!adaptive!immune!response!(270)!.!Also!it!has!been!found!that!TSLP!potently!activates!innate^like!mast!cells!to!produce!high! levels! of! Th2! cytokines! which! implies! a! crucial! role! for! the! innate! allergic!immune! response! in! the! pathogenesis! of! allergic! diseases! (268)! .! ! iNKT! cells! have!
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significant!roles!in!innate!responses!(324)!and!innate!allergic!immune!response!(325)!.!The!work! in! this! chapter! illustrates! that!TSLP!has! a!direct! effect!on! iNKT!cells! in!both!expansion!and!cytokine!production.!!The! experiments! in! this! chapter! showed! that! TSLP! significantly! increased! iNKT!cells!numbers!in!PBMC!in!healthy!donors!when!combined!to!the!iNKT!cell!specific!glycolipid! antigen! KRN7000.! This! finding! may! lead! to! the! assumption! that! iNKT!cells!may!have! a! crucial! role! in!many!allergic!diseases! especially!when! combined!with! glycolipid! antigen.! This! leads! to! the! possibility! of! having! natural! glycolipid!ligand!that!is!presented!in!the!presence!of!TSLP!either!in!the!lungs!as!in!asthma!or!in!the!skin!as!in!atopic!dermatitis,!which!makes!certain!individual!more!susceptible!to!these!allergic!diseases.!! !
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Chapter!6:!Secretory! response! of! enriched!isolated!iNKT!cells! !
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6.1!Aims!!The! results! described! in!Chapter!5! show! ! an! increase! in!production!of! both! !Th2!cytokines! and! IFN^γ! occurs! in! ! ! PBMC! cultures! ! which! contain! stimulated!proliferating!iNKT!cells.!The!experiments!described!in!this!chapter!were!carried!out!to!determine! !whether!the!detected!cytokines!are!directly!produced!by! iNKT!cells!themselves.!!!To! investigate! this!possibility,!analysis!of!cytokine!production!by!stimulated! iNKT!cells!!after!further!purification!was!carried!out.!!Two!sources!of!purified!iNKT!cells!were! used.! Firstly! iNKT! cells! were! isolated! from! mixed! cultures! of! PBMCs!stimulated!for!14!days!with!both!KRN7000!and!TSLP.! !Separating!iNKT!cells! from!other!PBMC!into!new!media!at!day!14!and!then!culturing!these!isolated!cells!further!would!demonstrate!the!ability!of! these!cells!to!produce!cytokines!after!14!days!of!culture! rather! than! accumulation! of! production! over! this! period! as! analysed! in!Chapter! 5.! Secondly,! two! different! clones,! that!were! prepared! and! produced! in! a!similar!protocol,!of!iNKT!preparation!and!termed!!‘cell!lines’!were!kindly!provided!by!Professor!Stephan!Gadola,!University!of!Southampton.!!!To! further! extend! the! analysis! of! pro^inflammatory! cytokine! production! of! cells!stimulated!with!a!combination!of!KRN7000!and!TSLP,!a!panel!of!pro^inflammatory,!anti^inflammatory!cytokines,!chemokines!and!enzymes!was!analysed.!Expression!of!IL^33! was! investigated! since! it! is! produced! mainly! by! epithelial! cells! (326)! and! it!promotes!cells!to!secrete!TSLP.!! !
!!
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6.2!Materials!and!methods!6.2.1!Donor!separated!cells!
6.2.1.1'Proliferation'of'donor'stimulated'cells'For! testing! purified! iNKT! cells’! secretory! response! after! have! been! stimulated!within!PBMC!population! for!14!days! then! in! isolation! for! further!24!hours,!PBMC!from! 9! healthy! donors!were! stimulated!with! both! 100ng/ml! KRN7000! and! TSLP!(10ng/ml)!for!14!days!to! induce!the!highest!possible!secretory!response!(Chapter!5)! before! isolation,! re^stimulation! and! testing.! Cells! from! each! donor! were!proliferated! in! KRN7000! alone! for! the! purpose! of! determining! high! from! low!responders.!!!!
6.2.1.2'iNKT'cells'separation'from'PBMC'Proliferated! cells! were! separated! using! EasySep! from! STEM! CELL! Technologies!(catalogue!number!18557).! iNKT!cells!were!positively!selected!after!binding!them!with!the!anti!V?24!PE!conjugated!monoclonal!antibody!which!then!form!antibody!complexes!with!dextran!coated!magnetic!beads!(Figure!6.1).!The!unwanted!cells!are!poured!into!a!separate!tube!according!to!the!manufacturer’s!instructions.!Separation!purity!was!calculated!using!FACSCalibur!on!the!positively!collected!cell!suspension!of! the!already!Vα24!antibody!separated!cells.!Purity!was!measured!as!iNKT!cells!as!a!percentage!of!the!total!PBMC!population.!!The! recovery! of! separation! as! a! percentage! was! calculated! from! total! absolute!numbers! of! recovered! iNKT! cells! and! the! total! absolute! number! of! original! iNKT!cells.!The!total!absolute!number!of!cells!in!both!cases!was!calculated!starting!from!suspensions!volumes!and!the!concentration!of!cells!(measured!by!counting!suitable!events!in!FACS!analysis!of!a!specific!volume!of!stained!cell!suspension;!100µl).!!!Purity!and!recovery!were!calculated!as!follows:!!
!!
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Purity' % = *+,-./'01'2324'607898:.';.<<7'8='7.6>/>9.?';.<<7@9+-.A09><'=+,-./'01'B>9.?';.<<7'8='9ℎ.'7>,.'9+-. D100!!! Recovery' % = '*+,-./'01'2324'607898:.';.<<7'8='7.6>/>9.?';.<<7@9+-.A09><'=+-./'01'2324';.<<7''-.10/.'7.6>/>980= D'100!!Cell!viability!was!tested!using!propidium!iodide!(Chapter!2.5.1).!!!
!!
Figure'6.1'Demonstrates'binding'of'the'EasySep'beads'to'target'cells'The!positive!selection!of!iNKT!cells!is!done!by!the!binding!of!dextran!coated!magnetic!beads!to!PE!conjugated!Vα24!antibodies!that!are!already!bound!to!target!iNKT!cells.!!
6.2.1.4'Stimulation'of'separated'cells'At! day14! proliferated! some! of! the! PBMC! were! collected! for! FACS! analysis! to!determine!whether! the!subject!a!high!or! low!responder.!After! that!at!day14! iNKT!cells! were! separated! using! EasySep! beads! ! (6.2.1.3! above),! adjusted! in! culture!media! to! 1million! cells/ml! and! left! for! 24hours! in! a! high! CO2! high! humidity!incubator.!The!remaining!PBMC!after!depletion!of! iNKT!cells!were! treated!exactly!the! same! as! the! separated! iNKT! cells! of! that! person! for! comparison! and! to!determine! the! cell! source! of! produced! cytokines.! After! 24hours! of! separation!supernatant!was! collected! and! cytokine! production!measured! in! the! supernatant!
EXAMPLE: EASYSEP® PE SELECTION PROFILE - MOUSE CD4
Start: 16.4% CD4+ Cells Selected: 98.1% CD4+ Cells
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Product Information Sheet.
Catalog #18551 (Human) For labeling 109 total cells
Catalog #18554 (Mouse) For labeling 109 total cells
Catalog #18557 (Other) For labeling 109 total cells
Components:
• EasySep® PE Selection Cocktail 1.0 mL
• Species-Specific Blocker (Human & Mouse Only):
Anti-Human CD32 (Fcγ RII) Blocker (#18551 Only) 1.0 mL
Mouse FcR Blocker (#18554 Only) 0.1 mL
• EasySep® Magnetic Nanoparticles 1.0 mL
• RoboSep® Vial for Primary Conjugated Antibody (not required for manual use) 1 vial
EXAMPLE: EASYSEP® PE SELECTION PROFILE - HUMAN CD3
Start: 27.8% CD3+ Cells Selected: 98.7% CD3+ Cells
CD3 PE
REQUIRED EQUIPMENT:
EasySep® Magnet (Catalog #18000), or “The Big Easy” EasySep® Magnet (Catalog #18001),
or RoboSep® (Catalog #20000).
PRODUCT DESCRIPTION AND APPLICATIONS:
EasySep® PE Selection Cocktail and EasySep® Magnetic Nanoparticles target cells that are
labeled with PE-(phycoerythrin-)conjugated antibodies (not supplied) for magnetic separation.
The species-specific FcR blocker (anti-human CD32, anti-mouse CD16/32) is used to
prevent non-specific selection of monocytes and macrophages. Note: When selecting cells
from other species, an appropriate species-specific FcR blocking antibody may be required
to achieve desired purities. A final concentration of 0.5 - 3.0 µg/mL is recommended for the
blocking antibody. These reagents are designed to positively select cells labeled with
PE-conjugated antibody.
EASYSEP® LABELING OF CELLS:
Target cells that have been specifically labeled with PE-conjugated antibody are then labeled
with dextran-coated magnetic nanoparticles using bispecific Tetrameric Antibody Complexes
(TAC). These complexes recognize both dextran and the PE molecule on the PE-conjugated
antibody (Figure 1). Magnetically labeled cells are then separated from unlabeled cells using
the EasySep® procedure (reverse side).
NOTES AND TIPS:
Preparing a Cell Suspension. Prepare a mononuclear cell suspension from human
peripheral blood by Ficoll-Paque™ PLUS density separation (Catalog #07957). Previously
frozen mononuclear cells should be incubated with 100 µg/mL DNase I (Catalog #07900) in
medium without EDTA for at least 15 minutes at room temperature prior to labeling and
separation to reduce clumping. Filter clumpy suspensions through a 70 µm mesh nylon
strainer for optimal results. Mouse spleen and bone marrow cells should be prepared
following standard procedures and filtered through a 70 µm mesh nylon strainer.
Recommended Medium. The recommended medium is PBS with 2% FBS (Catalog
#07905) and 1 mM EDTA. Medium should be Ca++ and Mg++ free.
Assessing Purity. Since the positively selected cells have already been labeled by the PE-
conjugated antibody, their purity can be assessed by flow cytometry without additional
labeling.
Opti izing Purity. For samples with a desired cell starting frequency of less han 10 - 15%,
additional separation rounds will likely improve purity. If desired, repeat Steps 7 and 8 an
additional 1 - 3 times. Please note that recovery will decrease with each additional round of
separation. When isolating cells representing less than 2% of the initial population,
the purity of the enriched sample may be improved by starting with a cell concentration of
2 x 108 cells/mL. For some cell types, decreasing the amount of PE Selection Cocktail added
can increase purity while decreasing recovery. This will also reduce side scatter during
subsequent flow cytometry analysis. Performance may also be improved by adding a wash
step. After incubating the sample with PE-conjugated antibody (Step 3), wash once with
10-fold excess medium and resuspend to original volume. Please note that this wash step
can not be automated by RoboSep®.
Optimizing Recovery. Recovery of positively selected PE-labeled cells is dependent on the
quality of the PE-conjugated antibody used. Antibodies that have expired or that have been
stored improperly may show lower affinity for the surface marker on the target cell, resulting
in lower recovery. It is important to add sufficient PE-conjugated antibody to ensure a
significant fluorescence intensity of the target cells, as there is a strong correlation between
fluorescence intensity and cell recovery.We recommend that the fluorescence intensity of the
positively selected cells be at least 100-fold (2 logarithms) greater than that of the negative
control for adequate recovery. Recovery may also be improved by increasing separation times
















EasySep® PE Selection Cocktail code #18151
This cocktail contains a combination of monoclonal antibodies purified from hybridoma culture
supernatant by affinity chromatography using Protein A or Protein G Sepharose. These
antibodies are bound in bispecific tetrameric antibody complexes (TAC) which are directed
against PE (phycoerythrin) and dextran. These mouse monoclonal antibodies are of subclass
IgG1. This cocktail is supplied in phosphate buffered saline. It should be noted that this product
is a biological reagent, and as such cannot be completely characterized or quantified. Some
variability is unavoidable.
Anti-Human CD32 (Fcγ RII) Blocker code #18520
This antibody recognizes human CD32 (Fcγ RII) present on monocytes, platelets, macrophages,
and granulocytes. Supplied in phosphate buffered saline.
EasySep® Mouse FcR Blocker code #18720
This antibody recognizes mouse CD16/CD32 (Fcγ III/II Receptor) present on monocytes,
macrophages and other FcR+ cells. Supplied in phosphate buffered saline in 0.1% BSA and
0.1% sodium azide.
EasySep® Magnetic Nanoparticles code #18150
A suspension of magnetic dextran iron particles in water.
RoboSep® Vial for Primary Conjugated Antibody code #18550
Empty vial compatible with RoboSep® - the fully automated cell separator. If using RoboSep®,
transfer PE-conjugated antibody to this empty vial before loading into the appropriate position
in the RoboSep® carousel. If not using RoboSep®, this vial can be discarded.
STABILITY AND STORAGE:
EasySep® PE Selection Cocktail. Stable at 4°C for 2 years. Do not freeze this product.
Contents sterile in unopened tube. This product may be shipped at room temperature, and
should be refrigerated upon receipt.
Human or Mouse FcR Blocker. Stable at 4°C for 2 years (human) or 1 year (mouse).
Contents sterile in unopened tube. This product may be shipped at room temperature, and
should be refrigerated upon receipt. Do not freeze.
EasySep® Magnetic Nanoparticles. Stable at 4°C for 2 years. Contents sterile in unopened
tube. This product may be shipped at room temperature, and should be refrigerated upon
receipt.
Hazardous Ingredient: Sodium Azide. Avoid exposure to skin and eyes, ingestion and
contact with heat, acids and metals. Wash exposed skin with soap and water. Flush eyes with
water. Dilute with running water before discharging into plumbing.
Ficoll™ and Ficoll-Paque™ PLUS are trademarks of GE Healthcare Ltd.
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from!both!iNKT!cells!and!iNKT!depleted!populations!(the!rest!of!PBMC)!of!the!same!donor.!Detection!of!IL^13,!IFNγ!and!IL^33!was!done!using!ELISA!from!eBiosciences!(IL^13,!IFNγ)!and!R&D!Systems!(IL^33;!Diagram!6.1).!!!!
!Diagram! 6.1! demonstrating! the! course! of! PBMC! cell! culture! and! iNKT! cells!separation.!!!! !
!!
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6.2.1.5'ELISA'cytokine'measurement''ELISA!was! carried!out! as!mentioned! in!Chapter!2.6!on! supernatants!of! separated!iNKT!cells!and!cell!lines!for!IL^13,!IFN^γ!(both!ready^set^go!from!eBiosciences)!and!IL^33!(R!and!D!Systems).!!
6.2.1.6'Cytokine'panel'of'selected'donor'Thirty!different!analytes!were!measured!in!the!supernatant!of!enriched!iNKT!cells!(marked!as!positive)!and!the!rest!of!PBMC!populations!(marked!as!negative)!for!a!single!subject!(subject!56).!These!mediators!were!part!of!a!different!study!and!were!kindly! analysed! by! Dr! Benedict! Michael! in! the! University! of! Liverpool! and!Liverpool’s! Walton! centre.! The! analytes! can! be! divided! into! several! groups;! the!cytokine! group! that! includes! IL^1α,! β,! IL^6,! IL^8,! IL^17a,! IL^4! and! IL^10;! the!chemokine! group! that! include! CCL3,! CXCL9,! CCL5,! and! others! such! as!myeloperoxidase!MPO,!Granzyme!B!GM^CSF!and!sICAM.!This!was!performed!using!multiplex!cytometric!bead^based!array!immunoassay.!!The! assay! enables! the! measurement! of! multiple! proteins! in! one! sample!simultaneously!(multiplex!measurement).!Beads!of!different!size!and!fluorescence!intensity!that!are!unique!to!each!analyte!are!loaded!with!specific!antibodies.!After!the!addition!of!sample,!labeled!detector!antibodies!that!are!specific!to!each!analyte!but! loaded!with!a!general! fluorescence!dye!are!added!to!form!a!sandwich!binding!similar!to!ELISA.!!!Cytokine! expression! is! measured! using! fluorescence! intensity! and! levels! are!determined! from! the!median! fluorescence! intensity! (MFI)! of! the! detector! dye! for!the!specific!population!of!each!analyte.!!Analyte! levels! are! determined! using! specific! standard! for! each! analyte.! Standard!curves! are! plotted! using! minimum! and! maximum! dynamic! range! levels! and!multiple!point!standards!for!each!cytokine.!!
!!
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6.2.2!Cell!line!
6.2.2.1'Cell'line'source'Professor! Stephan!Gadola! from! Southampton!University! kindly! provided! two! cell!lines.!!The!lines!were!prepared!from!human!PBMC!and!stored!in!liquid!nitrogen.!iNKT!cell!lines!were!generated!by!sorting!of!Vα24positive!!and!Vβ11!positive!cells.!!These!cells!were!stimulated!for!three!weeks!with!1µg/ml!!phytohaemagglutinin!in!the!presence!of!autologous!?^irradiated!PBMC!and!IL^2!(200IU/ml)!(327)!.!!
6.2.2.2'Thawing'and'activation'of'cell'lines'Two!separate!cell!lines,!a!and!b!from!two!healthy!donors,!were!thawed!quickly!and!washed!twice!with!culture!media!to!remove!DMSO.!Cells!were!counted!and!checked!for!viability!by!using!Trypan!blue!(10µl!cells!+10µl!TB)!then!were!readjusted!to!1!million!viable!cells/ml.!Non^autologous!gamma^irradiated!PBMC!were!used!as!antigen!presenting!cells! in!the!ratio!1!cell!line!to!5!PBMC!(million!cells/ml).!Cell!line!viability!was!tested!using!trypan!blue!as!mentioned!in!Chapter!2.5.2.!!!
6.2.2.3'Cell'line'stimulation'Each! cell! line! was! divided! into! four! parts! of! 1million! cells/ml! each! and! was!distributed! in! a! 12! well! sterile! plate.! In! the! first! well! non^autologous! irradiated!PBMC! were! added! to! the! iNKT! cell! line! (5:1! volume! to! volume),! 100ng/ml!KRN7000,!10ng\ml!TSLP!and!400units/ml!of!IL^2.!The!second!well!had!all!but!the!cell!line,!the!third!well!had!all!but!TSLP!and!the!final!well!had!all!but!PBMC!(Figure!6.3).!Cells!then!were!incubated!in!high!humidity!high!CO2!37C°! for!24!hours.!After!that!supernatant!was!collected!to!investigate!cytokine!production.!!!
!!
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6.2.2.4'Cell'line'ELISA'cytokine'measurement''Supernatants!were!collected!after!one!day!of!stimulation!to!investigate!IFN^?,! IL^13!and!IL^33!production.!This!was!done!using!ELISA!as!described!in!Chapter!2.!!!!!! !
!!
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6.3!Results!6.3.1!Donor!separated!iNKT!cells!
6.3.1.1'iNKT'cell'separation'Cell! separation! was! successfully! performed! after! 14! days! PBMC! culture! with!KRN7000! and! TSLP! stimulation.! Purity! varied! between! 95^99%! and! recovery!varied!between!70%^90%.!!There! was! no! difference! in! cell! purity! and! recovery! between! high! and! low!responders.!!!!! !
!!





11.!!A! gating! for! lymphocytes! in! PBMC! population! before! separating,! B! ! dot! plot! showing!proliferated!Vα24!positive! iNKT! cells! (upper! right!15.4%)! in! stimulated!PBMC!with!both!KRN7000!and!TSLP.!!!C,!gating!for!lymphocytes!in!the!non^iNKT!cells!after!separation!(rest!of!PBMC),!D,!dot!plot!for!the!non^iNKT!cell!lymphocyte!population!after!separation!showing!negative! Vα24! PE! staining.! E,! gating! for! separated! iNKT! cells! population,! F,! dot! plot! for!separated!anti!Vα!24!PE!positive!iNKT!cells.!!!!!!
!!
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6.3.1.2'ILV13'Analysis'in'separated'iNKT'cells'Figure!6.3! shows! IL^13!expression! in! the! supernatant!one!day!after! separation!of!iNKT! cells! from! the! PBMC! population! (N=9)! of! separated! iNKT! cells! (labelled! as!positive! cells)! and! the! rest! of! PBMC! for! the! same! subject! (labelled! ! ! as! negative!cells).!In!four!of!nine!donors!IL^13!levels!were!high!(45^150pg/ml)!and!significantly!higher! (paired! student! test! showed! p<0.05! between!means)! than! the! rest! of! the!PBMC!from!the!same!individual!(0^33pg/ml),!whereas!the!other!four!donors’!iNKT!cell!IL^13!secretion!did!not!exceed!10pg/ml.!The!rest!of!PBMC!IL^13!secretion!was!inconsistent.!Some!of!the!subjects!PBMC!had!less!secretion!of!IL^13!than!iNKT!cells,!others!had!more.!!Similar!to!the!previous!chapter,!the!four!subjects!that!showed!increased!IL^13!were!strong! responders! with! the! increase! in! iNKT! cell! percentage! more! than! 5! folds!between! day! 0! and! day! 14! values! after! stimulation! with! KRN7000,! whereas! the!other!subjects!showed!less!or!no!increase.!!!!Correlation!between!IL^13!in!supernatant!of!PBMCs!stimulated!with!a!combination!of! KRN7000! and! TSLP,! obtained! from! the! results! of! Chapter! 5,! and! IL^13! in!supernatant! of! separated! iNKT! cells! and! non^iNKT! cells! was! performed! using!Pearson’s! product^moment! correlation! coefficient.! There! was! a! statistically!significant! correlation!with! separated! iNKT! cells! (r=0.91,! P<0.05).!Non^iNKT! cells!however! did! not! show!a! significant! correlation!with! PBMC’s! IL^13! levels! (r=0.43,!P=0.12).!! !
!!




subjects.!This! figure! shows! that! iNKT! cells! (marked! as! positive! or! pos)! produced! IL^13! in! some!individuals! (subjects! 1,3,7! and! 9! at! 150,125,! 50! and! 90pg/ml! respectively)! where! IL^13!levels!were! insignificant! in! the! rest! of! PBMC!of! the! same! subject! (marked! as!negative! or!neg).!!!!!!!!!!!!!!!!
!!
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!
!!
Figure'6.4'ILV13'levels'in'separated'populations'of'iNKT'cells'and'nonViNKT'cells.''!(A)!all!subjects!(average!of!50pg/ml!for! iNKT!cells!and!20pg/ml!for!the!non!iNKT!cells!),!(B)!high!responders!(!average!of!100pg/ml!for!iNKT!cells!and!20pg/ml!for!non!iNKT!cells!)!and(C)! low!responders!(levels!below!the!ELISA!detection!range).! [*]!denotes!a!significant!difference!(P<0.05).!!!!!!
!!
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!!
!!!!
Figure' 6.5' Correlation' analysis' between' ILV13' levels' in' PBMCs' stimulated' with'
KRN7000'+'TSLP'and'ILV13'levels'in'supernatant'of'separated'cells.!!iNKT!cells!in!blue,!there!is!a!significant!correlation!between!IL^13!levels!between!enriched!iNKT! cells! and! iNKT! cells! in! mixed! PBMC! population! ! (r=0.91),! whereas! there! is! no!significant!correlation!between!IL^13!levels!of!!!non^iNKT!cells,!in!green,!and!IL^13!levels!in!iNKT!cells!in!mixed!PBMC!populations!(r=0.43).! !
!!
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6.3.1.3'IFNV.3Analysis'in'separated'iNKT'cells'Similar! to! IL^13,! four! out! of! the! nine! donors’! IFN^?! levels! were! high! (89^744pg/ml).! PBMC! IFN^?! levels! for! those! subjects! varied! between! 12pg/ml! and!73pg/ml.!However,!there!were!no!statistically!significant!differences!between!IFN^
?! levels! in! iNKT!cells!and!in!the!rest!of!PBMC!(p>0.05)!as!shown!in!Figure!6.7!B,!whereas!the!other!four!donors’!iNKT!cell!IFN^?!secretion!did!not!exceed!10pg/ml.!The! rest! of! PBMC! IFN^?! secretion!was! inconsistent.! Some! of! the! subjects’! PBMC!had!less!secretion!of!IFN^?!than!iNKT!cells!but!others!had!more!as!shown!in!Figure!6.6!which!demonstrates!IFN^?!levels!in!nine!different!donors!with!separated!iNKT!cells!(labelled!as!positive!cells)!and!the!rest!of!PBMC!for!the!same!subject!(labelled!as!negative!cells).!!Similar! to! the!previous! chapter,! the! four! subjects! (the! same!donors)! that! showed!increased! IFN^γ!were! strong! responders! (Figure!6.7!B)!with! the! increase! in! iNKT!cell! percentage! more! than! 5! folds! between! day! 0! and! day! 14! values! after!stimulation!with!KRN7000,!whereas!the!other!subjects!showed!less!or!no!increase!(Figure!6.7!C).!!When! correlation! was! performed! between! IFN^γ! in! supernatant! of! PBMCs!stimulated! with! a! combination! of! KRN7000! and! TSLP,! obtained! from! Chapter! 5!results,!and!IFN^γ!in!supernatant!of!separated!iNKT!cells!and!non^iNKT!cells!there!was! not! a! statistically! significant! correlation! with! separated! iNKT! cells! (r=0.53,!P=0.14)!and!non^iNKT!cells!(r=0.38,!P=0.31).!!!!!!!!!!
!!
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!!
Figure' 6.6' IFNV' (pg/ml)' levels' in' separated' iNKT' cells' and' nonViNKT' cells' of' nine'
subjects.''
'This! figure! shows! that! iNKT! cells! (marked! as! positive! or! pos)! produce! IFN^γ! in! some!individuals! (subjects!1,3,7!and!9!at!730,190,!120!and!90pg/ml! respectively)!where! IFN^γ!levels!were! insignificant! in! the! rest! of! PBMC!of! the! same! subject! (marked! as!negative! or!neg).!!!!!!!!!
!!
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!!
Figure'6.7''IFNV'levels'in'separated'populations'of'iNKT'cells'and'nonViNKT'cells.''!(A)!all!subjects!(average!of!180pg/ml!for!iNKT!cells!and!15pg/ml!for!the!non!iNKT!cells),!(B)!high!responders!(!average!of!220pg/ml!for!iNKT!cells!and!15pg/ml!for!non!iNKT!cells!)!and(C)! low! responders! (! average! of! 45pg/ml! for! iNKT! cells! and! 15pg/ml! for! non! iNKT!cells).![*]!denotes!a!significance!difference!(P<0.05).!!!!!!!
!!
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Figure' 6.8' Correlation' analysis' between' IFNV' levels' in' PBMCs' stimulated' with'
KRN7000'+'TSLP'and'IFNV'levels'in'supernatant'of'separated'cells.''iNKT! cells! in! blue,! there! is! more! significant! correlation! between! IFN^γ! levels! between!enriched!iNKT!cells!and!iNKT!cells!in!mixed!PBMC!population!!(r=0.53)!whereas!there!is!no!significant!correlation!between!IL^13!levels!of!!!non^iNKT!cells,!in!green,!and!IL^13!levels!in!iNKT!cells!in!mixed!PBMC!population!(r=0.38).!!!!!! !
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6.3.1.4'ILV33'Analysis'in'separated'iNKT'cells'IL^33!secretion!was!negative!and!did!not!exceed!20pg/ml!in!both!cell!groups,!iNKT!cells! and! the! rest!of!PBMC.!Figure!6.9!demonstrates! IL^33! levels! in!nine!different!donors!with!separated!iNKT!cells!(labelled!as!positive!cells)!and!the!rest!of!PBMC!for!the!same!subject!(labelled!as!negative!cells).!!!!!!!!!!!!!!!!!!!!!!!!!!!!
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!!!!! !!!!!!!!!!!!!!Figure!6.9!IL^33!(pg/ml)!levels!in!iNKT!cells!and!non^iNKT!cells!separated!cells!of!nine!subjects.!!!This!figure!shows!that!iNKT!cells!(marked!as!positive!or!pos)!do!not!produce!IL^33!in!all! individuals.!It!also!shows!that!the!rest!of!PBMC!(marked!as!negative)!do!not!produce!IL^33!either.!All!production!did!not!exceed!20pg/ml.!The!cut!off!value!for!IL^33!is!18pg/ml!!!!!! !
!!
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6.3.1.5'Cytokine'panel'of'a'single'selected'donor'The!levels!of!detected!analyte!were!divided!into!high!and!moderate!according!to!the!absolute!numbers!regardless!of!the!relative!cytokine!detection!levels.!!!
6.3.1.5.12HighSlevel2analytes2in2separated2iNKT2cells2supernatant2There!were! ten! analytes! that! showed! concentrations! higher! than! 500! pg/ml! per!million!cells.!These! include! five!chemokines;!CCL5!(1960!pg/ml!per!million!cells),!CXCL9! (1653! pg/ml),! CCL3! (1152! pg/ml),! MCP1! (498! pg/ml)! and! IL^8! (CXCL8)!(938!pg/ml).!The! analytes! also! include! two! enzymes;! Granzyme! B! at! 3156! pg/ml! and!myeloperoxidase!(MPO)!at!1310!pg/ml.!Also! there!were!one!soluble!receptor! IL^1RA!(695!pg/ml),!one!adhesion!molecule!sICAM! (! 3676!PG/ML)! and! one! colony! stimulation! factor!GM^CSF! (678!pg/ml)! as!shown!in!Figure!6.12.!!!
6.3.1.5.22ModerateSlevel2analytes2in2separated2iNKT2cells2supernatant2There!were! eleven! analytes! that!were!detectable!but! had! concentration! less! than!500! pg/ml! per! million! cells.! Seven! of! these! analytes! are! cytokines;! IL^1a! (242!pg/ml),! IL^2b! (228! pg/ml),! IFN^?! (162! pg/ml),! IL^10! (155! pg/ml)! IL^17a! (430!pg/ml),!TNF?!(358!pg/ml)!and!IL^4!(369!pg/ml).!!There! was! one! signal! protein,! Vascular! Endothelial! growth! factor! (VEGF)! at! 309!pg/ml.!One!adhesion!molecule,!soluble!vascular!cell!adhesion!molecule!(sVCAM)!at!167!pg/ml.!!!One! soluble! ligand,! Tumour! necrosis! factor^! related! apoptosis^inducing! ligand!(TRAIL)! at! 241pg/ml! and! one! soluble! receptor.! Tumour! necrosis! factor! receptor!(TNFR1)!at!30!pg/ml!as!shown!in!Figure!6.13.!!!
!!
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6.3.1.5.32Undetectable2analytes2in2separated2iNKT2cells2supernatant2There!were!nine!molecules!for!which!!FACS!dye!levels!were!below!the!lower!limit!of!the!assay!dynamic!range.!These!are!shown!in!Figure!6.14.!!
6.3.1.5.42Comparing2iNKT2cells2and2rest2of2PBMCs2analyte2levels2Eight!of!the!thirty!analytes!showed!significantly! lower!concentration!in! iNKT!cells!compared! to! the! rest! of! PBMC.! The! most! significant! difference! was! observed! in!soluble!ICAM!(3676!pg/ml!in!iNKT!cells!compared!to!7064!pg/ml!in!rest!of!PBMC;!52%)!and!IL^8!(938!pg/ml!in!iNKT!cells!compared!to!1896!pg/ml!in!rest!of!PBMC,!49%).! Other! analytes!with! significant! differences! are! CCL3! (1152! pg/ml! in! iNKT!cells!compared!to!1971!pg/ml!in!rest!of!PBMC,!58%),!GM^CSF!(678!pg/ml!in!iNKT!cells!compared!to!1027!pg/ml! in!rest!of!PBMC;!66%),!MPO! !(1310!pg/ml! in! iNKT!cells!compared!to!1940!in!rest!of!PBMC,!68%)!and!IL^1RA!(695!pg/ml!in!iNKT!cells!compared! to!987! in! rest!of!PBMC,!70%).!Finally! the! least! significant!difference!of!analyte! levels! between! the! two! groups!was! in! Granzyme!B! (3156! pg/ml! in! iNKT!cells!compared!to!3925!pg/ml!in!the!rest!of!PBMC,!80%),!CCL5!(1960!pg/ml!in!iNKT!cells! compared! to!2278!pg/ml! in! rest! of!PBMC;!85%)!and!CXCL9! (1645!pg/ml! in!iNKT!cells!compared!to!1929!pg/ml!in!rest!of!PBMC,!86%).!
22!!!!!!!!!!!!!!!!!!!
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!
!
Figure'6.10'A'and'B''panel'of'30''analyte'using'cytokine'multiplex'in'subject'56.'This!figure!demonstrates!that!purified!iNKT!cells!express!some!cytokines!and!chemokines.!However,! in! comparison! with! the! rest! of! PBMC,! iNKT! cell! production! is! less! for! most!analytes.!'!!
!!
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!!!
Figure' 6.11' These' figures' illustrate' the' 30' analytes' different' levels' in' the' separated'
iNKT'cells'only.!!!A! demonstrates! the! high^level! analytes! whose! average! concentration! is! higher! than! 500!pg/ml;!B!demonstrates!the!moderate^level!analytes!whose!average!concentration!is!higher!than!500pg/ml.!!!!
!!
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6.3.2!iNKT!cell!lines!
6.3.2.1'iNKT'cell'lines'secrete'ILV13'after'stimulation'with'TSLP'and'KRN7000'The! results! show! that! IL^13! levels! in! the! two! cell! lines! stimulated! by! non^autologous! irradiated!PBMCs! in! the!presence!of! both!KRN7000!and!TSLP! show!a!significant! increase! in! the! production! of! IL^13! at! 52! pg/ml! compared! to! cells!stimulated! by! non^autologous! irradiated! PBMCs! in! the! presence! of! K! alone! at! 11!pg/ml!as!shown!in!Figure!6.9.!!The!two!negative!controls!reflect!background!IL^13!levels!in!irradiated!PBMCs!and!in!non^stimulated!iNKT!cells.!These!levels!of!cytokine!production!were!subtracted!from! the! samples! cytokine! levels! to! reflect! cytokine! production! that! can! be!attributed!only!to!stimulation!of!cells!in!the!presence!of!a!mixture!of!K!RN7000!and!TSLP!showing!the!effect!of!the!later!on!iNKT!cells!cytokine!production.!!!! !
!!
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!!!
Figure'6.9'ILV13'production'by'iNKT'cell'line.!!The!figure!demonstrates!that!the!highest!levels!of!IL^13!were!produced!by!the!iNKT!cell!line!when!stimulated!with!both!KRN7000!and!TSLP!(52!pg/ml)!compared! to! (11pg/ml)!when!stimulated!with!KRN7000!alone.!Results!expressed!as!mean!of!2!samples!+/^!sem.!!!!! !
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6.3.2.2'iNKT'cell'lines'secrete'IFNVγ'after'stimulating'with'TSLP'and'KRN7000'In!a!similar!manner!to!IL^13,! IFN^γ!secretion!was!the!highest! in!the! iNKT!cell! line!stimulated!with!both!KRN7000!and!TSLP!at!175.5pg/ml!compared!to!23.07pg/ml!when!stimulated!with!KRN7000!alone.!!!!!
!
!!
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!
Figure'6.10'IFNV'production'by'iNKT'two'cell'lines.!!The! figure! demonstrates! the! average! IFN^γ! levels! produced! by! iNKT! cell! lines! when!stimulated! with! both! KRN7000! and! TSLP! (175! pg/ml)! compared! to! (24pg/ml)! when!stimulated!with!KRN7000!alone.!Results!expressed!as!mean!of!2!samples!+/^!sem.!! !
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6.3.2.3'ILV33'analysis'of'cell'line'iNKT'cells'Similar! to!the!results!obtained!earlier! in! this!Chapter!(6.3.2.3)! there!was!no!IL^33!secretion! in!all! four! types!of!different!cell!groups!or!different!stimulation.! !Figure!6.11! shows! that! IL^33! secretion! did! not! exceed! 20pg/ml! in! all! four! different!stimulation!groups.!!!!!!!!!!!!!!!!!!!!!! !
!!
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6.3!Discussion!!The!aim!of!this!chapter!was!to!answer!the!question!whether!iNKT!cells!are!the!main!producers! of! the! cytokines! investigated! in! the! previous! chapter.! This! was!performed!by!testing!cytokine!levels!in!enriched!iNKT!cells!and!iNKT!cell!lines.!The!experiments!showed! increased! IL^13!and! IFN^γ!production!when! iNKT!cells!were!stimulated! with! both! TSLP! and! KRN7000! in! some! donors.! Furthermore! and! for!screening! purposes,! a! panel! of! 30! different! cytokine! was! investigated! in! the!supernatants! of! separated! iNKT! cells! for! subject! 56.! This! showed! that! iNKT! cells!expressed!a!wide!range!of!chemokines!(such!as!CCL3!and!CXCL8),!cytokines!(such!as!IL^4,!TNFα)!and!other!analytes.!!6.3.1!Separated!cells!
The!work!described!in!this!chapter!is!related!to!the!production!of!cytokines.!IL^13,!IFN^?!and!IL^33!were!measured! in!both!separated! iNKT!cells!and! iNKT!cell! lines!after!stimulation!with!both!TSLP!and!KRN7000.!The!results!showed!that!four!out!of!the!eight!subjects!who!were!responders!(subjects!who!responded!to!KRN7000!by!proliferation!after!14!days!stimulation!and!before!separation)!showed!significantly!higher! IL^13! and! IFN^?! production! compared! to! the! rest! of! PBMC! for! the! same!subject.! The! other! four! subjects! (non^responders)! showed! little! secretion! and! no!obvious!difference!from!the!rest!of!the!PBMC!for!the!same!subjects.!These!findings!confirm! that! the! production! of! IL^13! in! fact! is!mainly! from! the! iNKT! cells! rather!than!other!cells!in!the!PBMC!population.!These!findings!are!consistent!with!reports!in!the!literature!which!had!confirmed!that!iNKT!cells!in!PBMC!populations!produce!IL^13! and! other! Th2! cytokines! when! exposed! to! TSLP! as! was! found! in! atopic!dermatitis!patients! (162)! .!Furthermore,! it!has!been!found!that!IL^13!and!other!Th2!cytokines!are!produced!as!a!response!from!TSLP!primed!myeloid!DC!(328)!,!showing!that!Th2!cytokine!response!could!result!from!iNKT!cell!stimulation!by!TSLP.!!!!
!!
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The! negative! response! of! IL^13! and! IFN^γ! production! to! TSLP! with! or! without!KRN7000!could!be!due!to!the!short!half^life!of!the!cytokines!that!might!have!been!produced!earlier!in!the!process.!!Although!IFN^γ!is!a!Th1!cytokine!it! is!also!a!pro^inflammatory!one.! iNKT!cells!can!produce! large! amount! of! a! range! of! cytokines! and! IFN^γ! is! one! of! them! which!!concurs!with!their!role!in!bridging!innate!and!adaptive!immunity.!Olson!et.al.found!that! activation! of! mouse! iNKT! cells! in. vivo. by! Borrelia. burgdorferi! result! in!production!of!IFN^γ!which!enhances!the!severity!of!Lyme!carditis.!IFN^γ!improved!the! recognition! and! phagocytosis! of! the! pathogen! by! macrophages,! and! IFN^γ!increased! macrophage! surface! expression! of! CD1d! and! therefore! iNKT! cells!activation!(329)!.!!!!6.3.2!Cytokine!Multiplex!Bead!Assay!
Multiplex! analysis! was! carried! out! with! the! assistance! of! Dr! B!Michael! from! the!University!of!Liverpool.!Multiplex!assay!provides!an!excellent!approach!to!analyse!a!broad!range!of!cytokines!in!a!small!volume!of!culture!supernatant,!especially!when!relatively! low! numbers! of! iNKT! cells! are! present,! which! makes! standard! ELISA!analysis!of!numerous!analytes!or!cytokines!impractical.!!Subject!56!was!chosen!due!to!availability!of!extra!amounts!of!supernatant!of!both!separated! stimulated! iNKT! cells! and! supernatant! of! rest! of! PBMCs! which! allows!direct! comparison!between! the! two!supernatants.!At! the! time!when!collaboration!with!Dr!Michael!was! considered,! only! the! samples! of! two! donors!were! available.!One! donor! was! a! low! responder! and! the! other! was! a! high! responder.! The! low!responder! was! chosen! since! the! aim! was! to! exploit! the! high! sensitivity! of! the!multiplex!assay!to!investigate!analyte!secretion!after!combined!KRN7000!and!TSLP!stimulation!that!may!otherwise!have!shown!a!negative!response!in!standard!ELISA.!Similarly,! the! other! side! of! the! argument! is! also! logical! and! a! choice! of! a! high!responder!has!also!its!benefits.!!!
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Three! repeats! of! two! samples! of! subject! 56! were! tested! corresponding! to! the!supernatant! of! two! populations! of! enriched! iNKT! cells! after! combined! KRN7000!and! TSLP! stimulation! (POS! population)! and! the! rest! of! PBMC! (NEG! population)!inline!with!the!ELISA!already!performed!on!the!nine!subjects.!This!enabled!a!direct!comparison!between!IFN^γ!of!standard!ELISA!results!and!IFN^γ!of!multiplex!assay!results! of! subject! 56! since! this! was! the! only! analyte! shared! between! the! two!experiments.!There!were!reasonably!similar!levels!of!IFN^γ!in!the!two!experiments!both! in! the! iNKT! cell! enriched! population! and! the! rest! of! PBMC! (differences! less!than!10%).!!!On! the! other! hand,! when! IL^4! was! tested! with! the! multiplex! assay! it! showed! a!considerable!level!of!production!(369pg/ml).!IL^4!was!not!tested!with!direct!ELISA!on! supernatant! of! enriched! iNKT! cells! since! it! showed! negative! results! in! all! the!supernatants!of!stimulated! iNKT!cells! in!mixed!populations!(Chapter!5.3.2.2).!The!difference! in! results! between! the! two! tests! cannot! be! attributed! to! the! high!sensitivity!of! the!Multiplex!test!since! IL^4!values!are!considerably!higher!than!the!low!point!of!the!dynamic!range!of!the!standard!ELISA!(around!10pg/ml).!Although!this!may! indicate! a! problem! in! the! standard! ELISA! test’s! ability! to!measure! IL^4,!other! possibilities! may! explain! this! discrepancy.! The! fact! that! positive! IL^4!production! was! tested! in! separated! cell! populations! may! indicate! that! the!separation! itself!may! have! resulted! in! the! increase! of! IL^4! production! from! iNKT!cells.!The!analytes!were!tested!at!day!15,!24!hours!after!separation!from!the!rest!of!PBMC.! This! is! enough! time! for! iNKT! cells! to! produce! these! amounts! of! IL^4!especially! with! the! fact! that! these! cells! are! know! to! produce! large! amounts! of!cytokines!in!short!time!(330)!.!!The!Multiplex! results!of! the! thirty! tested!analytes!were!divided! into! three!groups!according!to!their!levels!of!secretion!from!the!iNKT!cell!enriched!population.!These!groups!do!not!have!a! functional!or!physiological!significance!and!the!division!was!only!for!improving!the!presentation!of!a!large!number!of!analytes.!!!The! results! show! that! stimulated! iNKT! cells! produce! granzyme! B,! the! serine!protease! that! is! commonly! found! in! the! granules! of! cytotoxic! lymphocytes! and!
!!
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natural! killer! cells! (331)! .! In! target! cells! granzyme! B! promote! apoptosis! in! co^operation!with!another!protein,!perforin!(332)!and!this!may!be!the!role!of!produced!granzyme!B!in!the!stimulated!iNKT!cells.!In!lung!cancer!patients,!Konishi!et.al!have!shown!that!NKT!cells!have!cytotoxicity!against!cancer!cells!that!is!dependent!on!the!Granzyme! B/! perforin! pathway! and! independent! of! the! Fas/FasL! pathway! (333)! .!Interestingly,! this! effect!was! independent! of! CD1d! activation! and!may! show! that!NKT!cells!may!engage!in!direct!cytotoxicity!without!antigen!binding.!However,!this!may!not!be!the!only!cytotoxic!function!in!these!cells.!In!another!study!by!Wingender.
et.al!NKT!cells!had!antigenic^specific!cytotoxicity!as!well,!mediated!by!Fas/FasL!(334)!.! Granzyme! b! may! have! other! putative! roles! than! mediating! direct! cytotoxicity.!Recently!granzyme!B!was!shown!to!be!involved!in!inducing!inflammation!and!may!also!be!involved!in!autoimmune!diseases!(331)!.!!!The! enriched! iNKT! cell! multiplex! results! revealed! the! production! of! the! soluble!form!of!the!adhesion!molecule!ICAM^1!(sICAM).!Emoto!et!al!have!shown!that!NKT!cells! in!mice! express! both! ICAM^1! and! its! ligand! LFA^1! and! that! this! expression!plays!a!major!role!in!the!cells’!migration!to!specific!organs!such!as!liver!and!lymph!nodes.!Using!LFA^1!deficient!mice! they!were!able! to!show!a!dramatic!decrease! in!the!numbers!of!CD4+!NKT!liver!cells!(335)!.!The!soluble!form!of!this!molecule!(sICAM^1)!has!been!found!in!peripheral!blood!and!bronchoalveolar! lavage!fluid!of!asthma!and!allergic!rhinitis!patients!(336)!.!Another!study!has!also!shown!an!increased!level!of! circulating! sICAM^1! in! children! with! asthma! (337)! .! These! results! confirm! that!ICAM^1!is!an!important!molecule!in!iNKT!cell!migration!and!possibly!pathogenesis!in! allergic! diseases.! It! will! be! interesting! to! investigate! the! effect! of! TSLP!stimulation!on!expression!levels!and!secretion!of!this!marker.!!!The! results! also! showed! the! production! of! the! granulocyte^monocyte! colony!stimulating! factor!(GM^CSF)!but!not!any!of! the!granulocyte!specific!cytokines!(e.g.!G^CSF).! Hegde! et! al! have! looked! at! GM^CSF! production! from! NKT! cells! of! PBMC!purified!after!stimulation!with!?^GalCer.!They!found!increased!production!of!GM^CSF!that!is!dependent!on!?^GalCer!dose!(up!to!12!folds!increase!of!GM^CSF!for!?^
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GalCer! concentration!of!50ng/ml)! (338)! .! ! This! correlates!with! the!work!presented!here.! GM^CSF!was! also! shown! to! increase! in! different! allergic! diseases! including!asthma! (339)! .! Interestingly,!Hegde! et! al! propose! that!GM^CSF!produced! from!NKT!cells!may!play! a! role! in!pathogenesis!by!directing!monocytes! to!differentiate! into!dendritic! cells! rather! than! macrophages.! They! have! shown! that! combined!production!of! IL^13!and!GM^CSF! from!NKT!cells!direct!monocytes! to!differentiate!into! immature! dendritic! cells! and! thus! may! maintain! the! inflammatory! status!associated!with!many!autoimmune!and!allergic!diseases!(338)!.!!!Furthermore,! the! results! revealed! the! production! of! different! chemokines! from!iNKT!cell!enriched!populations.!Five!chemokines!where!shown!to!be!produced!by!combined!TSLP!and!KRN7000!stimulation!of!iNKT!cells.!CCL5!is!chemotactic!for!T!cells,! basophils! and! eosinophils! and! helps! to! recruit! these! leucocytes! into!inflammation!sites!(340)!.!Interestingly,!CCL5!was!also!shown!to!induce!formation!of!NK!cells! (341)! .! iNKT!cells! also!produced!CXCL9;!which! is,! similar! to!CCL5,! a!T^cell!chemokine! (342)! .! Another! chemokine! produced! by! enriched! iNKT! cells! is! IL^8,! a!chemokine! that! is! chemotactic! for! neutrophils! and! enhances! their! phagocytic!function! (343)! .! ! !Finally,! the!enriched!cells!also!produced!MCP^1!(CCL2)!and!CCL3,!which!are!chemoatractants!for!monocytes!and!neutrophils,!respectively.!The!closely!related! cell! type! NK! cells! produce! all! of! these! chemokines! (344)! ,! however! their!production!from!NKT!cells!is!unlikely!as!they!are!CD3!negative.!The!fact!that!these!chemokines! function! as! attractant! for! many! effector! cells! and! that! cytokine!production! from! iNKT! cells,! such! as! IFN^?! and! IL^4,! activate! these! effector! cells!may!suggest!a! role! for! iNKT!cells! in!both!recruiting!and!activating! these!different!effector!cells.!!The! multiplex! experiment! shows! some! results! expressing! discrepancies! that! are!difficult! to! interpret.! First! of! all! there! is! considerable! correlation! between! the!enriched!population!and!the!rest!of!PBMCs!both!in!positive!and!negative!outcomes!and!levels!obtained.!!Although!such!a!correlation!cannot!be!ruled!out!completely!it!needs! to!be! confirmed!with!multiple! testing!of! repeated!experiments! and!using!a!wider! panel.! Another! possibility!might! be! false! positives! generating! a! correlation!pattern.!This!may!rise!from!non^specific!binding!for!example.!This!may!explain!the!
!!
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results! showing!high!production!of!myeloperoxidase!enzyme! from!enriched! iNKT!cell!populations!to!levels!comparable!to!the!rest!of!PBMCs.!There!are!no!reports!for!the! production! of! this! enzyme! from! either! NK! or! NKT! cells!while! the! rest! of! the!PBMC!population!contains!monocytes!that!are!known!to!contain! large!amounts!of!myeloperoxidase! enzyme! (345)! .! Another! false! positive! may! arise! from! media!contamination.! For! example,! contamination! of! cell! culture! fluid! used! to! suspend!cells! in! both! populations! may! produce! similar! false! positives! and! can! lead! to!unexpected!results!and!unexpected!correlation!between!the!two!populations.!!!The! results! presented! here! show! relatively! wide! error! bars! that! represent! three!repeated!experiments!in!the!same!individual.!The!assay!itself!has!a!high!sensitivity!and!reproducibility!but!wider!error!bars!may!arise!from!true!sample!variability!or!from!reasons!of!false!positives!discussed!previously.!All!these!possibilities!need!to!be! investigated! further! for! a! full! confirmation! of! results! presented! here! and! this!may!be!the!subject!of!a!further!study.!!!! !
!!
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6.3.3!Cell!lines!
The! results! described!here! for! iNKT! cell! line! experiments!were! achieved!by!non^autologous!stimulation!of! the!cell! line^using!donor! irradiated!PBMC.!The!cell! lines!were!kindly!provided!by!Professor!Gadola!therefore!they!could!not!be!matched!to!feeder! cells.! This! shortcoming! was! addressed! by! only! stimulating! cells! in! the!absence!of!KRN7000!and!TSLP.!!!There!was!significant!production!of!IL^13!and!IFN^γ!when!cell!lines!were!stimulated!with!both!KRN7000!and!TSLP.!Although! significant! cytokine!production!has!been!detected,! this! may! not! represent! the! case! in! real! life! since! inCvivo! iNKT! cell!stimulation! is! achieved! through! autologous! antigen! presentation.! However,! in!cancer! patients! it! has! been! reported! that! monocyte^derived! DC! express! reduced!levels! of! cytokines! (346)! therefore! some! researchers! used! xenogenic!DC! instead! of!autologous!APC! to! test! the! function!of!NKT! cells! (347)! .! This,! however! can!only!be!used!in.vitro!since!murine!cells!can!not!result!in!expansion!of!human!NKT!cells.!The!use!of!the!non^autologous!APC!may!withstand!the!pitfall!of!allo!or!xenogeneic!cells!(348)! .! In! this! experiment! only! the! cytokine! production! function! of! iNKT! cells!was!investigated.! It! would! be! useful! for! future! studies! to! explore! the! effect! of! non^!autologous!APC!iNKT!cells!proliferation.!!As! mentioned! in! Chapter! 1,! cytokine! secretion! is! vital! to! the! immunoregulatory!function!of!iNKT!cells.!This!function!was!discussed!early!in!iNKT!cell!research!(349)!.!It!is!known!that!these!cells!are!capable!of!secreting!copious!amounts!of!cytokines!of!both!Th1!and!Th2!patterns!therefore!directing!the!immune!response!and!bridging!innate!and!adaptive!immunity.!The!secretion!of!at!last!two!cytokines,!IL^4!and!IFN^are!capable!of!secreting!copious!amounts!of!cytokines!of!both!Th1!and!Th2!patterns!therefore!directing!the!immune!response!and!bridging!innate!and!adregion!(350)!.!!Although! the! secretory! function! is! clearly! indispensable! for! the! role! of!NKT! cells,!the! full! cytokine! profile! NKT! cells! are! capable! of! releasing! is! still! lacking.! This! is!mainly!due!to!the!fact!that!majority!of!the!studies!focused!on!the!production!of!only!
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single!representative!Th1!and!Th2!cytokines,!IL^4!and!IFN^γ,!only!occasionally!was!data!also!provided!for!other!cytokines!such!as!IL^13!and!IL^33.!!Finally,! the! TSLP! effect!was! found! here! to! vary! between! individuals! this!may! be!attributed! to! the!highly! atopic!nature! of! these! individuals! since!TSLP! is! linked! to!allergic!conditions!such!as!asthma.!!!!It!should!be!mentioned!that!the!experimental!work!in!this!chapter!could!have!been!done!differently.!Ideally,!experiments!would!have!involved!more!sample!collection!at! 6,! 12! and! 24! hours! of! KRN7000! and! TSLP! stimulation.! ! Both! sample! size! and!financial! limitations! restricted! repeated! experiments! and! the! exploring! of! other!cytokine!production.!!! !
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Chapter!7!Discussion!
!!iNKT! cells! was! proven! to! bridge! the! innate! and! adaptive! immune! response! by!producing! large! amount! of! wide! variety! of! cytokines.! This! gives! these! cells! the!ability! to! induce!Th1,! Th2! or! Th17! type! of! cell! responses! as! discussed! in! section!1.6.4.!Furthermore,!they!are!subject!to!cytokine!signals!produced!from!other!cells!in!the!peripheral!blood!or!at!their!sites!of!action!in!inflammation!or!infection!sites!in!the!body!such!as!airways.!In!this!study!the!emphasis!of!the!work!presented!was!on!the! effect! of! TSLP! on! iNKT! cells! to! promote! a! special! type! of! cell! response! since!TSLP!was!implicated!in!Th2!tropism!in!different!studies!(309)!.!!The!first!approach!used!in!this!project!was!to!isolate!and!measure!iNKT!cell!number!in! ! the! blood! of! healthy! volunteers!which!would! facilitate! the! purpose! of! in.vitro.culturing!and!proliferation!of!these!cells..To!do!that!the!best!anti!Vα24!monoclonal!antibody!available!was!determined!for!the!rest!of!the!work!in!this!project.!This!was!the!Beckman!Coulter!PE!conjugate!and!the!PC7!conjugate!in!some!experiments.!The!normal! range! for! tested! healthy! volunteers! of! iNKT! cells! obtained! using! these!antibodies! were! between! 0.22%! ^! 0.96%! of! total! lymphocytes! of! PBMC.! This!correlates!with!what!has!been!reported!in!many!examples!of!the!iNKT!cell!literature!(351)! .! This! indicates! that! selection! criteria! for! healthy! volunteers! and! iNKT! cell!identification!methods!are!comparable!from!methods!used!in!iNKT!cells!research.!!iNKT! cells! used! in! later! experiments!were! proliferated! using! a! stimulation! assay!that!involved!adding!a!stimulatory!ligand!to!iNKT!cells!in!their!PBMC!environment.!This! increases! the! chance! that! iNKT! cells! receive! both! cellular! interactions! and!cytokine!signals!from!other!cells!within!the!PBMC!population!and!possibly!!a!closer!representation! to! their! in. vivo! environment.! Furthermore,! stimulation! by! simple!addition! of! ligand! to! PBMC! is! both! cheap! and! reproducible.! ! Researchers! used!different! method! to! stimulate! iNKT! cells! such! as! pulsed^ligand! experienced!dendritic!cells! (352)!or! ligand^loaded!CD1d!tetramers! (174)! .!These!methods!provide!
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opportunity! to! strictly! control! the! stimulation! conditions! however! they! lack! the!possibility! of! allowing! activation! in! the! context! of! a! broad! range! of! cytokine! and!cellular!interaction.!!Effective!proliferating!iNKT!cell!up!to!day!14!was!obtained!with!this!protocol!using!stimulation!with!100ng/ml!of!KRN7000!(section!3.4).!The!effectiveness!of!iNKT!cell!stimulation!was!measured!by!the!increase!in!their!numbers!as!a!percentage!of!total!lymphocytes!rather!than!fold!increase!since!it!was!found!to!be!more!accurate.!It!is!important!to!optimise!the!stimulation!test!to!ensure!that!even!minor!differences!of!stimulation,!if!present,!can!be!detected.!The!availability!of!relatively!small!number!of!subjects! in!comparing!stimulation!experiments!requires!a!highly!optimised!test!to!detect!a!statistically!significant!difference.!!The! PBMC! stimulation! test! was! successful! in! detecting! proliferation! response! of!iNKT!cells!to!KRN7000,!which!is!known!to!be!potent!stimulators!of!iNKT!cells.!Two!types!of!donor! iNKT!cell! response! to!KRN7000!where!observed.!Termed! low!and!high! responders,! they!were!defined! according! the! level! of! proliferation! at! day!14!(below!6%!or!above!6%!of!lymphocytes!for!low!and!high!responders,!respectively).!This! is! similar! to! results! from!other! studies! showing! to! presence! of! two! types! of!responses!to!KRN7000!(310)!.!All!these!facts!indicate!that!PBMC!stimulation!protocol!used!here!is!comparable!to!other!stimulation!tests!mentioned!in!the!literature.!!Surface!marker!analysis!of!proliferated! iNKT!cells,! from!different!donors!revealed!the! lack!of! expression!of! two!TLR! receptors! (TLR2!and!TLR4!as! in! section!4.4.6).!Different!studies!in!literature!indicate!the!importance!of!TLR!agonists!produced!by!pathogens! in! iNKT! cells! activation,! such! as! in! visceral! leishmaniasis! (353)! .! Others!indicate! that! this! is! due! to! a! TLR! agonist! effect! on! APCs! that! in! turn! leads! to!activated!iNKT!cells!rather!than!direct!effect!on!iNKT!cells!(354)!.!This!correlates!with!the!lack!of!TLR!expression!on!the!stimulated!iNKT!cells!in!this!study.!Interestingly,!this! highlights! again! the! importance! of! studying! iNKT! cells! in! a! heterogeneous!cellular! mixture! such! as! PBMC,! which! allows! for! broad! cellular! interaction! and!cytokine!production.!!
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When! other! markers! of! iNKT! cells! were! investigated! they! showed! similar!expression! and! distribution! to! other! stimulation! approaches! mentioned! in! the!literature.! In! this! study,! iNKT! cells! increased! expression! of! CD161,! decreased!expression! of! CD3! and! maintained! the! level! of! CD4! expression! while! they!proliferated!upon!stimulation!with!KRN7000.!All!these!changes!correlate!with!other!researchers!work!using!different!stimulation!approach.!This!indicates!again!that!the!stimulation! test! described! here! is! not! widely! different! from! other! researchers!stimulation!tests.!!InkT! cell! proliferation! in! this! system! did! not! lead! to! changes! in! distribution! of!subpopulations!of!iNKT!cells!such!as!CD4+!and!CD4^!ones.!This!suggested/indicates!that! at! least! phenotypically,! the! of! KRN7000! has! a! neutral! proliferative! effect! on!iNKT! cell! subtype! leading! to! equal! proliferation! of! each! type.! It! is! important! to!maintain! this! neutrality! in! order! for! any! added! ligand,! such! as! TSLP,! to! exert! its!effects! efficiently! especially! if! that! effect! is! limited! to! a! certain! subpopulation! of!iNKT!cells.!!!Investigation! of! surface!markers! also! revealed! for! the! first! time! on! human! iNKT!cells! the!expression!of!TSLP! receptor!on! iNKT!cells.!The! four!donors! investigated!expressed! TSLPr! in! iNKT! cells! at! day0! (mean! expression! at! day! 0! was! 0.08%).!Furthermore,! it! was! shown! that! this! receptor! was! upregulated! upon! stimulation!with! KRN7000! (mean! expression! at! day! 14! was! 8.4%).! TSLPr! was! investigated!using!monoclonal!anti^TSLPr!antibodies!and!FACSCalibur.!There!are!many!reports!on!the!effect!of!TSLP!on!iNKT!cells!in!diseases!such!as!rheumatoid!arthritis!(305)!and!atopic!dermatitis!(162)!.!However,!the!presence!of!TSLP!receptor!indicates!a!possible!direct!interaction!between!TSLP!and!its!receptor!TSLPr!on!iNKT!cells.!!!When! iNKT!cells!were! co^stimulated!with!a! combination!of!KRN7000!and!TSLP!a!statistically!significant!increase!in!proliferation!was!apparent!in!both!low!and!high!responders!(section!5.3.1!and!5.3.1.1).!Furthermore,!there!was!increase!in!cytokine!production!especially!so!called!Th2!type.!IL^13!(which!is!a!Th2!cytokine)!and!IL^17!(which! is! Th17! cytokine)! showed! statistically! significant! increase! after! combined!KRN7000!and!TSLP!stimulation!especially!in!high!responding!individuals.!However,!
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IL^4!levels!were!all!under!the!detection!limit!of!the!assay.!Interestingly,!IFN^γ!had!levels! that! increased! after! the! combined! stimulation.! Although! IFN^γ! is! a! Th1!cytokine!it!was!reported!that!iNKT!cells!produce!high!levels!of! it!after!stimulation!and!this!high!production!has!been!!linked!to!many!pathological!effects!of!these!cells!in!some!diseases!such!as!Helminths.and!other!parasites!infections!(186)!.!The!increase!in!IFN^γ!secretion!after!combined!stimulation!could!a!way!to!counter!act!a!possible!allergic!inflammation!as!was!found!in!the!airway!of!asthma!models!(318)!.!!!The!work! in! this!study!shows!the!ability!of!TSLP!to!affect! iNKT!cells!proliferation!and!cytokine!production.!This!effect!was!universal!in!all!donors!regardless!of!their!response! type! to! KRN7000! stimulation.! TSLP! increased! the! proliferative! effect! of!KRN7000! and! iNKT! cells! production! of! some! cytokines!was! increased! as!well.! It!could! be! postulated! that! iNKT! cells! pathology! in! allergic! reactions! may! function!through!the!effect!of!TSLP!on!these!cells,!probably!through!a!direct!interaction!since!this! work! have! also! demonstrated! the! up^regulation! of! TSLPr.! According! to! this,!high! responders! are! hypothesized! to! demonstrate! stronger! effects! from! TSLP!stimulation! since! they! show! increased! iNKT! cells! proliferation! numbers! and!cytokine!production!compared!to!low!responders.!!!It!will!be!highly!interesting!for!a!further!study!to!assess!this!hypothesis.!The!iNKT!cells!contribution!to!the!diseases! in!this!regard!can!be!tested! in!atopic!patients!of!known! iNKT! cells! involvement! such! as! asthma,! allergic! rhinitis! and! atopic!dermatitis.!One!example!is!to!investigate!whether!patients!with!these!diseases!are!all!high!responders!to!KRN7000!stimulation.!The!presence!of!increased!proportion!of!high!responders!in!an!atopic!population!would!support!this!hypothesis.!!!There! is! variability! in! the! response! to!KRN7000! stimulation!between! individuals.!!However,!since!KRN7000!is!a!potent!stimulator!it!may,!in!comparison!to!a!weaker!natural!or!pathologic! ligand,!produce!an! increase! in! iNKT!cells!or! an!emphasis! in!their!response!that!the!natural!ligand!by!itself!may!fail!to!produce.!!It!is!important!to!investigate!whether!there!is!an!atopy!in!certain!individuals!when!they!are!high!responders!to!KRN7000!and!have!elevated!TSLP.!High!responders!in!
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the! presence! of! pathological! ligand!may! have! increased! iNKT! cell! activation! and!cytokine! production! that! leads! to! Th2! polarised! response! found! in! many! atopic!diseases.!However!this!needs!to!be!tested!with!physiological!ligands!which!have!not!yet!been!defined.!Also,!in!asthma!patient!the!increased!effect!in!TSLP!could!be!due!to!less!production!in!IFN^γ.!!!One!of!the!ultimate!aims!in!iNKT!cell!research!is!the!therapeutic!use!of!proliferated!and! enriched! iNKT! cells! to! treat! many! diseases,! especially! cancer.! KRN7000! has!been!successfully!used!as!a!stimulator!to!iNKT!cells,!however!the!verity!of!response!within! individuals! puts! a! limitation! to! it.! In! this! study! it! was! shown! that! the!combined!TSLP!and!KRN7000!stimulated!cells!are!responded!with!increased!iNKT!cells!proliferation,!a!highly!desirable!effect.!This!increased!was!also!effective!in!low!responders!subjects.!This!may!counter!act!the!limitation!of!KRN7000!stimulation!in!low! responders.!Many! researchers!have! investigated!methods! to!proliferate! iNKT!cells!for!its!clinical!usage!and!the!method!described!here!is!an!important!one!since!it! affects! universally! all! donors! and! could! potentially! help! to! reduce! negative!treatment!outcomes!for!some!individuals.!!!Furthermore,! although! TSLP! promotes! Th2! type! of! cytokine! production! it! also!induced! IFN^γ! secretion,!which!may! provide!more! balanced,! rather! than,! skewed!response! type.! Finally,! it! is! vitally! important! that! the! proliferated! cells! are! not!functionally!compromised!so!they!can!be!used!as!therapy!and!the!work!presented!here! could! provide! a! proof! that! the! stimulated! and! proliferated! cells! are! still!functional.!!The! fact! that! iNKT! cells! are! a! source! of! cytokine! was! further! confirmed! in!experiments!using!both!enriched!iNKT!cells!(section!6.3.1.2!)!and!an!iNKT!cell!line!(section! 6.3.2).! Again! the! addition! of! TSLP,! as! well! as! ! KRN7000,! increased! the!production! of! cytokines! especially! Th2! such! as! IL^13! and! also! the! production! of!IFN^γ.!!!The! opportunity! provided! here! to! have! a! sample! measured! in! the! cytokine!multiplex!multi!bead!assay!shed!a!light!on!wider!range!of!chemokine,!cytokine!and!
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even!some!enzymes!that!have!been!detected!from!enriched!iNKT!cells.!The!results!obtained!were!very! interesting.!However,! the! financial! restriction!and! the! sample!limitations!prevented! further! and!more! structured!experiments! to!determine!any!statistically! significance! extended! outcome! in! the! results! shown.! Such! an!experiment!may!be!a!valuable!future!piece!of!work.!!!In!summary,!the!work!performed!here!showed!that!iNKT!cells!express!TSLPr,!which!is! especially! apparent! at! day! 14! of!KRN7000! stimulation.! Also,! TSLP! significantly!increased!iNKT!cells!numbers!in!PBMC!in!healthy!donors!when!combined!to!iNKT!cells!specific!glycolipid!antigen!KRN7000.!This!finding!!supports!the!possibility!that!iNKT!cells!!have!a!crucial!role!in!many!allergic!diseases!especially!when!combined!with! glycolipid! antigen.! This! leads! to! the! possibility! of! having! natural! glycolipid!ligand!that!is!presented!to!iNKT!cells!in!the!presence!of!TSLP,!either!in!the!lungs!in!asthma!or!in!the!skin!as!in!atopic!dermatitis,!which!makes!certain!individual!more!susceptible!to!these!allergic!diseases.!!!!!!!!
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